Target detection using temperature-controlled probes
M-Tec Probes enable rapid and accurate detection and quantification of multiple genetic targets by using enzyme-modified oligonucleotide components, addressing the limitations of current methods with simplified analysis.
Patent Information
- Application Number
- BR112025024805
- Authority / Receiving Office
- BR · BR
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-15
- Filing Date
- 2024-03-22
- Publication Date
- 2026-11-10
AI Technical Summary
Current methods for detecting and quantifying multiple targets in genetic analysis are slow, complex, and often require specialized software for interpretation, limiting their applicability and accuracy in clinical settings.
The use of multi-component controlled temperature probes (M-Tec Probes) that consist of at least two oligonucleotide components, where one is modified by an enzyme in the presence of a specific target, allowing for the generation of a detectable signal at a defined temperature, enabling simultaneous detection and quantification of multiple targets at a single wavelength.
M-Tec Probes facilitate rapid, simplified, and accurate detection and quantification of multiple targets without the need for complex algorithms, enhancing the efficiency and precision of genetic analysis.
Abstract
Description
[0001] The present invention relates generally to the field of molecular biology. More specifically, the present invention provides oligonucleotides and methods for their use in the detection and / or differentiation of targets. The oligonucleotides and methods find particular application in the amplification, detection, differentiation and / or quantification of multiple targets simultaneously. Incorporation by Reference
[0002] This application claims priority over Australian provisional application number 2023901468, filed on 15 May 2023, the full content of which is incorporated herein by reference. BACKGROUND
[0003] Any discussion of the state of the art throughout the descriptive report should in no way be considered as an admission that such state of the art is widely known or forms part of common general knowledge in the field.
[0004] Genetic analysis is routinely used in the clinic to assess disease risk, diagnose diseases, predict prognosis or patient response to therapy, and monitor patient progress. The introduction of such genetic testing depends on the development of simple, inexpensive, and rapid assays to differentiate genetic variations.
[0005] In vitro nucleic acid amplification methods have wide application in genetics and disease diagnosis. Such methods include polymerase chain reaction (PCR), reverse transcription polymerase chain reaction (RTPCR), quantitative polymerase chain reaction (qPCR), strand displacement amplification (SDA), cleavage enzyme amplification reaction (NEAR), helicase-dependent amplification (HDA), recombinant polymerase amplification (RPA), loop-mediated isothermal amplification (LAMP), amplification Petition 870250103739, dated 12 / 11 / 2025, pp. 385 / 635 2 / 184 by rolling circle amplification (RCA), transcription-mediated amplification (TMA), self-sustaining sequence replication (3SR), nucleic acid sequence-based amplification (NASBA), Ligase Chain Reaction (LCR), or Branching Amplification Method (RAM). Most of these target amplification strategies require the use of oligonucleotide primer(s). In most protocols, the amplification process results in the accumulation of amplicons that incorporate the oligonucleotide primers at their 5' ends of each strand and that contain newly synthesized copies of the sequences located between the primers.
[0006] One method for monitoring amplicon accumulation in real time, or at the conclusion of amplification, involves detection using PlexZymes, also known in the literature as Multicomponent Nucleic Acid Enzymes or MNAzymes. PlexZymes have been previously described for cleaving probes that are universal double-labeled substrates that have a linear or hairpin conformation. Linear substrates were the first type of reporter probes described for MNAzymes / PlexZymes and can be considered “standard” substrates or probes. PlexZyme substrates with hairpins are known in the art as LOCS (Loops Connected to Stems) probes or PlexPlus probes. LOCS probes have specific features that allow control of signal generation through temperature manipulation.Other methods, systems, and probe types for monitoring amplicon accumulation in real time, or at the conclusion of amplification, include specific target molecular beacons, sloppy beacons, binary DNA probes (also known as universal molecular beacons), Eclipse probes, TaqMan probes or hydrolysis probes, Scorpion Uni or Bi probes, catchers and pitchers for TOCE technology, dual hybridization probes, double-stranded probes (Yin-Yang probes), and / or the use of intercalating dyes such as SYBR Green.
[0007] Fusion curve analysis can be performed during or at the conclusion of several of these protocols to obtain additional information, since double-stranded nucleic acid molecules with different sequences denature in Petition 870250103739, dated 12 / 11 / 2025, pp. 386 / 635 3 / 184 different temperatures, known as melting temperatures or Tm. Such protocols measure melting curves that result from a) separation of the two strands of double-stranded amplicons in the presence of an intercalating dye, or b) separation of one strand of the amplicon and a target-specific complementary probe labeled with a fluorophore and a suppressor, or c) separation of duplexes unrelated to the target, for example, Catcher duplexes that are generated only in the presence of the target. Analysis of the melting curve provides information on the dissociation kinetics of two strands of nucleic acid during heating. The melting temperature (Tm) is the temperature at which 50% of the double-stranded nucleic acid molecules have dissociated. Tm depends on the length, sequence composition, and GC content of the paired nucleotides.The elucidation of information about the target DNA or RNA from melting curve analysis conventionally involves a series of fluorescence measurements acquired at small temperature intervals, typically over a wide temperature range. In some protocols, the derivative of this curve is then plotted as a function of temperature to obtain the melting curve. The melting temperature does not depend solely on the sequence of nucleic acid strands. Tm can be influenced by many factors, including the type of nucleic acid (DNA, RNA, LNA, or others), the concentrations of oligonucleotides, cations in the buffer (both monovalent (Na+) and divalent (e.g., Mg2+) salts), and / or the presence or absence of destabilizing agents such as urea or formamide.
[0008] Fusion curve analysis protocols are often slow and typically take 30 to 60 minutes to complete. Furthermore, fusion curve analyses may require interpretation by subject matter experts and / or the use of specialized software to interpret the results. Therefore, there is a high demand for faster and / or less complex alternatives to fusion curve analyses. Additionally, fusion curves are typically analyzed post-PCR and therefore only allow for a qualitative determination of the presence or absence of a target in a sample. In many cases, a determination Petition 870250103739, dated 12 / 11 / 2025, pp. 387 / 635 4 / 184 quantitative or semi-quantitative determination of the amount of genomic material present in a sample is necessary. Therefore, there is a great demand for rapid alternatives to fusion curve analysis that also provide quantitative information about a sample.
[0009] Hairpin probes or Stem-Loop probes have proven to be useful tools for nucleic acid detection and / or monitoring target amplification. One type of hairpin probe, which is doubly labeled with a fluorophore and suppressor dye pair, is commonly known in the art as a Molecular Beacon. In general, these molecules have three features: 1) a stem structure formed by hybridization of the complementary 5' and 3' ends of the oligonucleotide; 2) a loop region that is complementary to the target, or target amplicon, to be detected; and 3) a pair of fluorophore suppressor dyes attached to the ends of the Molecular Beacon. During PCR, the loop region binds to amplicons due to complementarity, causing the stem to open, thus separating the fluorophore suppressor dye pair.A key feature of molecular beacons is that the loop regions of these molecules remain intact during amplification and are not degraded or cleaved in the presence of the target or target amplicons. Separation of the dye pair attached to the terminals of an open molecular beacon causes a change in fluorescence, which is indicative of the presence of the target to which it is hybridized. The method is commonly used for multiplex analysis of multiple targets in a single PCR assay. In general, for multiplex analysis, each molecular beacon has a target-specific loop region and a unique fluorophore, so that the hybridization of each of the different molecular beacons for each amplicon species can be monitored in a separate channel, i.e., at a separate wavelength.One disadvantage of molecular beacons is that careful design and optimization of the reaction temperature are necessary to balance the transition between the hairpin conformation and the linear conformation adopted when the molecular beacons bind to the target.
[0010] The concept of Molecular Beacons has been extended in a strategy Petition 870250103739, dated 12 / 11 / 2025, pp. 388 / 635 5 / 184 known as Sloppy Beacons. In this protocol, the loop region of a single Beacon is long enough to tolerate mismatched bases and therefore bind to multiple closely related targets that differ by one or more nucleotides. After amplification, fusion curve analysis is performed, and different target species can be differentiated based on the temperature at which each of the duplexes formed by hybridization of the target species with the loop region of a Sloppy Beacon separates (fuses). In this way, several closely related species can be detected at a single wavelength and simultaneously differentiated by characterizing the fusion profile of specific targets with the single Sloppy Beacon. Standard Molecular Beacons and Sloppy Beacons differ from TaqMan and Hydrolysis probes in that they are not designed to be degraded or cleaved during amplification.One disadvantage of DNA hybridization-based technologies, such as sloppy beacons and TOCE, is that they can produce false-positive results due to non-specific hybridization between probes and non-target nucleic acid sequences.
[0011] In general, the number of available fluorescence channels capable of monitoring discrete wavelengths limits the number of targets that can be specifically detected and identified in a single reaction in a fluorescent reader. Recently, three protocols have been described that allow the detection and quantification of two or more targets at a single wavelength. The first protocol, known as “Tagging Oligonucleotide Cleavage and Extension” (TOCE), uses the Thrower and Catcher oligonucleotides. Throwers have two regions: the target portion, which is complementary to the target, and the tag portion, which is non-complementary and located at the 5' end. The Catcher oligonucleotide is doubly tagged and has a region at its 3' end that is complementary to the tag portion of the Thrower.During amplification, the pitcher binds to amplicons, and when primers extend the activity of the 5'-3' exonuclease polymerase, it can cleave the tag portion of the pitcher. The released tag portion then binds to the oligonucleotide. Petition 870250103739, dated 12 / 11 / 2025, pp. 389 / 635 6 / 184 The Catcher molecule functions as a primer to synthesize a complementary strand. The melting temperature of the double-stranded Catcher molecule (Caughter-Tm) then acts as a surrogate marker for the original template. Because it is possible to incorporate multiple Catchers with different sequences and lengths, all of which melt at different temperatures, it is possible to obtain a range of Catcher-Tm values, indicative of a range of targets, while still measuring at a single wavelength. Limitations of this approach include inherent complexity, as it requires the released fragment to initiate and complete a second extension on an artificial target, and post-amplification analysis of multiple targets requires complex algorithms to differentiate or quantify the signal proportion related to each specific target.The method measures fluorescence at various temperatures; however, at the lowest temperature, all double-stranded catcher molecules fluoresce, giving a combined signal to all targets. At the highest temperature at which fluorescence is acquired, only one double-stranded catcher molecule, which has the highest Tm, will remain as a double strand and therefore exhibit fluorescence. An algorithm is then needed to determine the contribution of one or more targets detected in the reaction.
[0012] In the second protocol, several LOCS reporters can be combined in the same reaction to measure multiple targets at a single wavelength. Intact LOCS reporters or probes contain a stem region, labeled with a pair of fluorophore suppressor dyes at each terminus, and a loop region comprising a substrate for an enzyme. In the presence of a target, the substrate can be cleaved or hydrolyzed, resulting in split LOCS structures. Enzymes suitable for mediating target-dependent substrate modification include catalytic nucleic acids, such as PlexZymes and DNAzymes, or protein enzymes, such as exonucleases or endonucleases. The melting temperatures of the stem regions of intact LOCS (Tm of intact LOCS) are higher than those of the resulting split LOCS (Tm of split LOCS), since intramolecular bonds are stronger than intermolecular bonds. Both LOCS Petition 870250103739, dated 12 / 11 / 2025, pp. 390 / 635 7 / 184 Both intact and split LOCS will either suppress or generate fluorescence, depending on whether the reaction medium temperature is above or below the melting temperature of their stems. The presence of fluorescence at temperatures below the Tm of intact LOCS, but above the Tm of split LOCS, is indicative of the presence of the target, which facilitates cleavage. The target can be detected directly, or amplicons produced by target amplification protocols can be detected. Multiple LOCS reporters can be combined to facilitate the detection of multiple targets at a single wavelength in a single reaction. In these reactions, all LOCS are labeled with dyes that can be monitored at the same wavelength; however, each has a stem designed to melt at a different temperature, and each has a handle that can only be cleaved in the presence of its specific target.In real-time PCR, specific fluorescence for two LOCs / two targets can be acquired at two temperatures, where a lower temperature is defined as suitable for measuring the fluorescence associated with the Split LOC only with the lower Tm probe. A second, higher temperature is suitable for measuring the combined signal for high and low Tm Split LOCs, but will not generate fluorescence from either LOC probe when intact.
[0013] Recently, a third approach has been described, which allows the detection of multiple targets at a single wavelength in real time, without the need for an algorithm to determine the contribution of one or more targets. The method combines LOCS reporters with other types of probes, for example, Molecular Beacons in unique reactions where probe pairs are labeled with fluorophores that produce fluorescence in the same channel. In a format at the first detection temperature, the Molecular Beacon can bind to a first target, causing spatial separation of the fluorophore and the suppressor and an increase in fluorescence. At a second, higher detection temperature, where it cannot bind to its target or form a suppressed hairpin, the Molecular Beacon can adopt a random spiral structure, which contributes only to the level Petition 870250103739, dated 12 / 11 / 2025, pp. 391 / 635 8 / 184 background fluorescence constant that is present regardless of the presence or absence of the first target. The LOCS reporter was designed to be cleaved in the presence of a second target and to have a Split LOCS Tm that is above the first detection temperature but below the second detection temperature. Thus, at the first temperature, the LOCS reporter remains suppressed regardless of the presence or absence of the second target, but causes increased fluorescence at the higher temperature if there is target-dependent cleavage of the Intact LOCS.In general, the Molecular Beacon is fluorescent at the first, lower detection temperature if the first target is present, and the LOCS is suppressed regardless of the presence or absence of the second target; whereas at the second, higher detection temperature, the Molecular Beacon contributes to background fluorescence at a constant level, which is not affected by the presence or absence of the first target, and the LOCS is fluorescent only if the second target is present. Thus, each temperature measures changes in fluorescence associated with only one probe type in the presence of a target, and therefore no algorithm is needed to determine a specific signal for each target and probe type.Although this protocol is advantageous and flexible, it uses Molecular Beacons or other types of probes that generally have restrictive design requirements regarding temperature; and / or may involve the use of specific reagents, including, for example, polymerases that do not have exonuclease activity.
[0014] There is a need for improved compositions and methods for the simultaneous detection, differentiation and / or quantification of multiple unique amplicons generated by PCR or by alternative target amplification protocols at a single wavelength.
[0015] One objective of the present invention is to overcome or improve at least one of the disadvantages of the prior art, or to provide a useful alternative. BRIEF DESCRIPTION OF THE INVENTION
[0016] This document provides methods and compositions that Petition 870250103739, dated 12 / 11 / 2025, pp. 392 / 635 9 / 184 expand the capabilities of multiplex target analysis. The present invention relates to methods and compositions for the detection and quantification of multiple targets at a single wavelength. These methods and compositions employ multi-component controlled temperature probes, referred to herein as M-Tec Probes. By way of example, M-Tec Probes are multi-component complexes composed of at least two oligonucleotide components wherein a first oligonucleotide component (OC1) connected to a first detection fraction is capable of being modified by an enzyme only in the presence of a specific target and a second oligonucleotide component (OC2) is labeled with a second detection fraction. The first oligonucleotide component comprises a first capture region capable of hybridization with the second oligonucleotide component by complementary base pairing to form a double-stranded portion.The region or position susceptible to enzymatic modification is located in OC1 between the first capture region and the first detection fraction. In some examples, OC1 is not directly labeled with more than one detection fraction. The first and second oligonucleotide components are capable of hybridizing together at temperatures below the melting temperature (Tm) of the double-stranded portion (Tm OC1 / OC2). The first oligonucleotide component is directly labeled with the first detection fraction or, alternatively, has a second region of complementarity with a third oligonucleotide component (OC3) that is directly labeled with a first detection fraction. If present, a third oligonucleotide component is capable of hybridizing with the first oligonucleotide component at temperatures below the Tm of the complementary regions (Tm OC1 / OC3).If this temperature is higher than Tm OC1 / OC2, then at temperatures below Tm OC1 / OC2 all oligonucleotide components in a complex will be hybridized. The first and second detection fractions may be, for example, a fluorophore and a suppressor or vice versa.
[0017] When all oligonucleotide components are hybridized, and the Petition 870250103739, dated 12 / 11 / 2025, pp. 393 / 635 10 / 184 The first oligonucleotide component is not modified, the fluorophore and suppressor remain close together, resulting in intact M-Tec Probe complexes that are suppressed. In the presence of the target that the M-Tec Probe is designed to detect, a sensing region of the first oligonucleotide component is modified, for example, by cleavage or hydrolysis by an enzyme. Enzymatic modification of the sensing region of the first oligonucleotide component generates a first fragment comprising the first capture region and a second fragment connected to the first detection fraction, thus allowing the first and second detection fractions to spatially separate and generate a first detectable signal. The first detectable signal can be distinguished from the background signal under the measurement conditions.In other words, modification of the sensing region causes the separation of the first capture region from the region of the first oligonucleotide component connected to the first detection fraction. When the present disclosure refers to two detection fractions that are spatially separated and generate a detectable signal, it will be understood that the detection fractions are spatially separated from each other, which allows one of the detection fractions to generate a detectable signal. When the present disclosure refers to the first and second detection fractions being capable of generating a detectable signal, it will be understood that only one of the detection fractions (i.e., the first or the second detection fraction) needs to emit a detectable signal, and that the emission is detectable due to the spatial separation of both detection fractions. In this sense, the first and second detection fractions are capable of generating a detectable signal, even if only one of the fractions emits the detectable signal.For example, the first detection fraction could be a fluorophore and the second detection fraction could be a suppressor; both detection fractions are capable of generating a detectable signal by spatial separation such that the fluorophore emits a detectable fluorescence signal. In some examples, the first and second detection fractions separate permanently or irreversibly, generating a detectable signal that is detectable within a defined temperature range. (By way of...) Petition 870250103739, dated 12 / 11 / 2025, pp. 394 / 635 11 / 184 For example, the modification of the sensing region occurs at a position between the detection fractions, so that it causes the separation of the fluorophore and the suppressor. Resulting target-dependent detectable signals, for example, increases in fluorescence, can be measured at temperatures below Tm OC1 / OC2. At temperatures above Tm OC1 / OC2, the first oligonucleotide component, or first fragment thereof, dissociates from the second oligonucleotide component, and the detection fractions are separated. The resulting fluorescence contributes to the observed background fluorescence in a way that is constant, regardless of the presence or absence of the target that the M-Tec probe was designed to detect.At this temperature, the second oligonucleotide component will no longer hybridize with the unmodified first oligonucleotide component in reactions where no target is present, or with a first hydrolyzed / cleaved fragment of the first oligonucleotide component that has been modified in the presence of the target.
[0018] In this way, M-Tec probes will generate target-dependent increases in fluorescence at temperatures below Tm OC1 / OC2, but no change in fluorescence will be observed, regardless of the presence or absence of the target, at temperatures above Tm OC1 / OC2.
[0019] Several types of M-Tec probes are disclosed and exemplified. One type of M-Tec probe is suitable for modification / cleavage by a PlexZyme (i.e., an MNAzyme). These probes, referred to herein as M-Tec-P probes, have a sensing region in OC1 that can serve as a substrate for a PlexZyme. In some embodiments, an OC2 hybridizes with a capture region of OC1 that does not hybridize / bind to the substrate binding arms of the PlexZyme. The M-Tec-P probe can bind to the substrate binding arms of a PlexZyme when it assembles in the presence of its specific target. Cleavage of the OC1 sensing region of the M-Tec-P probe results in the generation of a first fragment and a second fragment of OC1 and, therefore, in the separation of the fluorophore and the suppressor. At temperatures below Tm OC1 / OC2, an increase in Petition 870250103739, dated 12 / 11 / 2025, pp. 395 / 635 12 / 184 fluorescence is indicative of the presence of the target, which facilitated the assembly of PlexZyme. At temperatures above Tm OC1 / OC2, no change in fluorescence is observed, regardless of the presence or absence of the target. In addition to PlexZymes, M-Tec-P probes can also be cleaved by other types of DNA- or RNA-based enzymes, for example, deoxyribozymes (i.e., DNAzymes), aptazimes, or ribozymes. Because the enzymatic cleavage mechanism is not mediated by a protein enzyme, these M-Tec-P probes can be used for direct target detection in reactions that do not involve in vitro target amplification. In some embodiments, M-Tec-P probes can be used in detection protocols that are devoid of any protein enzymes.
[0020] Another type of M-Tec probe is suitable for cleavage by exonuclease activity, for example, the 5'-3' exonuclease of Taq polymerase, in the presence of the target. In these probes, referred to herein as M-Tec-H probes, the OC1 sensor region includes a sequence that is complementary to the target to be detected. In some embodiments, OC2 hybridizes with a region of OC1 that does not hybridize / bind to the target. During PCR, OC1 binds to the target amplicons and is hydrolyzed by the exonuclease activity of the polymerase, resulting in the generation of a first fragment and a second fragment and the separation of the fluorophore and suppressor. At temperatures below the Tm OC1 / OC2, an increase in fluorescence is indicative of the presence of the target. At temperatures above the Tm OC1 / OC2, no change in fluorescence will be observed, regardless of the presence or absence of the target.In some embodiments, hydrolysis of the first oligonucleotide component produces a first fragment that retains the ability to form the first double-stranded portion by hybridization with the second oligonucleotide component.
[0021] Another type of M-Tec probe is suitable for cleavage by endonuclease activity, for example, a cutting endonuclease in the presence of the target. In these probes, referred to herein as M-Tec-E probes, the region Petition 870250103739, dated 12 / 11 / 2025, pp. 396 / 635 The OC1 sensor includes a sequence that is complementary to the target to be detected. In some embodiments, OC2 hybridizes with a region of OC1 that does not hybridize / bind to the target. The OC1 of the M-Tec-E probe can bind to the target and form a double-strand recognition site for a cleavage enzyme. This enzyme can then cleave OC1, resulting in the generation of a first fragment and a second fragment and the separation of the fluorophore and suppressor, leaving the target intact. At temperatures below Tm OC1 / OC2, an increase in fluorescence is indicative of the presence of the target. At temperatures above Tm OC1 / OC2, no change in fluorescence will be observed, regardless of the presence or absence of the target. In other scenarios, the M-Tec probe can be cleaved by a restriction enzyme that cleaves both strands of a duplex.In some embodiments, M-TecE probes are suitable for use in methods where there is direct target detection, i.e., in reactions that are not subjected to in vitro amplification. In other embodiments, M-Tec-E probes are suitable for use in conjunction with in vitro amplification. Isothermal in vitro amplification protocols can utilize any endonuclease compatible with the reaction temperature. When in vitro amplification involves thermocycling, for example PCR, thermostable endonucleases may be preferred. In some embodiments, a first fragment generated from the cleavage of OC1 by the endonuclease retains the ability to form the first double-stranded portion by hybridization with the second oligonucleotide component.
[0022] In some embodiments, M-Tec Probes are used in combination with LOCS Probes. In other embodiments, M-Tec Probes can be combined with other types of probes and substrates well known in the art, which include, but are not limited to, linear double-labeled PlexZyme substrates, TaqMan probes or Hydrolysis probes, Molecular Beacons, Sloppy Beacons, Eclipse probes, Scorpion Uni-Probes or Bi-Probes, Catcher / Thrower oligonucleotides, double-stranded probes (Yin-Yang probes) and double hybridization probes. Petition 870250103739, dated 12 / 11 / 2025, pp. 397 / 635 14 / 184
[0023] Combining an M-Tec probe with other probe or substrate types allows for greater multiplexing capability, where multiple targets can be detected, identified, and / or quantified at a single wavelength. For example, an M-Tec probe, along with one or more LOCS probes, both incorporating the same detection fraction (e.g., the same fluorophore), can be used to individually differentiate multiple targets within a single reaction. The approach involves measuring the signal generated by the probes at discrete temperatures. In some embodiments, a first target is measured at a first temperature by monitoring any changes in fluorescence associated with the modification of an M-Tec probe, and a second target is measured at a second temperature by monitoring any changes in fluorescence associated with the modification of one of the LOCS probes.
[0024] This disclosure relates to at least the following embodiments:
[0025] Embodiment 1. Method for determining the presence or absence of a target in a sample, the method comprising: (a) preparing a mixture for a reaction by contacting the sample or a derivative thereof that purportedly comprises the target with: - a temperature-controlled multicomponent probe comprising a first oligonucleotide component and a second oligonucleotide component, wherein the first oligonucleotide component comprises a first capture region capable of hybridization with the second oligonucleotide component by complementary base pairing to form a first double-stranded portion, wherein the first oligonucleotide component further comprises a sensor region capable of serving as a substrate for an enzyme, wherein the first oligonucleotide component is connected to a first detection fraction and the second oligonucleotide component is Petition 870250103739, dated 12 / 11 / 2025, pp. 398 / 635 15 / 184 connected to a second detection fraction; - an enzyme capable of modifying the sensor region of the first oligonucleotide component only when the target is present in the sample; (b) treat the mixture under suitable conditions so that the enzyme modifies the sensing region of the first oligonucleotide component to generate a first fragment comprising the first capture region and a second fragment connected to the first detection fraction, thereby allowing the first and second detection fractions to spatially separate and generate a first detectable signal; (c) measure a background signal level or detectable signal generated at a defined temperature at or below which the first capture region is hybridized with the second oligonucleotide component; and (d) determine the presence or absence of the target based on the level of detectable signal measured at the defined temperature, where a detectable signal at the defined temperature is indicative of the presence of the target in the sample.
[0026] Embodiment 2. Method according to Embodiment 1, wherein the enzyme is able to digest the sensor region of the first oligonucleotide component only when the target is present in the sample, and wherein step (b) comprises treating the mixture under suitable conditions for the enzyme to digest the sensor region of the first oligonucleotide component in order to generate a first fragment comprising the first capture region and a second fragment connected to the first detection fraction.
[0027] Modality 3. Method, according to Modality 1 or Modality 2, wherein the method comprises: (i) measure a background signal level or detectable signal generated by the first and second detection fractions in the mixture at the defined temperature - at a time prior to or during the aforementioned treatment of the mixture, and - at one or more subsequent time(s) during or after said treatment of the mixture; and Petition 870250103739, dated 12 / 11 / 2025, pp. 399 / 635 16 / 184 (ii) determine the presence of or a change in the level of the detectable signal that differs from the background signal and is indicative of the presence of the target in the sample.
[0028] Modality 4. Method, according to Modality 3, wherein step (c) comprises the measurement of the detectable signal and / or any referred background signal: - at one or more times prior to the aforementioned treatment; - at one or more points during the aforementioned treatment; - at one or more points after the aforementioned treatment; - at one or more points during said treatment and at one or more points after said treatment; - at one or more times before the aforementioned treatment and at one or more times after the aforementioned treatment; or - at one or more times before and during said treatment and at one or more times after said treatment.
[0029] Modality 5. Method, according to Modality 3 or Modality 4, wherein step (d) comprises the use of a predetermined threshold value to determine whether the detectable signal differs from any said background signal at the defined temperature.
[0030] Modality 6. Method, according to Modality 1 or Modality 2, further comprising measuring a background control signal level generated at the defined temperature in a control mixture, and wherein step (c) comprises measuring a background or detectable signal level in the mixture in contact with the sample or derived therefrom, and wherein step (d) comprises determining whether a detectable signal that differs from the background control signal is generated and indicative of the presence of the target in the sample.
[0031] Modality 7. Method, according to Modality 1 or Modality 2, additionally comprising: to measure a background control signal level generated at temperature Petition 870250103739, dated 12 / 11 / 2025, pp. 400 / 635 17 / 184 defined in a control mixture, and determine whether the level of the control background signal measured in the control mixture differs from the level of the background signal or detectable signal measured in the mixture in step (c), wherein a difference in the level of the background signal or detectable signal measured in the mixture in step (c) compared with the level of the control background signal measured in the control mixture is indicative of the presence of the target in the sample.
[0032] Embodiment 8. Method, according to Embodiment 6 or Embodiment 7, wherein the control mixture does not comprise the target, but is otherwise equivalent to the mixture.
[0033] Embodiment 9. Method, according to Embodiment 6 or Embodiment 7, wherein the control mixture does not comprise the enzyme, but is otherwise equivalent to the mixture.
[0034] Modality 10. Method, according to Modality 1 or Modality 2, additionally comprising: to measure a level of detectable control signal generated at the defined temperature in a control mixture, wherein the control mixture comprises a predetermined quantity of the target, but is otherwise equivalent to the mixture; and to determine whether the level of detectable control signal measured in the control mixture differs from the level of background signal or detectable signal measured in the mixture in step (c), wherein a difference in the level of background signal or detectable signal measured in the mixture in step (c) compared with the level of detectable control signal measured in the control mixture is indicative of the presence and / or quantity of the target in the sample.
[0035] Embodiment 11. Method, according to any of Embodiments 1 to 10, wherein the target is a nucleic acid and at least a portion of the sensor region hybridizes with a complementary sequence in the target to thereby form a duplex between the sensor region and the target. Petition 870250103739, dated 12 / 11 / 2025, pp. 401 / 635 18 / 184
[0036] Embodiment 12. Method, according to Embodiment 11, in which the enzyme is an endonuclease that recognizes a sequence in the duplex.
[0037] Modality 13. Method, according to Modality 12, in which the endonuclease digests at least one strand of the duplex to form, thereby, the first and second fragments.
[0038] Embodiment 14. Method, according to Embodiment 12, wherein the endonuclease is a cutting endonuclease that digests the sensor region of the first oligonucleotide component after duplex formation in order to form the first and second fragments.
[0039] Embodiment 15. Method, according to Embodiment 11, wherein the enzyme is an exonuclease that hydrolyzes the sensor region of the first oligonucleotide component after duplex formation to form the first and second fragments.
[0040] Embodiment 16. Method, according to Embodiment 15, wherein the exonuclease is a polymerase with exonuclease activity.
[0041] Modality 17. Method, according to Modality 16, wherein - the target is a nucleic acid, - at least a portion of the sensor region hybridizes with a complementary sequence in the target to form a duplex between the sensor region and the target, - the said mixture further comprises a target primer capable of binding to the target in a region upstream of said complementary sequence, The aforementioned treatment of the mixture includes: Hybridization of the target primer with the target by complementary base pairing, extending the primer using a polymerase with exonuclease activity and using the nucleic acid target as a template, where the polymerase comprising exonuclease activity digests the sensor region of the first oligonucleotide component after the formation of the Petition 870250103739, dated 12 / 11 / 2025, pp. 402 / 635 19 / 184 duplex to form, thus, the first and second fragments.
[0042] Modality 18. Method, according to any of the Modalities 1 to 10, in which the enzyme is a DNA enzyme.
[0043] Embodiment 19. Method, according to any of Embodiments 1 to 10, in which the target is a nucleic acid and the sensing region of the first oligonucleotide component is not complementary to the target.
[0044] Embodiment 20. Method, according to any of Embodiments 1 to 10 or 19, wherein the target is a nucleic acid and the enzyme is a multicomponent nucleic acid enzyme (MNAzyme) comprising two partzyme oligonucleotides capable of self-assembling to form the MNAzyme only in the presence of the target.
[0045] Modality 21. Method, according to Modality 20, in which the aforementioned treatment comprises: Hybridize the MNAzyme sensor arms to the target by complementary base pairing, and hybridize MNAzyme substrate arms with at least a portion of the sensor region of the first oligonucleotide component by complementary base pairing to facilitate cleavage of the first oligonucleotide component and generation of the first and second fragments.
[0046] Modality 22. Method, according to any of Modalities 1 to 21, in which the target is a nucleic acid.
[0047] Modality 23. Method, according to Modality 22, in which the target is an amplicon of a nucleic acid.
[0048] Modality 24. Method, according to Modality 23, wherein the amplicon is produced by an amplification reaction selected from the group consisting of polymerase chain reaction (PCR), strand displacement amplification (SDA), cleavage enzyme amplification reaction (NEAR), helicase-dependent amplification (HDA), recombinant polymerase amplification (RPA), loop-mediated isothermal amplification (LAMP), amplification Petition 870250103739, dated 12 / 11 / 2025, pp. 403 / 635 20 / 184 by rolling circle (RCA), transcription-mediated amplification (TMA), self-sustaining sequence replication (3SR), nucleic acid sequence-based amplification (NASBA), ligase chain reaction (LCR) or branching amplification method (RAM), and reverse transcription polymerase chain reaction (RT-PCR).
[0049] Mode 25. Method, according to Mode 24, in which the aforementioned detection: - occurs before said amplification or within 1, 2, 3, 4, or 5 cycles of the start of said amplification; and / or - occurs after the aforementioned amplification is complete.
[0050] Modality 26. Method, according to any of the Modalities to 25, in which the said determination of the presence or absence of the target comprises an analysis of the fusion curve.
[0051] Modality 27. Method, according to any of the Modalities 1 to 10, where: The enzyme is either a DNA enzyme or a ribozyme that requires a cofactor for catalytic activity. The aforementioned treatment of the mixture involves the use of suitable conditions for: The cofactor binds to DNA enzyme or ribozyme to make it catalytically active, the DNA enzyme or ribozyme hybridizes to the first oligonucleotide component by complementary base pairing, the DNA enzyme or ribozyme becomes catalytic in digesting the first oligonucleotide component and generating the first fragment and the second fragment, and The target is the cofactor.
[0052] Embodiment 28. Method according to Embodiment 27, wherein the cofactor is a metal ion, such as a metal ion selected from: Mg2+, Mn2+, Petition 870250103739, dated 12 / 11 / 2025, pp. 404 / 635 21 / 184 Ca2+ and Pb2+.
[0053] Modality 29. Method, according to any of the Modalities 1 to 10, wherein the enzyme is an aptazyme in which: - the sensory region comprises a substrate for an aptazime; - the target is an analyte, protein, peptide, compound, or nucleic acid; - the mixture comprises an aptazime comprising an aptamer capable of binding to the target; and The aforementioned treatment of the mixture additionally includes binding the aptazyme to the target and the sensor region to facilitate the cleavage of the first oligonucleotide component, thereby generating the first fragment and the second fragment.
[0054] Modality 30. Method for determining the presence or absence of a target in a sample, the method comprising: (a) preparing a mixture for a reaction by contacting the sample or a derivative thereof that purportedly comprises the target with: - a temperature-controlled multicomponent probe comprising a first oligonucleotide component and a second oligonucleotide component, wherein the first oligonucleotide component comprises a first capture region capable of hybridization with the second oligonucleotide component by complementary base pairing to form a first double-stranded portion, wherein the first oligonucleotide component further comprises a sensor region capable of serving as a substrate for an enzyme, wherein the first oligonucleotide component is connected to a first detection fraction and the second oligonucleotide component is connected to a second detection fraction; - an enzyme capable of modifying the sensory region of the first Petition 870250103739, dated 12 / 11 / 2025, pp. 405 / 635 22 / 184 oligonucleotide component only when the target is present in the sample; (b) treat the mixture under suitable conditions so that the enzyme modifies the sensing region of the first oligonucleotide component to generate a first fragment comprising the first capture region and a second fragment connected to the first detection fraction, thus allowing the first and second detection fractions to spatially separate and generate a first detectable signal; (c) measure a level of detectable signal generated at a plurality of temperatures, including temperatures below and above a temperature at which the first capture region hybridizes with the second oligonucleotide component; and (d) determine the presence or absence of the target based on the presence or absence of a change in the detectable signal generating a melting curve peak, wherein the absence of a melting curve peak is indicative of the presence of the target in the sample and the presence of a melting curve peak is indicative of the absence of the target in the sample.
[0055] Modality 31. Method, according to any of the Modalities 1 to 30, in which the second oligonucleotide component is directly labeled with the second detection fraction.
[0056] Modality 32. Method, according to any of Modalities 1 to 31, in which the first fragment is not directly marked with a detection fraction.
[0057] Modality 33. Method, according to any of Modalities 1 to 32, in which the second fragment is not directly marked with the first detection fraction.
[0058] Modality 34. Method, according to any of the Modalities 1 to 33, in which the first oligonucleotide component is not directly labeled with the first detection fraction.
[0059] Modality 35. Method, according to any of the Modalities 1 Petition 870250103739, dated 12 / 11 / 2025, pp. 406 / 635 23 / 184 to 34, wherein the first oligonucleotide component is connected to the first detection fraction by means of a third oligonucleotide component, wherein the first oligonucleotide component additionally comprises a second capture region capable of hybridization with the third oligonucleotide component by complementary base pairing to form a second double-stranded portion, and the third oligonucleotide component is directly labeled with the first detection fraction.
[0060] Embodiment 36. Method, according to Embodiment 35, wherein the first double-tape portion and the second double-tape portion of the temperature-controlled multicomponent probe have a melting temperature (Tm) that is above the defined temperature.
[0061] Modality 37. Method, according to Modality 35 or Modality 36, where the Tm of the first double-stranded portion is less than the Tm of the second double-stranded portion.
[0062] Modality 38. Method, according to Modality 35 or Modality 36, where the Tm of the second double-strand portion is less than the Tm of the first double-strand portion.
[0063] Embodiment 39. Method, according to any of Embodiments 1 to 31, in which the first oligonucleotide component is directly labeled with the first detection fraction.
[0064] Modality 40. Method, according to any of the Modalities 1 to 39, in which the temperature-controlled multicomponent probe comprises no more than two detection fractions.
[0065] Modality 41. Method, according to any of the Modalities 1 to 40, in which the first oligonucleotide component is not directly labeled with more than one detection fraction.
[0066] Modality 42. Method, according to any of the Modalities 1 Petition 870250103739, dated 12 / 11 / 2025, pp. 407 / 635 24 / 184 to 41, where the first oligonucleotide component is not connected to more than one detection fraction.
[0067] Embodiment 43. Method, according to any of Embodiments 1 to 42, in which the second oligonucleotide component is not directly labeled with more than one detection fraction.
[0068] Modality 44. Method, according to any of the Modalities 1 to 43, in which the second oligonucleotide component is not connected to more than one detection fraction.
[0069] Modality 45. Method, according to any of the Modalities 1 to 44, where: The first detection fraction is a fluorophore and the second detection fraction is a suppressor; or the first detection fraction is a suppressor, and the second detection fraction is a fluorophore.
[0070] Modality 46. Method, according to any of the Modalities 1 to 45, where: the first detection fraction is a fluorophore and the second detection fraction is a suppressor; or the first detection fraction is a suppressor, and the second detection fraction is a fluorophore; and where the temperature-controlled multicomponent probe comprises no more than one suppressor.
[0071] Modality 47. Method, according to any of the Modalities 1 to 46, where: the first detection fraction is a fluorophore and the second detection fraction is a suppressor; or the first detection fraction is a suppressor, and the second detection fraction is a fluorophore; and in which the detectable signal is the fluorescence emitted in the presence of Petition 870250103739, dated 12 / 11 / 2025, pp. 408 / 635 25 / 184 target.
[0072] Embodiment 48. Method, according to any of Embodiments 1 to 47, wherein neither the first oligonucleotide component, nor the second oligonucleotide component, nor the third oligonucleotide component serves as a primer for a DNA polymerase in an extension reaction.
[0073] Embodiment 49. Method, according to any of Embodiments 1 to 48, wherein neither the first oligonucleotide component, nor the second oligonucleotide component, nor the third oligonucleotide component serves as a template for a DNA polymerase in an extension reaction.
[0074] Embodiment 50. Method, according to any of Embodiments 1 to 49, in which neither the second oligonucleotide component nor the third oligonucleotide component is enzymatically cleaved or degraded.
[0075] Modality 51. Method, according to any of the Modalities 1 to 50, in which the sensing region is located between the first capture region and the first detection fraction.
[0076] Embodiment 52. Method, according to any of Embodiments 1 to 51, in which after the said treatment of the mixture, the first fragment is able to hybridize with the second oligonucleotide component through the first capture region.
[0077] Modality 53. Method, according to any of Modalities 1 to 52, in which the biological sample is obtained from an individual.
[0078] Modality 54. Method, according to any of the Modalities 1 to 53, in which the generation of the detectable signal at the defined temperature is not reversible.
[0079] Modality 55. Method, according to any of the Modalities 1 to 54, in which the method is performed in vitro.
[0080] Modality 56. Method, according to any of the Modalities 1 to 55, in which the method is performed ex vivo.
[0081] Modality 57. Method for determining the presence or absence of a first target and a second target in a sample, the method comprising: Petition 870250103739, dated 12 / 11 / 2025, pp. 409 / 635 26 / 184 (a) prepare a mixture for a reaction by contacting the sample or a derivative thereof that purportedly comprises the first and / or second target with: - a temperature-controlled multicomponent probe for first target detection, the temperature-controlled multicomponent probe comprising a first oligonucleotide component and a second oligonucleotide component, wherein the first oligonucleotide component comprises a first capture region capable of hybridization with the second oligonucleotide component by complementary base pairing to form a first double-stranded portion, wherein the first oligonucleotide component further comprises a sensor region capable of serving as a substrate for an enzyme, wherein the first oligonucleotide component is connected to a first detection fraction and the second oligonucleotide component is connected to a second detection fraction, - a second nucleic acid probe for detection of the second target, the second nucleic acid probe comprising third and fourth detection fractions, wherein the first and second detection fractions are capable of generating a first detectable signal, and the third and fourth detection fractions are capable of generating a second detectable signal, and - a first enzyme capable of modifying the sensor region of the first oligonucleotide component only when the first target is present in the sample; (b) treat the mixture under suitable conditions to: - the first enzyme to modify the sensor region of the first oligonucleotide component in order to generate a first fragment that Petition 870250103739, dated 12 / 11 / 2025, p. 410 / 635 27 / 184 comprises the first capture region and a second fragment connected to the first detection fraction, thus allowing the first and second detection fractions to spatially separate and generate a first detectable signal. - the second target to induce a modification of the second nucleic acid probe, thus allowing the third and fourth detection fractions to spatially separate and generate a second detectable signal; (c) measure a background or detectable signal level: - at an initial temperature at or below which the first capture region is hybridized with the second oligonucleotide component, - at a second temperature equal to or higher than that at which the first capture region is not hybridized with the second oligonucleotide component, (d) determine whether at one or more time points during or after said treatment: - a first detectable signal is generated at or below the first temperature at which the first capture region is hybridized with the second oligonucleotide component, - A second detectable signal resulting from the aforementioned modification of the second nucleic acid probe is generated at the second temperature, where the second detectable signal is indicative of the presence of the second target in the sample.
[0082] Embodiment 58. Method according to Embodiment 57, wherein the first enzyme is able to digest the sensor region of the first oligonucleotide component only when the first target is present in the sample, and wherein step (b) comprises treating the mixture under suitable conditions for the first enzyme to digest the sensor region of the first oligonucleotide component in order to generate a first fragment comprising the first capture region and a second fragment connected to the first detection fraction.
[0083] Modality 59. Method, according to Modality 57 or Modality 58, in which a first detectable signal at the first temperature is indicative of the presence of the first target in the sample. Petition 870250103739, dated 12 / 11 / 2025, page 411 / 635 28 / 184
[0084] Modality 60. Method, according to Modality 59, in which the presence of the first target is determined at the first temperature based on the first detectable signal generated at the first temperature.
[0085] Modality 61. Method, according to any of Modalities 57 to 60, in which the presence of the second target is determined at the second temperature based on the second detectable signal generated at the second temperature.
[0086] Modality 62. Method, according to Modality 57 or Modality 58, in which: (i) at the first temperature - a first detectable signal is generated in the presence of the first target, - a second detectable signal is generated in the presence of the second target, or - a first detectable signal and a second detectable signal are generated in the presence of both the first target and the second target; and (ii) a second detectable signal is generated at the second temperature only in the presence of the second target.
[0087] Modality 63. Method, according to Modality 62, in which the presence of the first target is determined by subtracting any second detectable signal detected at the second temperature from any first and / or second detectable signal detected at the first temperature.
[0088] Modality 64. Method, according to any of the Modalities 57 to 63, wherein the method comprises: - to measure a background signal level or detectable signal at the first and second temperatures generated by the first and second detection fractions and by the third and fourth detection fractions in the mixture, - to determine the presence or a change in the level of the first detectable signal that differs from the background signal and is indicative of the presence of the first target in the sample, and - to determine the presence or a change in the level of the second detectable signal resulting from the aforementioned modification generated in the second temperature that Petition 870250103739, dated 12 / 11 / 2025, pp. 412 / 635 29 / 184 differs from the background signal and is indicative of the presence of the second target in the sample.
[0089] Embodiment 65. Method, according to any of Embodiments 57 to 64, in which at the second temperature, the dissociation of the second oligonucleotide component from the capture region of the first oligonucleotide component present in the absence of the first target, or of the first fragment generated by modification of the first oligonucleotide component in the presence of the first target, generates an equal, similar or equivalent background signal.
[0090] Modality 66. Method, according to any of Modalities 57 to 65, wherein the said determination comprises the detection of the first detectable signal and / or of any said background signal: - at one or more times before the aforementioned treatment - at one or more points during the aforementioned treatment; - at one or more points after the aforementioned treatment; - at one or more points during said treatment and at one or more points after said treatment; - at one or more times before the aforementioned treatment and at one or more times after the aforementioned treatment; or - at one or more times before and during said treatment and at one or more times after said treatment.
[0091] Modality 67. Method, according to any of Modalities 57 to 66, wherein the determination in part (d) comprises: - use a predetermined threshold value to determine whether the first detectable signal differs from any given background signal at the first temperature; and / or - Use a predetermined threshold value to determine if the second detectable signal differs from any given background signal at the second temperature.
[0092] Modality 68. Method, according to any of the Modalities 57 to 63, which comprises: to measure the level of the first background control signal at the first temperature provided by the first and second detection fractions and by the third Petition 870250103739, dated 12 / 11 / 2025, pp. 413 / 635 30 / 184 and fourth detection fractions in a control mixture; to measure a second background control signal level at the second temperature provided by the first and second detection fractions and by the third and fourth detection fractions in the control mixture; to determine whether a level of the first detectable signal generated at the first temperature in step (c) in the mixture in contact with the sample or derived therefrom differs from the level of the first background control signal measured in the control mixture, wherein a difference in the level of the detectable signal measured in the mixture at the first temperature in step (c) compared with the first background control signal measured in the control mixture is indicative of the first target in the sample; and to determine whether a level of the second detectable signal generated at the second temperature in step (c) in the mixture in contact with the sample or derived therefrom differs from the level of the second background control signal measured in the control mixture, wherein a difference in the level of the detectable signal measured in the mixture at the second temperature in step (c) compared with the second background control signal measured in the control mixture is indicative of the second target in the sample.
[0093] Embodiment 69.Method, according to Modality 68, in which the control mixture does not comprise: - the first target; - the second target; or - the first and second targets, but otherwise equivalent to the mixture.
[0094] Embodiment 70. Method, according to Embodiment 68, wherein the control mixture does not comprise the first enzyme, but is otherwise equivalent to the mixture.
[0095] Modality 71. Method, according to any of the Modalities 57 to 63, additionally comprising: to measure the level of the first detectable control signal generated at the first temperature in a control mixture, wherein the control mixture comprises Petition 870250103739, dated 12 / 11 / 2025, pp. 414 / 635 31 / 184 a predetermined quantity of the first target, the second target, or the first and second targets, but otherwise equivalent to the mixture; to measure a detectable second control signal level generated at the second temperature in the control mixture; To determine whether a level of the first detectable signal generated at the first temperature in step (c) in the mixture in contact with the sample or derived therefrom differs from the level of the first detectable control signal measured in the control mixture, wherein a difference in the level of the detectable signal measured in the mixture at the first temperature in step (c) compared with the first detectable control signal measured in the control mixture is indicative of the first target in the sample; and to determine whether a level of the second detectable signal generated at the second temperature in step (c) in the mixture in contact with the sample or derived therefrom differs from the level of the second detectable control signal measured in the control mixture, wherein a difference in the level of the detectable signal measured in the mixture at the second temperature in step (c) compared with the second detectable control signal measured in the control mixture is indicative of the second target in the sample.
[0096] Modality 72.Method, according to any of the Embodiments 57 to 67, wherein part (c) comprises measuring a first background signal at or within 1 °C, 2 °C, 3 °C, 4 °C or 5 °C of the first temperature, and a second background signal at or within 1 °C, 2 °C, 3 °C, 4 °C or 5 °C of the second temperature.
[0097] Modality 73. Method, according to Modality 72, wherein part (d) comprises determining whether at one or more times during or after said treatment: A first detectable signal is generated at the first temperature that differs from the first background signal and is indicative of the presence of the first target in the sample; and Petition 870250103739, dated 12 / 11 / 2025, pp. 415 / 635 32 / 184 a second detectable signal is generated at the second temperature, which differs from the second background signal and is indicative of the presence of the second target in the sample.
[0098] Mode 74. Method, according to any of Modes 57 to 73, in which at the first temperature the third and fourth detection fractions do not generate a signal that differs from the background signal.
[0099] Mode 75. Method, according to any of Modes 57 to 74, in which at the second temperature the first and second detection fractions do not generate a signal that differs from the background signal.
[00100] Modality 76. Method, according to any of Modalities 57 to 75, in which the first and second detectable signals are detectable by a single detector.
[00101] Modality 77. Method, according to any of Modalities 57 to 76, in which the first and second detectable signals are detectable in the same fluorescence channel.
[00102] Modality 78. Method, according to any of the Modalities 57 to 77, in which the first and second detectable signals are detectable as fluorescent emission at a single wavelength.
[00103] Modality 79. Method, according to any of the Modalities 57 to 78, wherein the first and second detection fractions, and the third and fourth detection fractions emit a detectable signal at the same wavelength or at a similar wavelength, which can be detected in the same fluorescence channel.
[00104] Embodiment 80. Method, according to any of Embodiments 57 to 79, in which the second oligonucleotide component is directly labeled with the second detection fraction.
[00105] Modality 81. Method, according to any of Modalities 57 to 80, in which the first fragment is not directly marked with a detection fraction. Petition 870250103739, dated 12 / 11 / 2025, pp. 416 / 635 33 / 184
[00106] Modality 82. Method, according to any of the Modalities 57 to 81, in which the second fragment is not directly marked with the first detection fraction.
[00107] Embodiment 83. Method, according to any of Embodiments 57 to 82, in which the first oligonucleotide component is not directly labeled with the first detection fraction.
[00108] Embodiment 84. Method, according to any of Embodiments 57 to 83, wherein the first oligonucleotide component is connected to the first detection fraction by means of a third oligonucleotide component, wherein the first oligonucleotide component additionally comprises a second capture region capable of hybridization with the third oligonucleotide component by complementary base pairing to form a second double-stranded portion, and the third oligonucleotide component is directly labeled with the first detection fraction.
[00109] Embodiment 85. Method, according to Embodiment 84, wherein the first double-tape portion and the second double-tape portion of the temperature-controlled multicomponent probe have a Tm that is above the first temperature.
[00110] Embodiment 86. Method, according to Embodiment 84 or Embodiment 85, wherein the first double-tape portion and / or the second double-tape portion of the temperature-controlled multicomponent probe have a Tm that is below the second temperature.
[00111] Modality 87. Method, according to any of Modalities 84 to 86, in which the Tm of the first double-strand portion is less than the Tm of the second double-strand portion.
[00112] Modality 88. Method, according to any of the Modalities 84 to 86, in which the Tm of the second portion of double tape is less than the Tm of the Petition 870250103739, dated 12 / 11 / 2025, pp. 417 / 635 34 / 184 first portion of double tape.
[00113] Embodiment 89. Method, according to any of Embodiments 57 to 80, in which the first oligonucleotide component is directly labeled with the first detection fraction.
[00114] Modality 90. Method, according to any of the Modalities 57 to 89, in which the temperature-controlled multicomponent probe comprises no more than two detection fractions.
[00115] Embodiment 91. Method, according to any of Embodiments 57 to 90, in which the first oligonucleotide component is not directly labeled with more than one detection fraction.
[00116] Modality 92. Method, according to any of the Modalities 57 to 91, in which the first oligonucleotide component is not connected to more than one detection fraction.
[00117] Embodiment 93. Method, according to any of Embodiments 57 to 92, in which the second oligonucleotide component is not directly labeled with more than one detection fraction.
[00118] Embodiment 94. Method, according to any of Embodiments 57 to 93, in which the second oligonucleotide component is not connected to more than one detection fraction.
[00119] Embodiment 95. Method, according to any of Embodiments 57 to 94, in which the second nucleic acid probe is directly labeled with the third and fourth detection fractions.
[00120] Embodiment 96. Method, according to any of Embodiments 57 to 94, in which the second nucleic acid probe is not directly labeled with the third and fourth detection fractions.
[00121] Modality 97. Method, according to any of the Modalities 57 to 96, where: The first detection fraction is a fluorophore and the second detection fraction is a suppressor; or Petition 870250103739, dated 12 / 11 / 2025, pp. 418 / 635 35 / 184 the first detection fraction is a suppressor, and the second detection fraction is a fluorophore. Modality 98. Method, according to any of the Modalities 57 to 97, where: the first detection fraction is a fluorophore and the second detection fraction is a suppressor; or the first detection fraction is a suppressor, and the second detection fraction is a fluorophore; and where the temperature-controlled multicomponent probe comprises no more than one suppressor.
[00122] Modality 99. Method, according to any of the Modalities 57 to 98, where: the first detection fraction is a fluorophore and the second detection fraction is a suppressor; or the first detection fraction is a suppressor, and the second detection fraction is a fluorophore; and where the first detectable signal is fluorescence emitted in the presence of the first target.
[00123] Embodiment 100. Method, according to any of Embodiments 57 to 99, wherein neither the first oligonucleotide component, nor the second oligonucleotide component, nor the third oligonucleotide component serves as a primer for a DNA polymerase in an extension reaction.
[00124] Embodiment 101. Method, according to any one of Embodiments 57 to 100, wherein neither the first oligonucleotide component, nor the second oligonucleotide component, nor the third oligonucleotide component serves as a template for a DNA polymerase in an extension reaction.
[00125] Embodiment 102. Method, according to any of Embodiments 57 to 101, in which neither the second oligonucleotide component nor the third oligonucleotide component is enzymatically cleaved or degraded. Petition 870250103739, dated 12 / 11 / 2025, pp. 419 / 635 36 / 184
[00126] Modality 103. Method, according to any of the Modalities 57 to 102, in which the sensing region is located between the first capture region and the first detection fraction.
[00127] Modality 104. Method, according to any of the Modalities 57 to 103, in which after the said treatment the first fragment is able to hybridize with the second oligonucleotide component through the first capture region.
[00128] Modality 105. Method, according to any of the Modalities 57 to 104, where: The third detection fraction is a fluorophore and the fourth detection fraction is a suppressor; or the third detection fraction is a suppressor, and the fourth detection fraction is a fluorophore.
[00129] Embodiment 106. Method, according to any of Embodiments 57 to 105, wherein the first target is a nucleic acid and at least a portion of the sensor region hybridizes with a complementary sequence in the first target to form, thereby, a duplex between the sensor region and the first target.
[00130] Modality 107. Method, according to Modality 106, in which the first enzyme is an endonuclease that recognizes a sequence in the duplex.
[00131] Modality 108. Method, according to Modality 107, in which the endonuclease digests the duplex to form the first and second fragments.
[00132] Embodiment 109. Method, according to Embodiment 107, wherein the endonuclease is a cutting endonuclease that digests the sensor region of the first oligonucleotide component after duplex formation in order to form the first and second fragments.
[00133] Embodiment 110. Method, according to Embodiment 106, wherein the first enzyme is an exonuclease that hydrolyzes the sensor region of the first oligonucleotide component after duplex formation to form, thereby, the Petition 870250103739, dated 12 / 11 / 2025, pp. 420 / 635 37 / 184 first and second fragments.
[00134] Embodiment 111. Method according to Embodiment 110, wherein the exonuclease is a polymerase with exonuclease activity.
[00135] Embodiment 112. Method according to Embodiment 111, wherein - the first target is a nucleic acid, - at least a portion of the sensor region hybridizes with a complementary sequence in the first target to form, thus, a duplex between the sensor region and the first target, - the said mixture further comprises a first target primer capable of binding to the first target in a region upstream of said complementary sequence, The aforementioned treatment of the mixture includes: Hybridization of the first target primer with the first target by complementary base pairing, primer extension using polymerase with exonuclease activity, and use of the first target as a template, where the polymerase comprising exonuclease activity digests the sensor region of the first oligonucleotide component after duplex formation.
[00136] Modality 113. Method, according to any of the Modalities 57 to 105, in which the first enzyme is a DNA enzyme.
[00137] Embodiment 114. Method, according to any of Embodiments 57 to 105, in which the first target is a nucleic acid and the sensing region of the first oligonucleotide component is not complementary to the first target.
[00138] Embodiment 115. Method, according to any of Embodiments 57 to 105 or 114, wherein the first target is a nucleic acid and the first enzyme is a first multicomponent nucleic acid target enzyme (MNAzyme) comprising two partzyme oligonucleotides capable of self-assembling to form the first MNAzyme target only in the presence of the first target. Petition 870250103739, dated 12 / 11 / 2025, pp. 421 / 635 38 / 184
[00139] Modality 116. Method, according to Modality 115, in which the aforementioned treatment comprises: Hybridize the sensor arms of the first target MNAzyme with the first target by complementary base pairing, and hybridize the substrate arms of the first target MNAzyme with at least a portion of the sensor region of the first oligonucleotide component by complementary base pairing to facilitate the cleavage of the first oligonucleotide component and the generation of the first and second fragments.
[00140] Modality 117. Method, according to any of the Modalities 57 to 116, in which: - the second nucleic acid probe is a substrate for a second target multicomponent nucleic acid enzyme (MNAzyme), the second target MNAzyme comprising two partzyme oligonucleotides capable of self-assembling to form the second target MNAzyme only in the presence of the second target; The mixture additionally includes: The second target MNAzyme is only able to cleave the second nucleic acid probe when the second target is present in the sample; The aforementioned treatment additionally includes: Hybridize the sensor arms of the second target MNAzyme with the second target by complementary base pairing, and hybridize the substrate arms of the second target MNAzyme with the second nucleic acid probe by complementary base pairing to facilitate the cleavage of the second nucleic acid probe, thus providing said modification to the second nucleic acid probe and allowing the third and fourth detection fractions to spatially separate and generate the second detectable signal.
[00141] Embodiment 118. Method according to Embodiment 117, wherein the second nucleic acid probe is a stem-loop oligonucleotide comprising a stem portion of hybridized nucleotides, strands Petition 870250103739, dated 12 / 11 / 2025, pp. 422 / 635 39 / 184 opposite which are linked by an uninterrupted single-stranded loop portion of unhybridized nucleotides, all or part of which is complementary to the substrate arms of the second target MNAzyme.
[00142] Embodiment 119. Method according to Embodiment 118, wherein the stem-loop oligonucleotide is an intact stem-loop oligonucleotide and said modification comprises cleaving the loop portion and forming a split stem-loop oligonucleotide.
[00143] Modality 120. Method, according to any of the Modalities 57 to 116, where: The second target is a nucleic acid. - the second nucleic acid probe is a stem-loop oligonucleotide comprising a double-stranded stem portion of hybridized nucleotides, the opposite strands of which are linked by an unbroken single-stranded loop portion of non-hybridized nucleotides, all or part of which is complementary to the second target, - the mixture additionally comprises a polymerase with exonuclease activity, The aforementioned treatment of the mixture involves the use of suitable conditions for: Hybridization of the second target with the single-stranded loop portion of the stem-loop oligonucleotide by complementary base pairing to form a first double-stranded sequence comprising a portion of the second target; hybridization of a primer with the second target to form a second double-stranded sequence located upstream relative to the first double-stranded sequence comprising a portion of the second target; extension of the primer using the polymerase with exonuclease activity and using the second target as a template, wherein the polymerase comprising exonuclease activity digests the single-stranded loop portion of the first double-stranded sequence and thus forms a... Petition 870250103739, dated 12 / 11 / 2025, pp. 423 / 635 40 / 184 split loop-stem oligonucleotide.
[00144] Modality 121. Method, according to any of the Modalities 57 to 116, in which: The second target is a nucleic acid. - the second nucleic acid probe is a stem-loop oligonucleotide comprising a double-stranded stem portion of hybridized nucleotides, the opposite strands of which are linked by an unbroken single-stranded loop portion of non-hybridized nucleotides, all or part of which is complementary to the second target, The mixture additionally includes an endonuclease, and The aforementioned treatment of the mixture involves the use of suitable conditions for: Hybridization of the second target with the single-stranded loop portion of the stem-loop oligonucleotide by complementary base pairing to form a double-stranded sequence comprising a portion of the second target, association of the endonuclease with the double-stranded sequence comprising a portion of the second target, and catalytic activity of the endonuclease allowing it to digest the single-stranded loop portion of the double-stranded sequence and thus form a split-stem-loop oligonucleotide.
[00145] Modality 122. Method, according to any of the Modalities 118 to 121, in which: - the stem portion of the intact stem-loop oligonucleotide has a melting point (Tm) that is higher than the Tm of the stem portion of the split stem-loop oligonucleotide; - the first temperature is below the Tm of the stem portion of the intact stem-loop oligonucleotide and the stem portion of the split stem-loop oligonucleotide; - the second temperature is below the Tm of the rod portion of Petition 870250103739, dated 12 / 11 / 2025, pp. 424 / 635 41 / 184 intact stem-loop oligonucleotide and is above Tm of the stem portion of the split stem-loop oligonucleotide; and The first temperature is lower than the second temperature.
[00146] Embodiment 123. Method, according to any of Embodiments 118 to 122, in which the Tm of the stem portion of the split stem-loop oligonucleotide is above the first temperature.
[00147] Embodiment 124. Method, according to any of Embodiments 118 to 123, in which the Tm of the stem portion of the intact and split stem-loop oligonucleotide(s) is greater than the Tm of the first double-stranded portion of the temperature-controlled multicomponent probe.
[00148] Modality 125. Method, according to any of the Modalities 57 to 116, where: The second nucleic acid probe is a stem-loop oligonucleotide comprising a double-stranded stem portion of hybridized nucleotides, the opposite strands of which are linked by an uninterrupted single-stranded loop portion of non-hybridized nucleotides, all or part of which is complementary to the second target, and wherein the modification of the second nucleic acid probe is a conformational change resulting from the hybridization of the second target with the single-stranded loop portion by complementary base pairing that causes spatial separation of the third and fourth detection fractions.
[00149] Embodiment 126. Method, according to Embodiment 125, in which the conformational change is the dissociation of the opposing strands in the double-stranded stem portion of the second nucleic acid probe.
[00150] Embodiment 127. Method, according to any of Embodiments 118 to 126, wherein the third and fourth detection fractions are connected to opposite strands of the double-stranded rod portion of the second nucleic acid probe.
[00151] Modality 128. Method, according to any of the Modalities 57 to 116, where: Petition 870250103739, dated 12 / 11 / 2025, pp. 425 / 635 42 / 184 The second target is a nucleic acid. The mixture additionally includes: a primer complementary to a first sequence in the second target, a pitcher oligonucleotide comprising a region complementary to a second sequence in the second target that differs from the first sequence, and a tag portion that is not complementary to the second target, a first polymerase comprising exonuclease activity, and optionally a second polymerase, and The aforementioned treatment of the mixture includes: Suitable conditions for hybridizing the primer and the pitcher oligonucleotide with the second target, extending the primer using the first or second polymerase and the second target as a template to cleave the tag portion, hybridizing the cleaved tag portion with the second nucleic acid probe by complementary base pairing, and extending the tag portion using the polymerase and the second nucleic acid probe as a template to generate a double-stranded catcher sequence comprising the second nucleic acid probe, thus providing said modification to the second nucleic acid probe and allowing the third and fourth detection fractions to provide the second detectable signal.
[00152] Modality 129. Method, according to Modality 128, where: - the double-tape collector sequence has a Tm that is above the first temperature; and - The second temperature is below the Tm of the double-strip collector sequence.
[00153] Mode 130. Method, according to Mode 128 or Mode 129, in which the said extension of the tag portion spatially separates the third and fourth detection fractions in order to generate the second detectable signal. Petition 870250103739, dated 12 / 11 / 2025, pp. 426 / 635 43 / 184
[00154] Embodiment 131. Method, according to any of Embodiments 57 to 116, wherein the second target is a nucleic acid and the second nucleic acid probe is a two-part probe comprising a first oligonucleotide part and a second oligonucleotide part, wherein: - the first part of the oligonucleotide is complementary to a first portion of the second target, - the second part of the oligonucleotide is complementary to a second portion of the second target, The first and second portions of the second target nucleic acid flank each other, but do not overlap. The aforementioned treatment of the mixture includes: to form a duplex structure comprising: A first double-stranded portion is created by hybridizing the first part of the oligonucleotide with the second target through complementary base pairing, and a second double-stranded portion is created by hybridizing the second part of the oligonucleotide with the second target through complementary base pairing, thus bringing the first and second parts of the oligonucleotides closer together and providing said modification to the second nucleic acid probe, allowing the third and fourth detection fractions to approach and generate the second detectable signal.
[00155] Modality 132. Method, according to Modality 131, in which the second detectable signal is a decrease in fluorescence.
[00156] Modality 133. Method, according to Modality 131, in which the second detectable signal is an increase in fluorescence.
[00157] Modality 134. Method, according to any of the Modalities 57 to 116, where: The second target is a nucleic acid. - the second nucleic acid probe comprises a sequence complementary to the second target, Petition 870250103739, dated 12 / 11 / 2025, pp. 427 / 635 44 / 184 The mixture additionally includes: a primer complementary to a portion of the second target, and a polymerase with exonuclease activity; The aforementioned treatment of the mixture includes: Hybridization of the primer with the second target by complementary base pairing, hybridization of the second nucleic acid probe with the second target by complementary base pairing, extension of the primer using the polymerase and the second target as a template to thus digest the second nucleic acid probe and provide said modification to the second nucleic acid probe, allowing the third and fourth detection fractions to spatially separate and generate the second detectable signal.
[00158] Embodiment 135. Method, according to any of Embodiments 57 to 116, wherein: The second target is a nucleic acid. - the mixture additionally comprises a restriction endonuclease capable of digesting a double-stranded duplex comprising the second target; and The aforementioned treatment of the mixture includes: Hybridization of the second nucleic acid probe with the second target by complementary base pairing to form the double-stranded duplex, digestion of the duplex using restriction endonuclease to provide the aforementioned modification to the second nucleic acid probe and allow the third and fourth detection fractions to spatially separate and generate the second detectable signal.
[00159] Modality 136. Method, according to any of the Modalities 57 to 116, in which: - The second nucleic acid probe is a second, temperature-controlled, multicomponent probe comprising a first oligonucleotide component and a second oligonucleotide component. Petition 870250103739, dated 12 / 11 / 2025, pp. 428 / 635 45 / 184 wherein the first oligonucleotide component of the second temperature-controlled multicomponent probe comprises a capture region capable of hybridization with the second oligonucleotide component of the second temperature-controlled multicomponent probe by complementary base pairing to form a double-stranded portion, wherein the first oligonucleotide component of the second temperature-controlled multicomponent probe further comprises a sensor region capable of serving as a substrate for a second enzyme only when the second target is present in the sample, wherein the first oligonucleotide component of the second temperature-controlled multicomponent probe is connected to the third detection fraction and the second oligonucleotide component of the second temperature-controlled multicomponent probe is connected to the fourth detection fraction, The mixture additionally includes the second enzyme. The aforementioned treatment of the mixture includes: Suitable conditions allow the second enzyme to digest the sensor region of the second multicomponent probe at a controlled temperature, thereby generating a first fragment comprising the capture region and a second fragment connected to the third detection fraction, allowing the third and fourth detection fractions to spatially separate and generate a second detectable signal.
[00160] Modality 137. Method, according to Modality 136, in which the first enzyme is the same as the second enzyme.
[00161] Embodiment 138. Method, according to Embodiment 136 or Embodiment 137, wherein the double-strand portion or portions of the second temperature-controlled multicomponent probe have a Tm above the Tm of the first double-strand portion and / or the second double-strand portion of the first temperature-controlled multicomponent probe. Petition 870250103739, dated 12 / 11 / 2025, pp. 429 / 635 46 / 184
[00162] Modality 139. Method, according to any of the Modalities 57 to 138, where: - the first target is a nucleic acid; - the second target is a nucleic acid; or The first target is a nucleic acid, and the second target is a nucleic acid.
[00163] Modality 140. Method, according to Modality 139, in which the first target and / or the second target is an amplicon of a nucleic acid.
[00164] Embodiment 141. Method, according to Embodiment 140, wherein the amplicon is produced by an amplification reaction selected from the group consisting of polymerase chain reaction (PCR), strand displacement amplification (SDA), cleavage enzyme amplification reaction (NEAR), helicase-dependent amplification (HDA), recombinant polymerase amplification (RPA), loop-mediated isothermal amplification (LAMP), rolling circle amplification (RCA), transcription-mediated amplification (TMA), self-sustaining sequence replication (3SR), nucleic acid sequence-based amplification (NASBA), ligase chain reaction (LCR) or branching amplification method (RAM) and reverse transcription polymerase chain reaction (RT-PCR).
[00165] Modality 142. Method, according to Modality 141, in which the aforementioned determination: - occurs before said amplification or within 1, 2, 3, 4, or 5 cycles of the start of said amplification; and / or - occurs after the aforementioned amplification is complete.
[00166] Modality 143. Method, according to any of the Modalities 140 to 142, in which the said determination of the presence or absence of the first and second targets comprises an analysis of the fusion curve.
[00167] Modality 144. Method, according to any of the Modalities 57 to 116 or 136 to 143, where: Petition 870250103739, dated 12 / 11 / 2025, pp. 430 / 635 47 / 184 - the mixture additionally comprises a DNA zyme or a ribozyme that requires a cofactor for catalytic activity; The aforementioned treatment of the mixture involves the use of suitable conditions for: The cofactor binds to DNA enzyme or ribozyme to make it catalytically active, the DNA enzyme or ribozyme hybridizes with the second nucleic acid probe through complementary base pairing, and the DNA enzyme or ribozyme becomes catalyticly active in digesting the second nucleic acid probe, thus providing the aforementioned modification to the second nucleic acid probe, allowing the third and fourth detection fractions to spatially separate and generate the second detectable signal. The second target is the cofactor.
[00168] Modality 145. Method, according to any of the Modalities 57 to 106 or 117 to 144, where: The first enzyme is a DNA enzyme or a ribozyme that requires a cofactor for catalytic activity. The aforementioned treatment of the mixture involves the use of suitable conditions for: The cofactor binds to DNA enzyme or ribozyme to make it catalytically active, the DNA enzyme or ribozyme hybridizes to the first oligonucleotide component by complementary base pairing, the DNA enzyme or ribozyme becomes catalytic in digesting the first oligonucleotide component and generating the first fragment and the second fragment, and The first target is the cofactor.
[00169] Modality 146. Method, according to Modality 144 or Modality 145, wherein the cofactor is a metal ion, as a metal ion Petition 870250103739, dated 12 / 11 / 2025, pp. 431 / 635 48 / 184 selected from: Mg2+, Mn2+, Ca2+ and Pb2+.
[00170] Modality 147. Method, according to any of the Modalities 57 to 106 or 117 to 144, wherein the first enzyme is an aptazyme in which: - the sensory region comprises a substrate for an aptazime; - the first target is an analyte, protein, peptide, compound or nucleic acid; - the mixture comprises an aptazime comprising an aptamer capable of binding to the first target; and The aforementioned treatment of the mixture additionally includes binding the aptazyme to the first target and the sensor region to facilitate the cleavage of the first oligonucleotide component, thereby generating the first fragment and the second fragment.
[00171] Modality 148. Method, according to any of the Modalities 57 to 147, in which the generation of the first detectable signal is not reversible at the first temperature.
[00172] Modality 149. Method for determining the presence or absence of a first target and a second target in a sample, the method comprising: (a) preparing a mixture for a reaction by contacting the sample or a derivative thereof that purportedly comprises the first and / or second target with: - a temperature-controlled multicomponent probe for first target detection, the temperature-controlled multicomponent probe comprising a first oligonucleotide component and a second oligonucleotide component, wherein the first oligonucleotide component comprises a first capture region capable of hybridization with the second oligonucleotide component by complementary base pairing to form a first double-stranded portion, wherein the first oligonucleotide component comprises Petition 870250103739, dated 12 / 11 / 2025, pp. 432 / 635 49 / 184 additionally a sensor region capable of serving as a substrate for an enzyme, wherein the first oligonucleotide component is connected to a first detection fraction and the second oligonucleotide component is connected to a second detection fraction, - a second nucleic acid probe for detection of the second target, the second nucleic acid probe comprising third and fourth detection fractions, wherein the first and second detection fractions are capable of generating a first detectable signal, and the third and fourth detection fractions are capable of generating a second detectable signal, and - a first enzyme capable of modifying the sensor region of the first oligonucleotide component only when the first target is present in the sample; (b) treat the mixture under suitable conditions to: - the first enzyme modifies the sensor region of the first oligonucleotide component to generate a first fragment comprising the first capture region and a second fragment connected to the first detection fraction, thus allowing the first and second detection fractions to spatially separate and generate a first detectable signal, - the second target to induce a modification of the second nucleic acid probe, thus allowing the third and fourth detection fractions to spatially separate and generate a second detectable signal; (c) measure a background or detectable signal level: - at an initial temperature at or below which the first capture region is hybridized with the second oligonucleotide component, - at a second temperature at or below which the first capture region is hybridized with the second oligonucleotide component, (d) determine whether at one or more time points during or after said Petition 870250103739, dated 12 / 11 / 2025, pp. 433 / 635 50 / 184 treatment: - a first detectable signal is generated at or below the second temperature at which the first capture region is hybridized with the second oligonucleotide component, - A second detectable signal resulting from the aforementioned modification of the second nucleic acid probe is generated at the first temperature, where the second detectable signal is indicative of the presence of the second target in the sample.
[00173] Modality 150. Method, according to any of Modalities 57 to 149, in which the first temperature is lower than the second temperature.
[00174] Modality 151. Method, according to any of the Modalities 57 to 150, in which the first enzyme does not digest the first target and / or the second target.
[00175] Modality 152. Method, according to any of the Modalities 57 to 151, in which the first temperature differs from the second temperature by more than: 1 °C, 2 °C, 3 °C, 4 °C, 5 °C, 6 °C, 7 °C, 8 °C, 9 °C, 10 °C, 11 °C, 12 °C, 13 °C, 14 °C, 15 °C, 16 °C, 17 °C, 18 °C, 19 °C, 20 °C, 25 °C, 30 °C, 35 °C, 40 °C, 45 °C, 50 °C, 55 °C or 60 °C.
[00176] Modality 153. Method, according to any of Modalities 57 to 152, in which the biological sample is obtained from an individual.
[00177] Modality 154. Method, according to any of the Modalities 57 to 153, in which the method is performed in vitro.
[00178] Modality 155. Method, according to any of the Modalities 57 to 154, in which the method is performed ex vivo.
[00179] Modality 156. Composition comprising: a temperature-controlled multicomponent probe comprising a first oligonucleotide component and a second oligonucleotide component, wherein the first oligonucleotide component comprises a first capture region capable of hybridization with the second oligonucleotide component by complementary base pairing to form a Petition 870250103739, dated 12 / 11 / 2025, pp. 434 / 635 51 / 184 first double-stranded portion, wherein the first oligonucleotide component is connected to a first detection fraction and the second oligonucleotide component is connected to a second detection fraction, wherein: The first oligonucleotide component additionally comprises a sensor region capable of serving as a substrate for an enzyme, wherein digestion of the sensor region by the enzyme generates a first fragment and a second fragment, and wherein the first fragment comprises the first capture region, and the second fragment is connected to the first detection fraction; and in what way: The temperature-controlled multicomponent probe comprises no more than two detection fractions; The first oligonucleotide component is not associated with more than one detection fraction; or the first fragment is not directly labeled with a detection fraction.
[00180] Embodiment 157. Composition according to Embodiment 156, wherein the first oligonucleotide component is hybridized with the second oligonucleotide component by complementary base pairing in the first capture region.
[00181] Modality 158. Composition, according to Modality 156 or Modality 157, wherein the second oligonucleotide component is not directly labeled with more than one detection fraction.
[00182] Embodiment 159. Composition, according to any of Embodiments 156 to 158, in which the second oligonucleotide component is not connected to more than one detection fraction.
[00183] Modality 160. Composition, according to any of the Petition 870250103739, dated 12 / 11 / 2025, pages 435 / 635 52 / 184 Modalities 156 to 159, in which the second oligonucleotide component is directly labeled with the second detection fraction.
[00184] Modality 161. Composition, according to any of the Modalities 156 to 160, in which the second fragment is not directly marked with the first detection fraction.
[00185] Embodiment 162. Composition, according to any of Embodiments 156 to 161, in which the first oligonucleotide component is not directly labeled with the first detection fraction.
[00186] Embodiment 163. Composition according to Embodiment 162, wherein the first oligonucleotide component is connected to the first detection fraction by means of a third oligonucleotide component, wherein the first oligonucleotide component further comprises a second capture region capable of hybridization with the third oligonucleotide component by complementary base pairing to form a second double-stranded portion, and the third oligonucleotide component is directly labeled with the first detection fraction.
[00187] Modality 164. Composition, according to Modality 163, where the first capture region differs in length or sequence from the second capture region.
[00188] Embodiment 165. Composition, according to any of Embodiments 156 to 160, in which the first oligonucleotide component is directly labeled with the first detection fraction.
[00189] Modality 166. Composition, according to any of the Modalities 156 to 165, where: The first detection fraction is a fluorophore and the second detection fraction is a suppressor; or the first detection fraction is a suppressor, and the second detection fraction is a fluorophore. Petition 870250103739, dated 12 / 11 / 2025, pp. 436 / 635 53 / 184
[00190] Modality 167. Composition, according to any of the Modalities 156 to 166, where: the first detection fraction is a fluorophore and the second detection fraction is a suppressor; or the first detection fraction is a suppressor, and the second detection fraction is a fluorophore; and wherein the temperature-controlled multicomponent probe comprises no more than one suppressor.
[00191] Modality 168. Composition, according to any of the Modalities 156 to 167, in which the sensing region is located between the first capture region and the first detection fraction.
[00192] Embodiment 169. Composition, according to any of Embodiments 156 to 168, in which after digestion of the sensor region, the first fragment is able to hybridize with the second oligonucleotide component through the first capture region.
[00193] Embodiment 170. Composition, according to any one of Embodiments 156 to 169, further comprising a multicomponent nucleic acid enzyme (MNAzyme) comprising two partzyme oligonucleotides, each partzyme oligonucleotide having a substrate arm capable of hybridizing with at least one portion of the sensor region of the first oligonucleotide component.
[00194] Embodiment 171. Composition according to Embodiment 170, wherein the substrate arms of the two partzyme oligonucleotides are hybridized with the sensor region of the first oligonucleotide component.
[00195] Embodiment 172. Composition, according to any one of Embodiments 156 to 171, which further comprises a DNA enzyme capable of cleaving the sensor region of the first oligonucleotide component only in the presence of a target.
[00196] Modality 173. Composition, according to any of the Petition 870250103739, dated 12 / 11 / 2025, pp. 437 / 635 54 / 184 Modalities 156 to 172, which additionally comprise an aptazyme capable of cleaving the sensor region of the first oligonucleotide component only in the presence of a target.
[00197] Embodiment 174. Composition, according to any one of Embodiments 156 to 173, further comprising a restriction endonuclease capable of cleaving the sensor region of the first oligonucleotide component only in the presence of a nucleic acid target.
[00198] Embodiment 175. Composition, according to any one of Embodiments 156 to 174, further comprising an exonuclease capable of digesting the sensor region of the first oligonucleotide component only in the presence of a nucleic acid target.
[00199] Embodiment 176. Composition according to Embodiment 175, wherein the exonuclease is a polymerase with exonuclease activity. BRIEF DESCRIPTION OF THE FIGURES
[00200] Preferred embodiments of the present invention will now be described, by way of example only, with reference to the accompanying Figures, as set forth below: Figure 1 Exemplary M-Tec probes (i) An M-Tec-P suitable for cleavage by a PlexZyme (i.e., MNAzyme) assembled in the presence of a target. This M-Tec-P has two oligonucleotide components, namely: a first oligonucleotide component (OC1) comprising, within its sensing region, a PlexZyme substrate and a first detection fraction, for example, a suppressor, at one terminus; and a second oligonucleotide component (OC2) labeled with a second detection fraction, for example, a fluorophore, which is capable of hybridizing by base pairing complementary to the capture region of OC1. The position in OC1 that is susceptible to enzymatic modification by PlexZyme is located between the first capture region and the region connected to the first detection fraction. In all figures, the target is represented in a 3' to 5' orientation. In one embodiment, OC2 hybridizes with a region of Petition 870250103739, dated 12 / 11 / 2025, pp. 438 / 635 55 / 184 capture of OC1 that does not bind to the substrate binding arms of PlexZyme. (ii) An M-Tec-H suitable for hydrolysis by exonuclease activity, for example, the 5'-3' exonuclease within Taq polymerase in the presence of the target. This M-Tec-H has two oligonucleotide components, namely: a first oligonucleotide component OC1 comprising, within its sensing region, a target binding region and a first detection fraction, for example, a suppressor at one terminal; and a second oligonucleotide component OC2 labeled with a second detection fraction, for example, a fluorophore, which is capable of hybridizing with OC1 by base pairing complementary to the capture region of OC1. The region that is susceptible to enzymatic modification is located in OC1 between the first capture region and the first connected detection fraction. In one embodiment, OC2 hybridizes with a capture region of OC1 that does not bind to the target.In M-Tec probes with M-Tec-P or M-Tec-H structure, the positions of the first and second detection fractions, for example, the fluorophore and the suppressor, can be reversed as shown in (iii) and (iv), respectively. In some embodiments, the capture region may be located at or near the 5' terminal of OC1, and the first detection fraction is directly connected to or near the 3' terminal (LHS (i) - (iv)). In other embodiments, the capture region is located at or near the 3' terminal of OC1, and the first detection fraction is directly connected to or near the 5' terminal (RHS (i) - (iv)). Figure 2. Exemplary components of M-Tec-P, PlexZymes, and complexes formed in the presence of a target. (i) The components for an M-Tec-P may include an OC1 labeled with a suppressor at one terminal and comprising a sensor region that serves as a substrate for a PlexZyme, and an OC2 labeled with a fluorophore that is capable of hybridizing with OC1. (ii) The components for a PlexZyme may include two PartZyme components, A and B, each of which has a target-complementary region known as the target-binding arm, a second PlexZyme substrate-complementary region known as the substrate-binding arm, and an intervening region that constitutes half of Petition 870250103739, dated 12 / 11 / 2025, pp. 439 / 635 56 / 184 a central catalytic sequence. (iii) A target sequence for detection. (iv) A fully assembled PlexZyme connected to an M-Tec-P. When the PartZyme target-binding arms A and B hybridize adjacently into a target, a catalytic enzyme complex known as PlexZyme is formed. The M-Tec-P OC1 sensing region can then hybridize with the PlexZyme substrate-binding arms. PlexZyme is capable of cleaving multiple M-Tec-P substrates in a multi-faceted manner; Figure 3. Exemplary structures formed by components of a MTec-P and fluorescence at various temperatures in the presence and absence of the target. In all panels, uncleaved or cleaved OC1s are black and marked with a suppressor (Q); OC2s are gray and marked with a fluorophore (F) that is in a suppressed state (circles) or in a non-suppressed / fluorescent state (stars). PartZymes, unassembled or assembled in PlexZymes, are gray; target nucleic acids are white with a gray outline; low temperatures are below the Tm for hybridization of the OC1 to OC2 capture region (Tm OC1 / OC2), while high temperatures are above the Tm OC1 / OC2. Panel (i) illustrates the reaction components at low temperatures in the presence of the target. PartZymes assemble into PlexZymes that cleave OC1, generating a first fragment and a second fragment, resulting in the separation of F and Q, which in turn results in an increase in fluorescence indicative of the presence of the target.At this temperature, OC2 remains hybridized to the first fragment of the cleaved OC1. Panel (ii) illustrates the reaction components at low temperatures in the absence of the target. PartZymes are free in solution and uncleaved OC1s remain suppressed due to the proximity of F and Q, since OC2 is still hybridized with OC1. Panel (iii) illustrates the reaction components at high temperatures in the presence of the target. In general, PartZymes do not assemble into PlexZymes at high temperatures; however, when cleavage has previously occurred at low temperature, both cleaved and uncleaved OC1s may be present in the reaction mixture, but neither will be. Petition 870250103739, dated 12 / 11 / 2025, pp. 440 / 635 57 / 184 hybridized with OC2. The contribution to the background fluorescence signal is present due to the separation of F and Q. Panel (iv) illustrates the reaction components at high temperatures in the absence of the target. PartZymes are free in solution and uncleaved OC1s will not be hybridized with OC2. The contribution to the background fluorescence signal is present due to the separation of F and Q. During the course of a reaction, at low temperatures, there will be an increase in fluorescence in the presence of the target (i), but no increase in fluorescence in the absence of the target (ii). At high temperatures, the fluorescence level is the same, regardless of the presence (iii) or absence (iv) of the target. At high temperatures, the measured fluorescence from an M-Tec-P probe contributes to a background reading that does not change during the reaction; Figure 4: Panels (i), (ii), (iii) and (iv) as described previously in Figure 3. The middle panels show exemplary amplification graphs for PCR where fluorescence (y-axis) is plotted against the number of PCR cycles (x-axis). The upper central panel shows the fluorescence signal obtained at low temperatures (below Tm OC1 / OC2) in reactions containing high (A) or low (B) number of target copies, or when no target (C) is present. The lower central panel shows the fluorescence signal obtained at high temperatures (above Tm OC1 / OC2) in the same reactions; Figure 5 illustrates three general designs for PlexZyme substrate probes that can be used alone or in combination to facilitate the detection of target nucleic acids. All three probe types can be cleaved by PlexZymes in the presence of the target, resulting in an increase in fluorescence. Panel (i) illustrates a “standard” linear PlexZyme substrate that is doubly labeled with a fluorophore (F) at one end and a suppressor (Q) at the other. When linear probes are cleaved, an increase in fluorescence above the background can be observed over a wide temperature range (at both low and high temperatures). Panel (ii) illustrates a hairpin handle-loop PlexZyme substrate (LOCS probe) that incorporates a PlexZyme substrate region in the handle and a handle region. Petition 870250103739, dated 12 / 11 / 2025, pp. 441 / 635 58 / 184 labeled with a fluorophore (F) at one end and a suppressor (Q) at the other. When LOCS probes are cleaved, an increase in fluorescence above the background can only be observed at high temperatures, which are above the Tm of the rod region of a split and cleaved LOCS probe, but below the Tm of the rod region of an intact, uncleaved LOCS probe. Panel (iii) illustrates an M-Tec-P probe as described in Figures 1-4. These probes only result in an increase in fluorescence above the background at low temperatures below the Tm OC1 / OC2; Figure 6 schematically illustrates an approach for multiplex analysis of two targets using the combination of an M-Tec-P probe (A) and a LOCS probe (B), both labeled with the same fluorophore (F) and suppressor (Q). The reaction mixtures contain an intact M-Tec-P probe (Ai) and an intact LOCS probe (Bi). In the presence of target 1 (T1), PlexZyme 1 (P1) assembles and cleaves Ai to generate a cleaved M-Tec-P probe (Ac). In the presence of target 2 (T2), PlexZyme 2 (P2) assembles and cleaves Bi to generate a split and cleaved LOCS probe (Bc). Panel (i) illustrates structures that can form at temperature 1, which is below the Tm OC1 / OC2 of Ai and Ac, and below the Tm of the rod of Bi and Bc. Panel (ii) illustrates structures that can form at temperature 2, which is above the Tm OC1 / OC2 of Ai and Ac, and above the Tm of the Bc rod, but below the Tm of the Bi rod. At temperature 1, fluorescence above the background is generated in the presence of T1, but not in the absence of T1.At this temperature, Bi can be cleaved, but no above-background fluorescence is generated from Bc, as the rod remains hybridized and the fluorophore remains suppressed. Therefore, an increase in above-background fluorescence at temperature 1 indicates the presence of T1, and the background fluorescence is the same regardless of the presence or absence of T2. At temperature 2, the OC1 and OC2 of the Ai and Ac complexes dissociate and contribute only to the constant background fluorescence. At this temperature, the Bc rod, but not the Bi rod, dissociates, resulting in an increase in above-background fluorescence. Therefore, an increase in above-background fluorescence... Petition 870250103739, dated 12 / 11 / 2025, pp. 442 / 635 59 / 184 background at temperature 2 indicates the presence of T2, and the background fluorescence is the same regardless of the presence or absence of T1; Figure 7. Exemplary structures formed by components of a MTec-H and fluorescence at various temperatures in the presence and absence of the target. In all panels, the first oligonucleotide components OC1, hydrolyzed or not, are black and marked with a suppressor (Q); the second oligonucleotide components OC2 are gray and marked with a fluorophore (F), which is in an extinguished state (circles) or in an unsuppressed / fluorescent state (stars); the PCR primers are gray arrows; the target nucleic acids are white with a gray outline. Low temperatures are below the Tm for hybridization of the OC1 to OC2 capture region (Tm OC1 / OC2), while high temperatures are above the Tm OC1 / OC2. Panel (i) illustrates the reaction components at low temperatures in the presence of the target.In the presence of the target, the 5'-3' exonuclease activity of the polymerase hydrolyzes OC1 during PCR, resulting in the generation of a first fragment and a second fragment and the separation of F and Q, which in turn results in an increase in fluorescence indicative of the presence of the target. At this temperature, OC2 remains hybridized to the first fragment of cleaved OC1. Panel (ii) illustrates the reaction components at low temperatures in the absence of the target. No OC1 hydrolysis occurs and M-Tec-H remains suppressed due to the proximity of F and Q. Panel (iii) illustrates the reaction components at high temperatures in the presence of the target. When a target is present, hydrolysis will have occurred at the lower temperature, and both the hydrolyzed OC1 (and the unhydrolyzed residue) will be present in the reaction, but neither will be hybridized with OC2. The contribution to the background fluorescence signal is present and constant due to the separation of F and Q.Panel (iv) illustrates the reaction components at high temperatures in the absence of the target. OC1 hydrolysis does not occur, and OC1 and OC2 will not be hybridized. The contribution to the background fluorescence signal is present and constant due to the separation of F and Q. During a reaction at low temperatures, there will be an increase in fluorescence. Petition 870250103739, dated 12 / 11 / 2025, pp. 443 / 635 60 / 184 in the presence of the target (i), but no increase in fluorescence in the absence of the target (ii). At high temperatures, the fluorescence level is constant, regardless of the presence (iii) or absence (iv) of the target. The measured fluorescence from MTec-H at high temperature is constant and provides a background reading that does not change during the reaction; Figure 8 schematically illustrates an approach for multiplex analysis of two targets using the combination of an M-Tec-H probe (A) and a LOCS probe (B), both labeled with the same fluorophore (F) and suppressor (Q). The reaction mixtures contain an intact M-Tec-H probe (Ai) and an intact LOCS probe (Bi). In the presence of target 1 (T1), the 5'-3' exonuclease activity of the polymerase hydrolyzes Ai to generate a cleaved M-Tec-H probe (Ac). In the presence of target 2 (T2), a PlexZyme (P) assembles and cleaves Bi to generate a cleaved LOCS probe (Bc). Panel (i) illustrates structures that can form at temperature 1, which is below the Tm OC1 / OC2 of Ai and Ac, and below the Tm of the stem of Bc and Bi. Panel (ii) illustrates structures that can form at temperature 2, which is above the Tm OC1 / OC2 of Ai and Ac, and above the Tm of the Bc rod, but below the Tm of the Bi rod. At temperature 1, the fluorescence above the background is generated by Ac in the presence of T1, but not by Ai in the absence of T1.At this temperature, Bi can be cleaved, but no above-background fluorescence is generated from Bc, as the rod remains hybridized and the fluorophore remains suppressed. Therefore, an increase in above-background fluorescence at temperature 1 indicates the presence of T1, and the background fluorescence is the same regardless of the presence or absence of T2. At temperature 2, OC1 and OC2 of the Ai and Ac complexes dissociate and contribute only to a constant level of background fluorescence. At this temperature, the Bc rod, but not the Bi rod, dissociates, resulting in an increase in above-background fluorescence. Therefore, an increase in above-background fluorescence at temperature 2 indicates the presence of T2, and the background fluorescence is the same regardless of the presence or absence of T1. Figure 9 An exemplary LOCS rod-handle reporter and its temperatures Petition 870250103739, dated 12 / 11 / 2025, pp. 444 / 635 61 / 184 melting points (Tm) in the Intact and Split conformations are illustrated. A LOCS reporter, as exemplified, can be used in combination with M-Tec probes and various other well-known standard reporter probes and substrates in the art for nucleic acid detection. Exemplary intact LOCS reporters (A, LHS; top and bottom) have a Loop region that can be cleaved or degraded, a Stem region, and detection fractions, for example, a pair of suppressor dyes (Q) and fluorophores (F). Cleavage or degradation of the Loop region in the presence of the target can produce split LOCS reporter structures (B, RHS; top and bottom). The Tm of the stem regions of Intact LOCS (Tm A) is greater than the Tm of the stem regions of Split LOCS (Tm B). Thus, the Stem of the Intact LOCS will melt and split at temperatures equal to or greater than Tm A.In contrast, the rod containing the two fragments of the Split LOCS will fuse and separate at temperatures equal to or greater than Tm B, resulting in increased fluorescence. Figure 10 illustrates an exemplary strategy for target detection using LOCS oligonucleotides, which are universal and can be used to detect any target. In this scheme, the LOCS oligonucleotide contains a stem region, a pair of fluorophore suppressor dyes, and a loop region. The loop region comprises a universal substrate for a catalytic nucleic acid, for example, a PlexZyme, also known in the art and in this document referred to as MNAzyme. PlexZymes are formed when the target-sensing arms of the component partzymes align adjacently on a target. The loop region of the LOCS oligonucleotide binds to the substrate-binding arms of the assembled PlexZyme, and the substrate within the LOCS loop is cleaved by PlexZyme to generate a cleaved split LOCS structure.Both intact and split LOCS will either suppress or generate fluorescence, depending on whether the reaction medium temperature is above or below the melting point of their stems, i.e., Tm A and Tm B, respectively. The presence of increased fluorescence at temperatures higher than Tm B but lower than Tm A is indicative of the presence of a target that facilitates cleavage. The target can be detected. Petition 870250103739, dated 12 / 11 / 2025, pp. 445 / 635 62 / 184 can be detected directly, or target amplicons produced by target amplification protocols can be detected; Figure 11 shows amplification curves where fluorescence was acquired at 52 °C (LHS) and 76 °C (RHS) for reactions containing a Chlamydia trachomatis (CT) specific M-Tec-P in the presence of various gene copy numbers (10000 (A), 400 (B) or 10 (C)) or no target (D); Figure 12 shows reactions where the target Trichomonas vaginalis (TV) is detected using M-Tec-P (MT) probes or Molecular Beacons (MB). Amplification plots are shown for reactions mediated by AptaTaq exo DNA polymerase (A) or AptaTaq DNA polymerase (B) with acquisition at 52 °C (MT-52 or MB52) or 76 °C (MT-76 or MB-76). The reactions contained 10,000 copies of the target (i), 100 copies of the target (ii) or no target (iii); Figure 13 shows reactions that use the same pair of universal probes, an M-Tec-P probe and a LOCS probe, in two separate reactions to simultaneously detect two targets at two temperatures on the same wavelength during PCR; Reaction Mixture 1 included reagents (primers, partzymes, etc.) plus an M-Tec-P probe that detected Trichomonas vaginalis (TV) at 52 °C (A) and a LOCS probe that detected TFRC in human genomic DNA (gDNA) at 76 °C (B). Reaction Mixture 2 included reagents (primers, partzymes, etc.) plus the same M-Tec-P probe used in Reaction Mixture 1 that detected Neisseria gonorrhoeae (NG) at 52 °C (C) and the same LOCS probe used in Reaction Mixture 1 that detected Chlamydia trachomatis (CT) at 76 °C (D); The figure shows real-time amplification curves generated using an M-Tec-P probe and a LOCS probe with acquisition in the FAM channel at 52 °C (A and C) and 76 °C (B and D) in the presence of Mixture 1 and 10000, 800 or 40 copies of TV only (solid black line), or TV and TFRC in gDNA (dashed gray line), or TFRC in gDNA only (dashed black line), or without template (solid gray line) A and B); or in the presence of Mixture 2 and 10000, 800 or 40 copies of NG only (line Petition 870250103739, dated 12 / 11 / 2025, pp. 446 / 635 63 / 184 solid black), or just CT (black dashed line), or NG and CT (gray dashed line) or no target (solid gray line) (C and D); Figure 14 shows real-time amplification curves generated using an M-Tec-H probe with acquisition in the HEX channel at 52 °C (A) and 76 °C (B) in the presence of 10,000 (i) or 40 copies (ii) of the target MG, or in the absence of the target (iii); Figure 15 shows real-time amplification curves generated in a single reaction using a Molecular Beacon (MB) for TV detection in the FAM channel (A), LOCS 1 probe for NGopa detection in the FAM channel (B), M-Tec-P (MT) probe for CT detection in the VIC channel (C), LOCS 2 probe for MG detection in the VIC channel (D), and PlexZyme Linear (LS) substrate for NGporA detection in the CY5 channel (E), with acquisition at 52 °C (top row) or 76 °C (bottom row). The reactions contained 10,000 copies of the target (a), 1,000 copies of the target (b), 100 copies of the target (c), or no target (d); Figure 16 illustrates exemplary components for an M-Tec-E probe suitable for hydrolysis by a restriction endonuclease, for example, a cleavage enzyme, in the presence of a target. This M-Tec-E has two oligonucleotide components, namely, a first oligonucleotide component OC1 and a second oligonucleotide component OC2. OC1 is labeled with a suppressor at one terminus and contains a sensor region that is complementary to the target and includes a double-stranded recognition site for the restriction endonuclease. OC2 includes a fluorophore at one terminus and a region that is capable of hybridizing with the capture region of OC1; Figure 17 illustrates exemplary components and structures for M-Tec-P probe complexes composed of (i) three oligonucleotide components, OC1, OC2, and OC3, (ii) Partzyme s A and B, and (iii) target template; wherein (iv) shows the complex formed when an M-Tec-P probe binds to an assembled PlexZyme in the presence of the target. In this complex, OC1 contains a substrate susceptible to cleavage by a PlexZyme. OC1 is connected to a detection fraction but is not directly labeled with the detection fraction. Components OC2 and OC3 contain Petition 870250103739, dated 12 / 11 / 2025, pp. 447 / 635 64 / 184 non-target sequences complementary to the respective first and second capture regions of OC1 are labeled with pairs of fluorophores and suppressor dyes. The melting temperature of the complementary regions of OC1 and OC2 (Tm OC1 / OC2) may be lower than the melting temperature of the complementary regions of OC1 and OC3 (Tm OC1 / OC3); At a first temperature below Tm OC1 / OC2, both OC2 and OC3 would bind to the intact OC1, resulting in suppressed complexes. If OC1 were cleaved by a PlexZyme assembled in the presence of the target, OC2 and OC3 would remain bound to the first and second fragments of OC1, respectively; however, the two detection fractions would separate, and an increase in fluorescence above the baseline would be measurable at that temperature. At a second temperature above Tm OC1 / OC2, OC2 would dissociate from the first fragments of intact OC1 and / or cleaved OC1, separating the two detection fractions so that a constant level of fluorescence would contribute to the background, regardless of whether the target is present in the reaction or not. Figure 18 Exemplary components and structures for M-Tec-H probe complexes comprising three oligonucleotide components, OC1, OC2, and OC3, together with a 5' primer, a polymerase with inherent 5'3' exonuclease activity (A). In this complex, OC1 contains a sensor region, of which at least one portion is complementary to the target. OC1 is connected to a detection fraction, but is not directly labeled with the detection fraction. Components OC2 and OC3 contain non-target sequences complementary to the respective first and second capture regions of OC1 and can be labeled with fluorophore pairs and suppressor dyes. The melting temperature of the complementary regions of OC1 and OC2 (Tm OC1 / OC2) may be lower than the melting temperature of the complementary regions of OC1 and OC3 (Tm OC1 / OC3); At an initial temperature below Tm OC1 / OC2, both OC2 and OC3 would bind to the intact OC1, resulting in suppressed complexes. If OC1 Petition 870250103739, dated 12 / 11 / 2025, pp. 448 / 635 If 65 / 184 were hydrolyzed by exonuclease activity in the presence of the target, OC2 and OC3 would remain bound to the first and second fragments of OC1; however, the two detection fractions would separate and an increase in fluorescence above the baseline would be measurable at that temperature. At a second temperature above Tm OC1 / OC2, OC2 would dissociate from the first fragments of intact OC1 and / or hydrolyzed OC1, separating the two detection fractions so that a constant level of fluorescence would be contributed to the background, regardless of whether the target is present in the reaction or not; Exemplary components and structures for M-TecE Probe complexes comprising three oligonucleotide components, OC1, OC2, and OC3, together with a cleavage endonuclease (B). In this complex, OC1 contains a sensor region, of which at least one portion is complementary to the target. OC1 is connected to a detection fraction but is not directly labeled with the detection fraction. Components OC2 and OC3 would contain non-target sequences complementary to the respective first and second capture regions of OC1 and would be labeled with fluorophore pairs and suppressor dyes. The melting temperature of the complementary regions of OC1 and OC2 (Tm OC1 / OC2) may be lower than the melting temperature of the complementary regions of OC1 and OC3 (Tm OC1 / OC3). Hybridization of the target with the sensor region of OC1 would create the double-stranded recognition sequence for the cleavage endonuclease; At a first temperature below Tm OC1 / OC2, both OC2 and OC3 would bind to the intact OC1, resulting in suppressed complexes. If OC1 were cleaved by endonuclease activity in the presence of the target, OC2 and OC3 would remain bound to the first and second fragments of OC1; however, the two detection fractions would separate, and an increase in fluorescence above the baseline would be measurable at that temperature. At a second temperature above Tm OC1 / OC2, OC2 would dissociate from the first fragments of intact OC1 and / or cleaved OC1, separating the two detection fractions so that a constant level of fluorescence would be contributed to the background. Petition 870250103739, dated 12 / 11 / 2025, pp. 449 / 635 66 / 184 regardless of whether the target is present in the reaction or not; Figure 19 Illustration of two M-Tec-P probes that can be used for single-channel multiplexing. Both the M-Tec-P probe A and the M-Tec-P probe B can be composed of two oligonucleotide components (OC1 and OC2), with both probes labeled with the same fluorophore (F) and suppressor dye (Q) pair. Each of the OC1s within the M-Tec-P probe A and the M-Tec-P probe B can contain different substrates specific to two PlexZymes capable of assembling in the presence of a first target (T1) or a second target (T2), respectively. The melting temperature of the two oligonucleotide components (Tm OC1 / OC2) of the M-Tec-P probe A would be lower than that of the M-Tec-P probe B; Figure 20 illustrates exemplary melting curve analysis graphs that can be generated for reactions containing two M-Tec probes where an M-Tec probe A has a lower Tm OC1 / OC2 than a second M-Tec probe B. Illustrative diagrams show the change in the first derivative of the RFU over a temperature range that would be generated after incubation in the absence of a first and a second target (Figure 20A), in the presence of a first and a second target (Figure 20B), in the presence of a first target and in the absence of a second target (Figure 20C), and in the presence of a second target and in the absence of a first target (Figure 20D). The local minima in the graph would represent the Tm OC1 / OC2 of each M-Tec probe, which could be observed in the absence of the specific target in the reaction, but could no longer be observed in the presence of the target(s); Figure 21 shows a qualitative endpoint analysis, displaying the difference in fluorescence before and after PCR (ΔRFU) in reactions containing an M-Tec-P probe and a LOCS probe at 52 °C (A) and 76 °C (B); and reactions containing a Molecular Beacon and a LOCS probe at 52 °C (C) and 76 °C (D). The graphs are displayed as averages of triplicates of reactions containing 10000, 800, or 40 copies of CT only, NG only, or NG and CT or no target (NTC). Error bars indicate the standard deviation; Petition 870250103739, dated 12 / 11 / 2025, pp. 450 / 635 67 / 184 Figure 22 illustrates an example of an M-Tec-P probe comprising OC1 and OC2 oligonucleotides and an aptazime. The OC1 oligonucleotides can be designed to contain a suppressor, a capture region complementary to a sequence of the OC2 oligonucleotide, and a sensor region that can function as a substrate for a specific DNAzyme. The complementary region between the OC1 and OC2 oligonucleotides could be designed to have a melting temperature higher than a first temperature but lower than a second temperature, where fluorescence measurements would be made. The OC2 oligonucleotide can be designed to contain a fluorophore. The aptazime can be designed to contain an aptamer region with specific affinity for a target, a DNAzyme region capable of cleaving the substrate sequence in the OC1 sensor region, and a cDNA region containing sequences complementary to the aptamer region.In the absence of the target, the DNA enzyme can be maintained in an inactive conformation due to the binding of the cDNA to the aptamer region. Binding of the specific target to the aptamer can induce dissociation of the double-stranded region of the cDNA / aptamer, which allows activation of the DNA enzyme. This DNA enzyme could then cleave the MTec-P probe and generate a detectable signal that can be measured at temperatures below Tm OC1 / OC2; and. Figure 23 illustrates the analysis of fluorescence data acquired in the VIC channel where M-Tec-P was used for direct detection of a nucleic acid target (TV), in the absence of target amplification. The target endpoint detection, which was calculated as the difference between the fluorescence signal acquired before and after isothermal incubation with target-specific partzymes, showed that there was a significant increase in the fluorescence signal only in the presence of the target, but not in its absence at 52 °C (A). In contrast, there was no significant increase in fluorescence, regardless of the presence or absence of the target, at 76 °C (B). Real-time fluorescence data acquired during the isothermal step at 52 °C (C) indicate a target-dependent increase in fluorescence at concentrations of 125 pM (solid gray line), 25 pM (gray line). Petition 870250103739, dated 12 / 11 / 2025, pp. 451 / 635 68 / 184 dashed line) and 12.5 pM (dashed gray line), but no significant increase in the absence of the target (solid black line). Analysis of the melting curve derived from 40 °C to 95 °C acquired after isothermal incubation (D) shows that there is a melting signature curve with a peak at 61.5 °C in reactions without a target mold (solid black line), but this is not observed in any of the reactions containing the target (solid gray line, dashed or dotted). DEFINITIONS
[00201] As used in this application, the singular forms “a”, “an”, “the”, and “the” include plural references unless the context clearly indicates otherwise. For example, the phrase “polynucleotide” also includes a plurality of polynucleotides.
[00202] As used in this document, the term “comprising” means “including”. Variations of the word “comprising”, such as “comprising” and “comprising”, have correspondingly varied meanings. Thus, for example, a polynucleotide “comprising” a sequence of nucleotides may consist exclusively of that sequence of nucleotides or may include one or more additional nucleotides.
[00203] As used in this document, the term “plurality” means more than one. In certain specific aspects or modalities, a plurality may mean 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, or more, and any integer derivable from it, and any range derivable from it.
[00204] As used in this document, the term “individual” includes any animal of economic, social, or research importance, including bovine, equine, ovine, primate, avian, and rodent species. Therefore, an “individual” can be a mammal, such as a human being, or a non-human mammal. It also encompasses individuals of microorganisms, including, but not limited to, bacteria, archaea, viruses, fungi / yeasts, Petition 870250103739, dated 12 / 11 / 2025, pp. 452 / 635 69 / 184 protists and nematodes. An “individual” according to the present invention also includes infectious agents, such as prions. An individual may also include an alga or a plant.
[00205] As used in this document, the terms “polynucleotide” and “nucleic acid” may be used interchangeably and refer to a single- or double-stranded polymer of deoxyribonucleotide or ribonucleotide bases, or analogues, derivatives, variants, fragments or combinations thereof, including, but not limited to, DNA, methylated DNA, alkylated DNA, RNA, methylated RNA, microRNA, siRNA, shRNA, mRNA, tRNA, snoRNA, stRNA, smRNA, pre- and pri-microRNA, other non-coding RNAs, ribosomal RNA, LNA, PNA derivatives thereof, amplicons thereof or any combination thereof. By way of non-limiting example, the source of a nucleic acid may be selected from the group comprising synthetic, mammalian, human, animal, plant, fungal, bacterial, viral, archaeal or any combination thereof.
[00206] As used in this document, the term “oligonucleotide” refers to a segment of DNA or a nucleic acid molecule containing DNA, or RNA or a molecule containing RNA, or a combination thereof. Examples of oligonucleotides include nucleic acid targets; components for M-Tec, substrates, for example, those that can be modified by a PlexZyme; primers such as those used for amplification of targets in vitro by methods such as PCR; PlexZyme components; and various other types of probes or reporter systems, including, but not limited to, TaqMan or Hydrolysis probes; Molecular Beacons; Sloppy Beacons; Eclipse probes; Scorpion Uni-Probe primers / probes, Scorpion Bi-Probes, double-stranded probes (Yin-Yang probes), Catchers and Throwers used in TOCE technology, and dual hybridization probes.The term “oligonucleotide” includes reference to any specified sequence as well as to the sequence complementary to it, unless otherwise indicated. Oligonucleotides may comprise at least one addition or substitution, including, but not limited to, the group comprising 4-acetylcytidine, 5Petition 870250103739, dated 12 / 11 / 2025, page 453 / 635. 70 / 184 (carboxy-hydroxymethyl)uridine, 2'-O-methylcytidine, 5-carboxymethylaminomethyl thiouridine, di-hydrouridine, 2'-O-methylpseudouridine, beta D-galactosylkeosine, 2'-Omethylguanosine, inosine, N6-isopentenyladenosine, 1-methyladenosine, 1methylpseudouridine, 1-methylguanosine, 1-methylinosine, 2,2-dimethylguanosine, 2methyladenosine, 2-methylguanosine, 3-methylcytidine, 5-methylcytidine, N6-methyladenosine, 7-methylguanosine, 5-methylaminomethyluridine, 5-methoxyaminomethyl-2-thiouridine, beta Dmannosylmethyluridine, 5-methoxycarbonylmethyluridine, 5-methoxyuridine, 2-methylthio-N6isopentenyladenosine, N-((9-beta-ribofuranosil-2-metiltiopurina-6yl)carbamoyl)threonina, N-((9-beta-ribofuranosilpurina-6-il)N-metil-carbamoyl)threonina, metiléster do ácido uridina-5-oxiacetico, ácido uridina-5-oxiacetico (v), wibutoxosina, pseudouridina, queosina, 2-thiocitidine, 5-metil-2-thiouridina, 2-thiouridina, 4-thiouridina, 5-metiluridina, N-((9-beta-D-ribofuranosilpurina-6-yl)carbamoyl)threonina, 2'-O-metil-5metiluridina,2'-O-methyluridine, wibutosine, 3-(3-amino-3-carboxypropyl)uridine, beta Darabinosyl uridine, beta D-arabinosyl thymidine.,
[00207] The terms “polynucleotide”, “nucleic acid” and “oligonucleotide” include reference to any specified sequence as well as to the sequence complementary to it, unless otherwise indicated.
[00208] As used in this document, the terms “complementary”, “complementarity”, “match” and “matched” refer to the ability of nucleotides (e.g., deoxyribonucleotides, ribonucleotides, or combinations thereof) to hybridize with each other through Watson-Crick base pairing, non-canonical base pairing, including wobble base pairing and Hoogsteen base pairing (e.g., LNA, PNA, or BNA), or unnatural base pairing (UBP). Linkages can be formed through Watson-Crick base pairing between adenine (A) and uracil (U) bases, between adenine (A) and thymine (T) bases, and between cytosine (C) and guanine (G) bases. A wobble base pair is a non-canonical base pair between two nucleotides in a polynucleotide duplex (e.g., guanine-uracil, inosine-uracil, inosine-adenine, and inosine-cytosine). Petition 870250103739, dated 12 / 11 / 2025, pp. 454 / 635 71 / 184 Hoogsteen base pairs are pairings that, like Watson-Crick base pairs, occur between adenine (A) and thymine (T) bases and cytosine (C) and guanine (G) bases, but with a different purine conformation relative to pyrimidine compared to Watson-Crick base pairs. A non-natural base pair is a manufactured subunit, synthesized in the laboratory and not occurring in nature. Nucleotides called "complementary" or that are the "complement" of each other are nucleotides that have the ability to hybridize with each other by Watson-Crick base pairing or by non-canonical base pairing (wobble base pairing, Hoogsteen base pairing) or by non-natural base pairing (UBP) between their respective bases.A nucleotide sequence that is “complementary” to another nucleotide sequence in this document may mean that a first sequence is 100% identical to the complement of a second sequence in a region of 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 100 or more nucleotides. The reference to a nucleotide sequence that is “substantially complementary” to another nucleotide sequence in this document may mean that a first sequence is at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 97%, 98%, or 99% identical to the complement of a second sequence in a region of 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 100 or more nucleotides.
[00209] As used in this document, the terms “non-complementary,” “not complementary,” “incompatibility,” and “incompatible” refer to nucleotides (e.g., deoxyribonucleotides, ribonucleotides, and combinations thereof) that lack the ability to hybridize with each other by Watson-Crick base pairing or by wobble base pairing between their respective bases. A nucleotide sequence that is “non-complementary” to another nucleotide sequence in this document may mean that a first sequence is 0% identical to the complement of a second sequence in Petition 870250103739, dated 12 / 11 / 2025, pp. 455 / 635 72 / 184 a region of 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 100 or more nucleotides.
[00210] Reference to a nucleotide sequence that is “substantially non-complementary” to another nucleotide sequence in this document may mean that a first sequence is less than 1%, 2%, 3%, 4%, 5%, 10%, 15%, 20%, 25%, 30%, 35% or 40% identical to the complement of a second sequence in a region of 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 13, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 100 or more nucleotides.
[00211] As used in this document, the term “target” refers to any molecule or analyte present in a sample that the methods of the present invention can be used to detect. The term “target” will be understood as including nucleic acid targets and non-nucleic acid targets, such as, for example, proteins, peptides, analytes, ligands and ions (e.g., metal ions).
[00212] As used in this document, an “enzyme” refers to any molecule that can catalyze a chemical reaction (e.g., amplification of a polynucleotide, cleavage of a polynucleotide, etc.). Non-limiting examples of enzymes suitable for use in the present invention include nucleic acid enzymes and protein enzymes. Non-limiting examples of suitable nucleic acid enzymes include ribozymes, MNAzymes (i.e., PlexZymes), deoxyribozymes (i.e., DNAzymes), and aptazimes. Non-limiting examples of suitable protein enzymes include polymerases, reverse transcriptase, exonucleases, and endonucleases. Enzymes generally provide catalytic activity that assists in carrying out one or more of the methods described in this document. By way of non-limiting example, exonuclease activity may be an inherent catalytic activity of, for example, a polymerase.As a non-limiting example, endonuclease activity could be considered an activity. Petition 870250103739, dated 12 / 11 / 2025, pp. 456 / 635 73 / 184 inherent catalytic activity of, for example, a restriction enzyme including a cleavage endonuclease, a riboendonuclease or a duplex-specific nuclease (DSN).
[00213] As used in this document, an “amplicon” refers to nucleic acid (e.g., DNA or RNA, or a combination thereof) that is a product of natural or artificial nucleic acid amplification or replication events, including but not limited to PCR, RT-PCR, SDA, NEAR, HDA, RPA, LAMP, RCA, TMA, LCR, RAM, 3SR, NASBA, and any combination thereof.
[00214] As used in this document, the term “stem-loop oligonucleotide” shall be understood as a DNA or DNA-containing molecule, or an RNA or RNA-containing molecule, or a combination thereof (i.e., DNA-RNA hybrid molecule or complex), comprising or consisting of a double-stranded stem component joined to a single-stranded loop component. The double-stranded stem component comprises a forward strand hybridized by complementary base pairing to a complementary reverse strand, with the 3' nucleotide of the forward strand joined to the 5' nucleotide of the single-stranded loop component, and the 5' nucleotide of the reverse strand joined to the 3' nucleotide of the single-stranded loop component. The two strands of the stem need not necessarily form a blunt-ended structure. There may be additional bases resulting in a single strand overhang, and these overhanging bases still provide suitable sites for the attachment of detection fractions.The dual-strand rod component may comprise one or more detection fractions, including, but not limited to, a fluorophore on one strand (e.g., the forward strand) and one or more suppressors on the opposite strand (e.g., the reverse strand). Other non-limiting examples include a gold or silver nanoparticle on both strands for colorimetric detection, immobilization of one strand on a gold surface (e.g., the forward strand) and a gold nanoparticle on the opposite strand (e.g., the reverse strand) for SPR detection, and immobilization of one strand on an electrode surface (e.g., the forward strand) and a methylene blue molecule on the opposite strand (e.g., the reverse strand). Petition 870250103739, dated 12 / 11 / 2025, pp. 457 / 635 74 / 184 reverse) for electrochemical detection.
[00215] As used in this document, the terms “M-Tec Probe” and / or “M-Tec Substrate” and / or “M-Tec Complex” and / or “Temperature Controlled Multicomponent Probe” are used interchangeably to mean a multicomponent Temperature Controlled probe, substrate, or complex. As used in this document, M-Tec Probes may comprise two or more oligonucleotide components. M-Tec Probes comprising at least two oligonucleotide components may have a “first oligonucleotide component” and a “second oligonucleotide component.” The terms “first oligonucleotide component” or “first component oligonucleotide” or “OC1” may be used interchangeably to mean a first component molecule of an M-Tec probe.The terms “second oligonucleotide component” or “second component oligonucleotide” or “OC2” can be used interchangeably to mean a second component molecule of an M-Tec probe. The terms “third oligonucleotide component” or “third component oligonucleotide” or “OC3” can be used interchangeably to mean a third component molecule of an M-Tec probe.
[00216] The first oligonucleotide component comprises a “sensing region” that can serve as a substrate for an enzyme only in the presence of the target to be detected. The first oligonucleotide component also comprises a first “capturing region” that is complementary to the second oligonucleotide component. In some embodiments, the first oligonucleotide component is connected to a single sensing fraction that may be, for example, a fluorophore or a suppressor. Optionally, the first oligonucleotide component may additionally comprise a second “capturing region” that is complementary to the third oligonucleotide component. Preferably, the capturing region does not overlap with the sensing region. The regions of complementarity between the first and second oligonucleotide components Petition 870250103739, dated 12 / 11 / 2025, pp. 458 / 635 75 / 184 may be capable of hybridization or association at temperatures below the melting temperatures of the complementary regions of the first and second oligonucleotide components. The first and third oligonucleotide components may have complementary regions that may be capable of hybridization or association at temperatures below the melting temperatures of the complementary regions of the first and third oligonucleotide components.
[00217] The term “Tm OC1 / OC2” as used herein refers to the melting temperature of the complementary regions of the first and second oligonucleotide components. The term “Tm OC1 / OC3” as used herein refers to the melting temperature of the complementary regions of the first and third oligonucleotide components. The first oligonucleotide component may be connected to a first detection fraction, and the second oligonucleotide component may be connected to a second detection fraction. In some examples, the first oligonucleotide component is directly labeled with (i.e., directly linked, as covalently linked to) a first detection fraction and the second oligonucleotide component is directly labeled with (i.e., directly linked, as covalently linked to) a second detection fraction.In other examples, the first oligonucleotide component is connected to the first detection fraction via a third oligonucleotide component, wherein the first oligonucleotide component additionally comprises a second capture region capable of hybridization with the third oligonucleotide component by complementary base pairing, and wherein the third oligonucleotide component is directly tagged with (i.e., directly linked, as covalently linked) the first detection fraction. In such examples, it will be understood that the first oligonucleotide component is, however, connected to the first detection fraction (via hybridization with the third oligonucleotide component), but is not directly tagged with the first. Petition 870250103739, dated 12 / 11 / 2025, pp. 459 / 635 76 / 184 detection fraction. Consequently, the first oligonucleotide component can be connected to the first detection fraction directly (i.e., directly labeled) or indirectly (e.g., via a third oligonucleotide component, which in turn is directly labeled with the first detection fraction).
[00218] If present, the third oligonucleotide component may be capable of hybridization with the first oligonucleotide components at temperatures below Tm OC1 / OC3, which is higher than Tm OC1 / OC2. Thus, at temperatures below Tm OC1 / OC2, all oligonucleotide components in a complex will be hybridized. The first and second detection fractions may be, for example, a fluorophore and a suppressor or vice versa.
[00219] The first oligonucleotide component may be capable of modification in the presence of a target molecule to be detected. The modification may be mediated by enzymatic activity. Modification by enzymatic activity may be, for example, cleavage by a PlexZyme and / or hydrolysis by the exonuclease activity of a polymerase and / or cleavage by a restriction endonuclease, for example, a cleavage endonuclease. Some M-Tec probes incorporate first oligonucleotide components comprising nucleic acid enzyme substrates that may be universal and capable of catalytic cleavage by nucleic acid enzymes such as PlexZymes, DNAzymes, ribozymes, and aptazimes.
[00220] Enzymatic modification of an oligonucleotide substrate may include cleavage or hydrolysis by a protein enzyme or a catalytic nucleic acid. Cleavage and / or hydrolysis may be referred to as digestion. Similarly, cleavage and / or hydrolysis in this context may be referred to as digestion. In some examples, the first oligonucleotide component is not connected to a separate locking group, where the locking group is not a fluorophore or a suppressor. In some examples, the second oligonucleotide component is not connected to a separate locking group, where the locking group is not Petition 870250103739, dated 12 / 11 / 2025, pp. 460 / 635 77 / 184 is a fluorophore or a suppressor.
[00221] As used in this document, the terms “Intact M-Tec probe” and “unmodified M-Tec probe” are used interchangeably to refer to an M-Tec probe in which the first oligonucleotide component of the complex has not been modified by cleavage, hydrolysis, or cutting by an enzyme. The terms “Cleaved M-Tec probe” or “Hydrolyzed M-Tec probe” or “Modified M-Tec probe” are used to refer to an M-Tec probe in which the first oligonucleotide component of the probe complex has been modified by cleavage, cutting, or hydrolysis by an enzyme in the presence of the target.The terms “intact first oligonucleotide component”, “intact OC1”, “unmodified first oligonucleotide component”, “unmodified OC1”, and “unmodified first oligonucleotide component” are used interchangeably to refer to a first oligonucleotide component that has not been modified by cleavage, hydrolysis, or cutting by an enzyme. The terms “cleaved first oligonucleotide component”, “cleaved OC1”, “cleaved first oligonucleotide component”, “hydrolyzed first oligonucleotide component”, “hydrolyzed OC1”, “hydrolyzed first oligonucleotide component”, “modified first oligonucleotide component”, “modified OC1”, and “modified first oligonucleotide component” are used to refer to a first oligonucleotide component that has been modified by cleavage, hydrolysis, or cutting by an enzyme.The modification of a first oligonucleotide component can generate multiple “first oligonucleotide component fragments”, “OC1 fragments”, “first component oligonucleotide fragments”, “first component oligonucleotide fragments”, “component first oligonucleotide fragments”, or “OC1 fragments”. The cleavage or hydrolysis of substrates present in the first oligonucleotide component of an intact M-Tec probe complex by an enzyme can generate multiple first oligonucleotide component fragments that are associated with the modified M-Tec probes. Petition 870250103739, dated 12 / 11 / 2025, pp. 461 / 635 78 / 184
[00222] In some embodiments, the position or region of the first oligonucleotide component that is modified by cleavage, hydrolysis, or cutting by an enzyme is located between the first capture region and the first connected detection fraction.
[00223] Several types of M-Tec probes are disclosed in this document. The term “M-Tec-P” probe, as used in this document, refers to an M-Tec complex that may be suitable for cleavage by a catalytic nucleic acid, such as a PlexZyme assembled in the presence of a target. An M-Tec-P probe comprising at least two oligonucleotides may have a first oligonucleotide component comprising, within its sensing region, a PlexZyme substrate region. An M-Tec-P probe may be suitable for cleavage by other types of catalytic nucleic acids, such as DNAzymes, aptazimes, or ribozymes, which are activated only in the presence of the target. An M-Tec-P probe comprising at least two oligonucleotides may have a first oligonucleotide component comprising, within its sensing region, a substrate region for a catalytic nucleic acid, such as a DNAzyme, an aptazide, or a ribozyme.The term “M-Tec-H” probe, as used in this document, refers to an M-Tec complex that may be suitable for hydrolysis by exonuclease activity, for example, by intrinsic 5' to 3' exonuclease activity of the polymerase in the presence of the target. An M-Tec-H probe comprising at least two oligonucleotides may have a first oligonucleotide component comprising, within its sensing region, a sequence that is complementary to the target. The first oligonucleotide component may be able to bind or hybridize with the target at a site that is 3' from the upstream direct PCR primer. The term “M-Tec-E” probe, as used in this document, refers to an M-Tec complex that may be suitable for cleavage or cutting by an endonuclease, for example, by a cutting endonuclease. An M-Tec-E probe comprising at least two oligonucleotides may have a first oligonucleotide component comprising, within its region. Petition 870250103739, dated 12 / 11 / 2025, pp. 462 / 635 79 / 184 sensor, a sequence that is complementary to the target. The first oligonucleotide component may be able to hybridize with the target and form a double-stranded recognition sequence for a specific endonuclease.
[00224] As used in this document, the term “capture region” refers to a region of the first oligonucleotide component that hybridizes with the second oligonucleotide component or with the region of the first oligonucleotide component that hybridizes with a third oligonucleotide component, if one is present.
[00225] As used in this document, the term “universal M-Tec-P probe” refers to an M-Tec structure containing a first “universal component oligonucleotide” with a first “universal capture region” and a “universal sensor region” comprising a universal catalytic nucleic acid substrate that can be cleaved by any PlexZyme with complementary substrate-binding arms, regardless of the sequences of the PlexZyme’s target-sensing arms. The catalytic nucleic acid substrate is not complementary to the target and is therefore universal, as it can be bound to any target via the incorporation of target-specific partzymes. A single universal M-Tec-P probe can be used as a surrogate marker for any target capable of facilitating the cleavage of a specific M-Tec-P probe. A series of universal M-Tec-P probes can be incorporated into any multiplex assay designed to analyze any set of targets.
[00226] Furthermore, the first universal oligonucleotide component can be connected to a first detection fraction that can be a suppressor molecule that has the ability to quench a range of different fluorescent detection fractions. In such cases, the first universal capture region of the first oligonucleotide component may be capable of hybridization with any one of a series of second oligonucleotide components, each of which has the same sequence but is labeled with a different fluorescent detection fraction that can be suppressed by the suppressor connected to the first. Petition 870250103739, dated 12 / 11 / 2025, pp. 463 / 635 80 / 184 oligonucleotide component.
[00227] Alternatively, a series of first oligonucleotide components for multiplexing or multi-target detection can be connected to different first detection fractions, each of which can be a different fluorophore molecule, and each in the series can additionally comprise a universal capture region. In such cases, the universal capture region of the first oligonucleotide component may be capable of hybridization with a single second universal oligonucleotide component, which is tagged with an extinction detection fraction that can extinguish the multiple fluorophores connected to different first oligonucleotide components.
[00228] Alternatively, or additionally, if the first oligonucleotide component has a first and a second capture regions, both universal and capable of hybridization with universal second and third oligonucleotide components, respectively, then the first oligonucleotide component can be universal with respect to both detection fractions (e.g., the fluorophore and the suppressor), as well as with their orientation. The sequences of the second and third oligonucleotide components can remain the same; however, assay manufacturers and developers would have freedom of choice regarding which fluorophore and suppressor molecules can be attached to the second and third oligonucleotide components. They can be used in conjunction with a first oligonucleotide component that is not directly labeled with any detection fraction.
[00229] Finally, M-Tec-P probes comprising nucleic acid enzyme substrates within the sensor regions can be universal with respect to the type of catalytic nucleic acid that can cleave them. As an example, the same nucleic acid enzyme substrate sequence can be cleaved by PlexZymes, aptazimes, and / or DNAzymes. As a further example, a nucleic acid enzyme substrate sequence suitable for cleavage with DNAzyme 10:23 can also be cleaved by an aptazide incorporating one. Petition 870250103739, dated 12 / 11 / 2025, pp. 464 / 635 81 / 184 DNAzyme 10:23 or a PlexZyme composed of partzymes containing partially catalytic core sequences homologous to regions of DNAzyme 10:23.
[00230] As used in this document, the term “stem-loop oligonucleotide” shall be understood to include “LOCS”, also referred to in this document as an “oligonucleotide LOCS”, “LOCS structure”, “LOCS reporter”, “Intact LOCS”, “LOCS probes” and “PlexPlus Probes”. The single-strand loop component of a LOCS may comprise a region capable of serving as a substrate for a catalytic nucleic acid, such as, for example, an MNAzyme (i.e., a PlexZyme), a DNAzyme, a ribozyme, an apta-PlexZyme or an aptazyme. Additionally, or alternatively, the single-strand loop component may comprise a region that is complementary to a target nucleic acid (e.g., a target for detection, quantification and the like) and / or amplicons derived therefrom, and which may additionally be capable of serving as a substrate for an exonuclease enzyme. As a non-limiting example, exonuclease can be an inherent activity of a polymerase enzyme.In addition, or alternatively, the single-stranded loop component region may comprise a region that can: (i) be complementary to the target being detected, (ii) comprise a strand of a double-stranded restriction enzyme recognition site; and (iii) be capable of serving as a substrate for a restriction enzyme, for example, a cleavage endonuclease.As used in this document, the terms split stem-loop oligonucleotide, split LOCS, split LOCS oligonucleotide, split LOCS structure, split LOCS reporters, split LOCS probes, cleaved LOCS, and degraded LOCS are used interchangeably in this document and shall be understood as referring to a LOCS in which the single-stranded loop component has been cleaved, digested, and / or degraded (e.g., by an enzyme as described in this document) such that at least one link between adjacent nucleotides within the loop is removed, thus providing a non-contiguous section in the loop region. In split LOCS, the forward and reverse strands of the portion... Petition 870250103739, dated 12 / 11 / 2025, pp. 465 / 635 82 / 184 of the double-stranded rod can retain the ability to hybridize with each other to form a rod in a temperature-dependent manner.
[00231] LOCs are designed to include a cleavable loop region, allowing target-dependent cleavage of the loop region by an enzyme, generating a split LOC. This, in turn, can facilitate target detection from a detectable signal generated at specific temperature(s) after association (hybridization) or dissociation of the stem portion of intact or split LOCs. In contrast, a Molecular Beacon, as used herein, refers to a loop-stem oligonucleotide designed to include a loop region that is not cleavable during the methods described herein. Molecular Beacons can mediate target detection by generating detectable signals at specific temperatures after association (hybridization) or dissociation (separation) of the probe loop portion with the target to be detected.Thus, a primary difference between these two types of rod-loop structures in the context of the present invention is that LOCs are monitored by measuring changes in signals due to hybridization or dissociation of the rod region of intact or split LOCs, whereas Molecular Beacons are monitored by measuring changes in signal due to hybridization or dissociation of the loop and target region.
[00232] As used in this document, the term “universal stem” refers to a double-stranded sequence that can be incorporated into any LOCS structure. The same “universal stem” can be used in LOCS containing handles comprising catalytic nucleic acid substrates or sequences complementary to a target of interest. A single universal stem can be used as a surrogate marker for any target capable of facilitating the splitting of a specific LOCS. A series of universal stems can be incorporated into a series of LOCS designed for analysis of any set of targets.
[00233] As used in this document, the term “universal LOCS” refers Petition 870250103739, dated 12 / 11 / 2025, pp. 466 / 635 83 / 184 refers to a LOCS structure containing a “universal stem” and a “universal handle” comprising a universal catalytic nucleic acid substrate that can be cleaved by any PlexZyme with complementary substrate-binding arms, regardless of the PlexZyme target detection arm sequences. A single universal LOCS can be used as a surrogate marker for any target capable of facilitating the cleaving of a specific LOCS. A series of universal LOCS can be incorporated into any multiplex assay designed to analyze any set of targets.
[00234] Some LOCS probes comprise nucleic acid enzyme substrates within the loop regions that may be universal and are capable of catalytic cleavage by nucleic acid enzymes such as PlexZymes, DNAzymes, and aptazimes. Other LOCS probes comprise target-specific sequences within the loop region that are capable of catalytic cleavage by protein enzymes, including endonucleases and exonucleases.
[00235] As used in this document, the terms “nucleic acid enzyme”, “catalytic nucleic acid”, “nucleic acid with catalytic activity” and “catalytic nucleic acid enzyme” are used interchangeably in this document and shall mean a DNA or DNA-containing molecule or complex, or an RNA or RNA-containing molecule or complex, or a combination thereof (i.e., DNA-RNA hybrid molecule or complex), that can recognize at least one substrate and catalyze a modification (such as cleavage) of at least one substrate. The nucleotide residues in catalytic nucleic acids may include the bases A, C, G, T and U, as well as derivatives and analogs thereof.The terms above include single-molecular nucleic acid enzymes that may comprise a single DNA or DNA-containing molecule (also known in the art as a “DNA enzyme”, “deoxyribozyme” or “DNAzyme”) or an RNA or RNA-containing molecule (also known in the art as a “ribozyme”) or a combination thereof, being a DNA-RNA hybrid molecule that can recognize at least one substrate and catalyze a modification. Petition 870250103739, dated 12 / 11 / 2025, pp. 467 / 635 84 / 184 (such as cleavage) of at least one substrate. The above terms include nucleic acid enzymes comprising a DNA or DNA-containing complex or an RNA or RNA-containing complex or a combination thereof, being a DNA-RNA hybrid complex, which can recognize at least one substrate and catalyze a modification (such as cleavage) of at least one substrate. The terms “nucleic acid enzyme”, “catalytic nucleic acid”, “nucleic acid with catalytic activity”, “catalytic nucleic acid complex” and “catalytic nucleic acid enzyme” include PlexZymes in their meaning.
[00236] As used in this document, the terms “PlexZymes”, “MNAzymes” and “multicomponent nucleic acid enzyme” have the same meaning and refer to multicomponent nucleic acid enzymes that have two or more oligonucleotide sequences (e.g., partzymes) that, only in the presence of a PlexZyme assembly facilitator (e.g., a target), form an active nucleic acid enzyme that is capable of catalytically modifying a substrate. The terms “PlexZyme”, “MNAzyme” and “multicomponent nucleic acid enzyme” encompass bipartite structures, composed of two molecules, or tripartite structures, composed of three nucleic acid molecules, or other multipartite structures, for example, those formed by four or more nucleic acid molecules.
[00237] PlexZymes and MNAzymes can catalyze a range of reactions, including cleavage of a substrate and other enzymatic modifications of a substrate or substrates. Component partzymes A and B bind to an assembly facilitator (e.g., a target DNA or RNA sequence) via base pairing. A PlexZyme only forms when the sensor arms of partzymes A and B hybridize adjacent to each other on the target assembly facilitator. The substrate arms of the PlexZyme engage the substrate, whose modification (e.g., cleavage) is catalyzed by the catalytic core of the PlexZyme, formed by the interaction of the partial catalytic domains of partzymes A and B. PlexZymes can cleave chimeric DNA / RNA reporter substrates. Petition 870250103739, dated 12 / 11 / 2025, pp. 468 / 635 85 / 184
[00238] It is understood that the terms “PlexZyme”, “MNAzyme” and “multicomponent nucleic acid enzyme”, as used herein, encompass all known and modified MNAzymes, including those disclosed in one or more of the PCT patent publication numbers WO / 2007 / 041774, WO / 2008 / 040095, WO2008 / 122084 and related U.S. patent publication numbers 2007-0231810, 2010-0136536, and 2011-0143338 (the contents of each of these documents are incorporated herein by reference in their entirety).Non-limiting examples of MNAzymes and modified MNAzymes encompassed by the terms “MNAzyme” and “multicomponent nucleic acid enzyme” include MNAzymes with cleavage catalytic activity (as exemplified herein), disassembled or partially assembled MNAzymes comprising one or more assembly inhibitors, MNAzymes comprising one or more aptamers (“apta-MNAzymes”), MNAzymes comprising one or more truncated sensor arms and, optionally, one or more stabilizing oligonucleotides, MNAzymes comprising one or more activity inhibitors, inactive multicomponent nucleic acid proenzymes (MNAi), each of which is described in detail in one or more of the documents WO / 2007 / 041774, WO / 2008 / 040095, US 2007-0231810, US 2010-0136536, and / or US 2011-0143338.
[00239] As used in this document, the terms “partzyme”, “partzyme component” and “partzyme component” refer to an oligonucleotide containing DNA or RNA or DNA-RNA, two or more of which, only in the presence of a PlexZyme assembly facilitator as defined in this document, can together form a “PlexZyme”. In certain preferred embodiments, one or more partzyme components, and preferably at least two, may comprise three regions or domains: a “catalytic” domain, which is part of the catalytic core that catalyzes a modification; a “sensor arm” domain, which may associate with and / or bind to an assembly facilitator; and a “substrate arm” domain, which may associate with and / or bind to a substrate. The terms “arm” Petition 870250103739, dated 12 / 11 / 2025, pp. 469 / 635 The terms “86 / 184 sensor,” “target sensor arm,” or “target detection arm” or “target arm” may be used interchangeably to describe the partzyme domain that attaches to the mounting facilitator, for example, the target. Partzymes may comprise at least one additional component, including, but not limited to, an aptamer, referred to herein as an “apta-partzyme.” A partzyme may comprise several components, including, but not limited to, a partzyme component with a truncated sensor arm and a stabilizer arm component that stabilizes the PlexZyme structure when interacting with a mounting facilitator or substrate.
[00240] The terms “assembly facilitator,” “PlexZyme assembly facilitator,” “MNAzyme assembly facilitator,” and “target assembly facilitator,” as used herein, refer to entities that can facilitate the self-assembly of component partzymes to form a catalytically active PlexZyme by interacting with the sensor arms of the PlexZyme. As used herein, assembly facilitators can facilitate the assembly of PlexZymes that have cleavage or other enzymatic activities. In some instances, an assembly facilitator is required for the self-assembly of a PlexZyme. An assembly facilitator may consist of a single molecule or may consist of two or more “assembly facilitator components” that can pair or bind to the sensor arms of one or more oligonucleotide “partzymes.”The assembly facilitator may comprise one or more nucleotide components that do not share sequence complementarity with the PlexZyme sensor arm(s). The assembly facilitator may be a target. The target may be a nucleic acid selected from the group consisting of DNA, methylated DNA, alkylated DNA, RNA, methylated RNA, microRNA, siRNA, shRNA, tRNA, mRNA, snoRNA, stRNA, smRNA, pre- and primicroRNA, other non-coding RNAs, ribosomal RNA, derivatives thereof, amplicons, or any combination thereof. The nucleic acid may be amplified. Amplification may comprise one or more of the following: PCR, RT. Petition 870250103739, dated 12 / 11 / 2025, pp. 470 / 635 87 / 184 PCR, SDA, NEAR, HDA, RPA, LAMP, RCA, TMA, RAM, LCR, 3SR or NASBA.
[00241] PlexZymes are capable of cleaving substrates embedded in various types of probes, including, but not limited to, (i) linear substrates, (ii) substrates that are present in the Loop region of a stem-loop LOCS reporter probe structure, and (iii) substrates that are present in the first oligonucleotide component of M-Tec-P probe complexes, as described herein. Doubly labeled linear PlexZyme substrates are known in the art and have been used for direct detection of nucleic acid sequences and / or to monitor amplicon accumulation by various amplification methods. Cleavage of a linear substrate can separate a fluorophore and a suppressor, allowing target detection over a wide temperature range.Linear substrates are known in the art as MNAzyme substrates, MNAzyme reporters, MNAzyme probes, PlexZyme substrates, PlexZyme reporters, PlexZyme probes, linear PlexZyme probes, or standard PlexZyme probes. Cleavage of the Loop region of a LOCS by a PlexZyme can generate a split LOCS structure composed of two fragments that can remain hybridized and associated at temperatures below the melting temperature of the stem and that can separate and dissociate at temperatures above the melting temperature of the stem of the split LOCS. Dissociation of a split LOCS substrate can separate a fluorophore and a suppressor, allowing the detection of a target at relatively high temperatures, which are above the melting temperature of split stems but below the temperature of intact LOCS stems.The cleavage of substrates present in the first oligonucleotide component of an intact MTec-P probe by a PlexZyme can generate cleavage fragments of the first oligonucleotide component that are hybridized with a second oligonucleotide component at temperatures below the melting temperature of duplexes of the first capture region and the second oligonucleotide component. At these temperatures, the second oligonucleotide component may also remain hybridized to the intact first oligonucleotide component and not. Petition 870250103739, dated 12 / 11 / 2025, pp. 471 / 635 88 / 184 modified. At temperatures above the melting temperature of the complementary regions of the first capture region and the second oligonucleotide component, or of the capture region of the first fragment of the first oligonucleotide component and the second oligonucleotide component, the second oligonucleotide component may separate and dissociate. At temperatures above the melting temperature of the complementary regions of the first capture region and the second oligonucleotide, a constant signal level will contribute to a background level of fluorescence, regardless of whether the first oligonucleotide component is intact or cleaved. Thus, target-dependent increases in fluorescence associated with target-dependent cleavage can only be detected at lower temperatures below the melting temperature of the complementary regions of the first capture region and the second oligonucleotide.
[00242] Cleavage of PlexZyme from a substrate can lead to separation of the fluorophore and a pair of suppressor dyes, which, in turn, can generate a fluorescence signal. Cleavage of various types of PlexZyme substrates can result in changes in above-background fluorescence, which are observable over a wide temperature range or only at specific temperatures. For example, cleavage of doubly labeled linear PlexZyme substrates can generate above-background fluorescence, which can be monitored over a wide temperature range. In other examples, cleavage of substrates within the loop of a LOCS reporter probe can generate above-background fluorescence, which can only be monitored at temperatures above the melting temperature of the cleaved fragments of a Split LOCS structure.In other examples, the cleavage of PlexZyme substrates present in the first oligonucleotide component of an M-Tec-P probe can generate fluorescence above the background, which can be monitored at temperatures below the melting temperature of the complementary regions of the capture region of the first component and the second oligonucleotide component. Petition 870250103739, dated 12 / 11 / 2025, pp. 472 / 635 89 / 184
[00243] The terms “detectable effect” and “detectable signal” are used interchangeably in this document and will be understood to have the same meaning. The terms refer to a signal or effect generated from the detection fraction of a probe of the present invention (e.g., an oligonucleotide(s), reporter probe or substrate), typically by modifying the probe to alter its conformation, structure, orientation, position relative to other entity(ies) and the like. The modification may, for example, be induced by the presence of a target that the probe was designed to detect. The detectable effect and the detectable signal may be measurable only under specific measurement conditions that may or may not be the same as the conditions that may induce modification of the probe in the presence of the target.The detectable effect and detectable signal are target-dependent effects or signals that can be measured under specific measurement conditions for the probe designed to detect the specific target. The detectable effect or signal differs from the background signal and may increase or decrease in magnitude compared to background levels. The change in the detectable effect or signal compared to the background signal or effect may be observable only in the presence of the target, but not in the absence of the target, under specific measurement conditions. The detectable effect or signal may comprise contributions generated both by the target-dependent modification of a first measurable probe at a defined temperature, combined with any background signal generated by the first probe and / or other probes in the mixture.Non-limiting examples of such modifications (e.g., those induced by the presence of the target) include the opening of the stem-loop portion of a Molecular Beacon, the opening of the double-strand portion of Scorpion Unisondes and Bisondes, the binding of Dual Hybridization Probes and Double-Strand Probes (Yin-Yang probes) to a target sequence, the production of a Duplex Catcher-Thrower, and the cleavage / digestion of a linear PlexZyme substrate, M-Tec probe, LOCS probe, or a TaqMan probe and the like. The detectable signal can be detected by a variety of methods, including fluorescence spectroscopy, surface plasmon resonance (SPR), etc. Petition 870250103739, dated 12 / 11 / 2025, pp. 473 / 635 90 / 184 mass spectrometry, NMR, electron spin resonance, polarization fluorescence spectroscopy, circular dichroism, immunoassay, chromatography, radiometry, photometry, scintigraphy, electronic methods, electrochemical methods, UV, visible or infrared light spectroscopy, enzymatic methods, or any combination thereof. The detectable signal / effect can be detected or quantified, and its magnitude can be indicative of the presence and / or quantity of an input, such as the quantity of a target molecule present in a sample. Additionally, the magnitude of the detectable signal / effect provided by the detection fraction can be modulated by altering the conditions of a reaction in which a probe comprising the detection fraction is used, including, but not limited to, the reaction temperature.The ability of detection fractions attached or otherwise connected to oligonucleotides to generate target-dependent and / or target-independent background signals can therefore be modulated. A “detection fraction” can be a fluorophore or a suppressor.
[00244] As used in this document, the terms “background signal,” “background level,” and “baseline signal” are used interchangeably and will be understood to have the same meaning. The terms refer to the signal generated by the detection fraction of a first probe in the absence of the first specific target that the first probe was designed to measure or detect under the first specific measurement conditions. The additional fluorescence signal generated by a detection fraction of additional probes present in the reaction, which are not designed to measure or detect the first specific target under the first specific measurement conditions, may also contribute to the “background signal” and the “baseline signal.” The additional probes may be designed to detect additional target(s) under different measurement conditions.The “background signal” and the “baseline signal” generated under the first specific measurement conditions by the additional probes may be independent of the presence or absence of the additional target(s) that the additional probes were designed to detect. The detection fractions in the first and additional probes may be... Petition 870250103739, dated 12 / 11 / 2025, pp. 474 / 635 91 / 184 can be the same or different fractions that are measurable, for example, at the same wavelength.
[00245] As used in this document, the terms “background fluorescence” and “baseline fluorescence” are used interchangeably and will be understood to have the same meaning. The terms refer to the fluorescence signal generated by the detection fraction of a first probe in the absence of the first specific target that the first probe was designed to measure or detect under the first specific measurement conditions. The additional fluorescence signal generated by a detection fraction of additional probes present in the reaction, which are not designed to measure or detect the first specific target under the first specific measurement conditions, may also contribute to the “background fluorescence” and the “baseline fluorescence”. The additional probes may be designed to detect additional target(s) under different measurement conditions.The “background fluorescence” and “baseline fluorescence” generated under the first specific measurement conditions by the additional probes may be independent of the presence or absence of the additional target(s) that the additional probes were designed to detect. The detection fractions in the first and additional probes may be the same or may be different fractions that are measurable, for example, at the same wavelength.
[00246] The terms “polynucleotide substrate” and “oligonucleotide substrate,” as used herein, include any single- or double-stranded polymer of deoxyribonucleotide or ribonucleotide bases, or analogs, derivatives, variants, fragments, or combinations thereof, that is capable of being recognized, acted upon, or modified by an enzyme, including a catalytic nucleic acid enzyme. A “polynucleotide substrate” or “oligonucleotide substrate” may be modified by various enzymatic activities, including, but not limited to, cleavage. Cleavage or degradation of a “polynucleotide substrate” or “oligonucleotide substrate” may provide a detectable effect for monitoring the catalytic activity of an enzyme. The “substrate Petition 870250103739, dated 12 / 11 / 2025, pp. 475 / 635 92 / 184 polynucleotide” can be cleaved or degraded by one or more enzymes, including, but not limited to, catalytic nucleic acid enzymes such as PlexZymes, AptaPlexZymes, DNAzymes, Aptazimes, ribozymes and / or protein enzymes such as exonucleases or endonucleases.
[00247] A “reporter substrate”, as used in this document, is a substrate that is particularly adapted to facilitate the measurement of the cleavage or degradation of a substrate or the appearance of a cleaved product in connection with a catalyzed reaction. Reporter substrates may be free in solution or bound (or “trapped”), for example, to a surface or to another molecule. A reporter substrate may be labeled by a wide variety of means, including, for example, fluorophores (with or without one or more additional components such as scavengers), radioactive markers, biotin (e.g., biotinylation) or chemiluminescent markers. These markers may be referred to as “detection fractions”.
[00248] As used in this document, a linear PlexZyme substrate or linear MNAzyme substrate is a substrate, for example, a reporter substrate, that is recognized and catalytically acted upon by a plurality of PlexZymes. A “linear PlexZyme substrate” does not contain sequences at its 5' or 3' ends that are capable of hybridizing to form a stem. Alternatively, “PlexZyme substrates” may be present in the Loop region of a LOCS probe. In other examples, “PlexZyme substrates” may be present in the first oligonucleotide component of an M-Tec-P probe.
[00249] As used in this document, a “universal substrate” is a substrate, for example, a reporter substrate, that is recognized and catalytically acted upon by a plurality of PlexZymes, each of which can recognize a different assembly facilitator. The use of such substrates facilitates the development of separate assays for the detection, identification, or quantification of a wide variety of assembly facilitators using structurally related PlexZymes, all of which recognize a substrate. Petition 870250103739, dated 12 / 11 / 2025, pp. 476 / 635 93 / 184 universal. Additionally, the same “universal substrate” sequence may be present in several probe types, including “Linear PlexZyme substrate” and / or the loop region of a “LOCS probe” and / or the first oligonucleotide component of an “M-Tec-P” probe complex. Each of these universal substrates can be independently labeled with one or more markers. In some embodiments, independently detectable markers are used to label one or more universal substrates to allow the creation of a convenient system for independently or simultaneously detecting a variety of assembly facilitators using PlexZymes. In some embodiments, the “universal substrates” may be capable of catalytic modification by DNA enzymes that are catalytically active in the presence of a cofactor, for example, a metal ion cofactor such as lead or mercury.In some embodiments, substrates may be susceptible to catalytical modification by aptazymes, which can become catalytically active in the presence of an analyte, protein, compound, or molecule capable of binding to the aptamer portion of the aptazyme, thus activating the catalytic potential of the enzymatic portion of the nucleic acid.
[00250] The terms “probe” and “reporter probe,” as used herein, refer to an oligonucleotide(s) or oligonucleotide complex that is used for the detection of a target molecule (e.g., a nucleic acid or an analyte). Non-limiting examples of Standard Probes or Reporter probes, which are well known in the art, include, but are not limited to, linear PlexZyme substrates, LOCS probes, TaqMan probes or hydrolysis probes, Molecular Beacons, Sloppy Beacons, Eclipse probes, Scorpion Uni-Probe, Scorpion Bi-Probe primers / probes, catcher / thrower oligonucleotides, Double-stranded probes (Yin-Yang probes), and dual hybridization probes. The embodiments of the present invention combine standard probes with M-Tec probes.
[00251] The term “product” refers to the new molecule or molecules that are produced as a result of the enzymatic modification of a substrate. According Petition 870250103739, dated 12 / 11 / 2025, p. 477 / 635 94 / 184 used in this document, the term “cleavage product” or “cleavage fragment” are used interchangeably to refer to a new molecule produced as a result of cleavage, degradation, or endonuclease activity by an enzyme. In some embodiments, the products may be produced by enzymatic cleavage or degradation of the first oligonucleotide component of an M-Tec probe. In other embodiments, the products may be produced by enzymatic cleavage or degradation of an intact LOCS structure comprising two oligonucleotide fragments, collectively referred to as Split LOCS, wherein the two oligonucleotide fragments may be capable of hybridization or dissociation / separation, depending on the reaction temperature.
[00252] As used in this document, the use of the terms “melting temperature” and “Tm” in the context of a polynucleotide will be understood as a reference to the temperature at which half of two complementary strands of the polynucleotide are in a single-stranded state. The melting temperature (Tm) can be estimated using Wallace's rule, where Tm = 2 °C (A+T) + 4 °C (G+C) (see Wallace et al., (1979) Nucleic Acids Res. 6, 3543). The effects of sequence composition on the melting temperature can be understood using the nearest neighbor method, which is governed by the following formula: Tm (°C) = ΔH° / (ΔS° + R ln[oligo]) - 273.15. In addition to the length and composition of the sequence of fully or partially complementary regions, other factors affecting the melting temperature include ionic strength, the presence of specific solvents, and the concentration of oligonucleotides.A higher concentration of oligonucleotides and / or ions increases the chance of duplex formation, leading to an increase in the melting temperature. In contrast, a lower concentration of oligonucleotides and / or ions favors stem dissociation, leading to a decrease in the melting temperature. In some non-limiting embodiments, when the defined measurement temperature of a fluorescence associated with an M-Tec probe is selected to be, for example, below the Tm of the duplex formed by the first and second oligonucleotide components, a. Petition 870250103739, dated 12 / 11 / 2025, pp. 478 / 635 95 / 184 temperature can be chosen so that most of the oligonucleotide components are double-stranded. Alternatively, when setting the temperature to measure the fluorescence generated by an M-Tec probe, for example, below the Tm of the duplex formed by the first capture region and the second oligonucleotide components, the temperature can be chosen so that most of the first capture regions and the second oligonucleotide components are double-stranded. Similarly, when setting the temperature to measure the fluorescence generated by a LOCS probe, for example, above the Tm of the duplex formed by the two fragments of a cleaved LOCS probe, the temperature can be chosen so that most of the fragments are single-stranded.A suitable measurement temperature for detecting cleaved LOCS probes may also be below the Tm of the duplex formed by the two rods of an intact LOCS probe; the temperature is chosen so that most intact LOCS probes are in a clamp conformation.
[00253] As used in this document, the term “suppressor” includes any molecule that, when in close proximity to a fluorophore, absorbs emission energy generated by the fluorophore and dissipates the energy as heat or emits light of a wavelength longer than the emission wavelength of the fluorophore. Non-limiting examples of suppressors include Dabcyl, TAMRA, graphene, FRET fluorophores, ZEN suppressors, ATTO suppressors, Black Hole Quenchers (BHQ), Iowa Black Dark Quenchers, and Black Berry Quenchers (BBQ).
[00254] A “fluorophore” is a photoreactive molecule that can emit light upon excitation. A fluorophore can be directly linked to another molecule, such as an oligonucleotide or a protein, where it serves as a tag or marker. A fluorophore can be directly linked to an oligonucleotide, forming a probe that can be used to detect a specific target. Fluorophores or fluorophore fractions may also be called “reporter fractions” or “reporter markers.” Different fluorophores may emit at different wavelengths, or they may emit at the same wavelength or at a single wavelength. Petition 870250103739, dated 12 / 11 / 2025, pp. 479 / 635 96 / 184 similar. Non-limiting examples of fluorophores include fluorescein, Texas red, Alexa Fluor 350, BODIPY FL, Oregon Green 488, SUN fluorophore, and ATTO 647N. Fluorophores and suppressors are examples of detection fractions that can be directly linked to oligonucleotides useful as reporter probes.
[00255] As used in this document, the term “base”, when used in the context of a nucleic acid, will be understood to have the same meaning as the term “nucleotide”.
[00256] As used in this document, the term “blocker” or “blocking molecule” refers to any molecule or functional group that can be incorporated into an oligonucleotide to prevent a polymerase from using a portion of the oligonucleotide as a template for the synthesis of a complementary strand. By way of non-limiting example, a hexethylene glycol blocker may be incorporated, for example, into a Scorpion probe to link its 5' probe sequence to its 3' preparation sequence, wherein the blocker functions to prevent a polymerase from using the probe sequence as a template.
[00257] As used in this document, the terms “normalize”, “normalizing” and “normalized” refer to the conversion of a measured signal (e.g., a detectable signal generated by a detection fraction) into a scale relative to a known and repeatable value or a control value.
[00258] As used in this document, the term “kit” refers to any delivery system for delivering materials. These delivery systems include systems that allow for the storage, transport, or delivery of reaction reagents (e.g., markers, reference samples, support material, etc., in appropriate containers) and / or support materials (e.g., buffers, written instructions for performing an assay, etc.) from one location to another. For example, kits may include one or more containers, such as boxes, containing the relevant reaction reagents and / or support materials. The term “kit” includes both fragmented and combined kits. Petition 870250103739, dated 12 / 11 / 2025, pp. 480 / 635 97 / 184
[00259] As used in this document, the term “fragmented kit” refers to a delivery system comprising two or more separate containers, each containing a sub-portion of the total kit components. The containers may be delivered to the intended recipient together or separately. Any delivery system comprising two or more separate containers, each containing a sub-portion of the total kit components, is included within the meaning of the term “fragmented kit”.
[00260] As used in this document, a “combined kit” refers to a delivery system containing all the components of a reaction assay in a single container (e.g., in a single box that houses each of the desired components).
[00261] It will be understood that the use of the term “about” in this document in reference to a recited numerical value includes the recited numerical value and numerical values within plus or minus ten percent of the recited value.
[00262] It will be understood that the use of the term “between” in this document, when referring to a range of numerical values, encompasses the numerical values at each endpoint of the range. For example, a polypeptide with a length between 10 and 20 residues includes a polypeptide with a length of 10 residues and a polypeptide with a length of 20 residues.
[00263] Any description of prior art documents contained herein, or statements herein derived from or based upon such documents, does not constitute an admission that the documents or derived statements are part of the general common knowledge of the relevant art.
[00264] For descriptive purposes, all documents mentioned herein are incorporated by reference in their entirety, unless otherwise indicated. ABBREVIATIONS
[00265] The following abbreviations are used in this document and throughout the descriptive report: Petition 870250103739, dated 12 / 11 / 2025, pp. 481 / 635 98 / 184 M-Tec probe: Multi-component controlled temperature probe; M-Tec-P probe: M-Tec probe suitable for cleavage by a catalytic nucleic acid, such as a PlexZyme; M-Tec-H probe: M-Tec probe suitable for hydrolysis by an exonuclease; M-Tec-E probe: M-Tec probe suitable for cleavage by an endonuclease; OC1: First oligonucleotide component of an M-Tec Probe; OC2: Second oligonucleotide component of an M-Tec Probe; OC3: Third oligonucleotide component of an M-Tec Probe; Tm OC1 / OC2: melting temperature of the complementary regions of OC1 and OC2; Tm OC1 / OC3: melting temperature of the complementary regions of OC1 and OC3; LOCS: handle connected to the rods; MNAzima (also called PlexZyme): multicomponent nucleic acid enzyme; Partzyme: Partial enzyme containing oligonucleotide; PCR: polymerase chain reaction; gDNA: Genomic DNA; NTC: No mold control; qPCR: Quantitative real-time PCR; Ct; Limit cycle; QC; Quantification cycle; R2; Correlation coefficient; nM; Nanomolar; mM; Millimolar; pM: Picomolar; Petition 870250103739, dated 12 / 11 / 2025, pp. 482 / 635 99 / 184 μL; Microliter; μM; Micromolar; dNTP; Deoxyribonucleotide triphosphate; NF-H2O: nuclease-free water; LNA: blocked nucleic acid; F: fluorophore; Q: suppressor; N = A, C, T, G or any analogue thereof; N' = any nucleotide complementary to N, or capable of pairing with N; (N)x: any number in N; (N) x: any number in N'; W: A or T; A: A, G or AA; rN: any ribonucleotide base; (rN)x: any number of rN; rR: A or G; rY: C or U; M: A or C; H: A, C or T; D: G, A or T; JOE or 6-JOE: 6-carboxy-4',5'-dichloro-2',7'-dimethoxyfluorescein; FAM or 6-FAM: 6-Carboxyfluorescein; HEX: Hexachlorofluorescein; SUN: SUN™ fluorophore; ATTO647N: ATTO 647N (NHS ester); BHQ1: Black Hole Quencher 1; BHQ2: Black Hole Quencher 2; Phos: Phosphorylation RT-PCR: reverse transcription polymerase chain reaction; Petition 870250103739, dated 12 / 11 / 2025, pp. 483 / 635 100 / 184 SDA: tape displacement amplification; NEAR: Enzyme-cutting amplification reaction; HDA: helicase-dependent amplification; RPA: Recombinase Polymerase Amplification; LAMP: loop-mediated isothermal amplification; RCA: rolling circle amplification; TMA: transcription-mediated amplification; 3SR: self-sustaining sequence replication; NASBA: nucleic acid sequence-based amplification; LCR: Ligase Chain Reaction; RAM: Branching Amplification Method; IB: Iowa Black® FQ; IBR: Iowa Black® RQ; shRNA: short RNA hairpin; siRNA: short interfering RNA; mRNA: messenger RNA; tRNA: transfer RNA; snoRNA: small nucleolar RNA; stRNA: small temporal RNA; smRNA: small modulating RNA; pre-microRNA: precursor microRNA; pri-microRNA: primary microRNA; LHS: Left side; RHS: Right side; DSO: double-stranded oligonucleotide; Tm: Melting Point; RFU: Relative Fluorescence Units; CT: Chlamydia trachomatis; NG: Neisseria gonorrhoeae; Petition 870250103739, dated 12 / 11 / 2025, pp. 484 / 635 101 / 184 SPR: surface plasmon resonance; GNP: gold nanoparticles; DNS: Duplex-specific nuclease. DETAILED DESCRIPTION
[00266] The following detailed description conveys examples of embodiments of the present invention with sufficient detail to enable those skilled in the art to practice the present invention. Features or limitations of the various embodiments described do not necessarily limit other embodiments of the present invention or the present invention as a whole. Therefore, the following detailed description does not limit the scope of the present invention, which is defined only by the claims.
[00267] The present invention relates to methods and compositions for the multiplexed detection of one or more targets (e.g., nucleic acids, proteins, analytes, compounds, molecules and the like). The methods and compositions each employ a combination of oligonucleotide complexes herein referred to as M-Tec Probes, optionally used together with other oligonucleotide reporters, probes or substrates, which may additionally be used in combination with various other agent(s). - PROBES AND SUBSTRATES
[00268] According to the present invention, multiplex detection of target molecules is facilitated by using M-Tec probes in combination with another nucleic acid suitable for use as a probe in a multiplex detection assay.
[00269] Many nucleic acid probes for detecting nucleic acid targets have been described and are well known in the art. Suitable nucleic acid probes that can be used in combination with M-Tec Probes include, but are not limited to, LOCS probes, linear PlexZyme substrates, TaqMan or Hydrolysis probes, Molecular Beacons, Sloppy Beacons, Eclipse probes, Amplifluor / Sunrise primer probes, Scorpion Uni-Probe, Scorpion Bi-Probes, dual hybridization probes, double-stranded probes (Yin-Yang probes), and Catcher / Thrower probes. Petition 870250103739, dated 12 / 11 / 2025, pp. 485 / 635 102 / 184
[00270] In some embodiments, these nucleic acid probes bind directly to the target or target amplicon to facilitate their detection; however, probe types incorporating PlexZyme substrates and Catcher oligonucleotides for TOCE provide an exception, as they can be universal and suitable for detecting any target.
[00271] In some embodiments, nucleic acid probes generate fluorescence in the presence of the target due to enzymatically mediated cleavage or degradation, for example, M-Tec probes, LOCS probes, linear PlexZyme substrates and TaqMan or Hydrolysis probes.
[00272] In other embodiments, nucleic acid probes provide different levels of fluorescence signal as a result of a conformational change induced by binding to a target or target amplicon (e.g., Molecular Beacons, Sloppy Beacons, Eclipse probes, Scorpion Uni-Probe, Scorpion BiProbes, double-stranded probes (Yin-Yang probes), and dual hybridization probes).
[00273] In the TOCE system, the Catcher alters fluorescence as a result of conformational changes induced by the binding and extension of the Thrower, which is only activated and released in the presence of the target.
[00274] Any or all of these types of reporter nucleic acid probes are suitable for use in conjunction with M-Tec probes to mediate the detection of multiple targets by measuring changes related to a single detection fraction, including, but not limited to, a change in fluorescence measured at a single wavelength. It is also possible to combine M-Tec probes with other types of probes, where the probes are labeled with different fluorophores that have equal or similar emission spectra and are therefore measurable at the same wavelength.
[00275] Oligonucleotides for M-Tec probes or for probes used in combination with M-Tec probes can be synthesized according to standard protocols. For example, they can be synthesized by phosphoramidite chemistry, using nucleosidic and non-nucleosidic phosphoramidites in synthetic cycles. Petition 870250103739, dated 12 / 11 / 2025, pp. 486 / 635 103 / 184 sequential processes involving the removal of the protecting group, coupling of phosphoramidites, coating and oxidation, both in solid phase and solution phase and, optionally, in an automated synthesizer device. Alternatively, they can be purchased from commercial sources. Non-limiting examples of commercial sources from which linear or LOCS PlexZyme substrates, TaqMan or hydrolysis probes, Molecular Beacons, Sloppy Beacons, Eclipse probes, Scorpion Uni-Probe, Scorpion Bi-Probes, dual hybridization probes, double-strand probes (Yin-Yang probes) and Catcher / Thrower probes can be purchased or otherwise obtained include: PlexZyme substrates can be purchased from SpeeDx (plexpcr.com); TaqMan and hydrolysis probes can be purchased from Thermo Fisher Scientific (www.thermofisher.com), Sigma Aldrich (www.sigmaaldrich.com), Promega (www.promega.com), Generi Biotech (www.generi-biotech.Molecular Beacons and Sloppy Beacons can be purchased from Integrated DNA Technologies (www.idtdna.com), Eurofins (www.eurofinsgenomics.com), and TriLink BioTechnologies (www.trilinkbiotech.com); Eclipse probes can be purchased from Integrated DNA Technologies (www.idtdna.com); Scorpion Uni-Probes can be purchased from Sigma Aldrich (www.sigmaaldrich.com) and Bio-Synthesis (https: / / www.biosyn.com); Scorpion bi-Probes can be purchased from Bio-Synthesis (https: / / www.biosyn.com); dual hybridization probes can be purchased from Bio-Synthesis (https: / / www.biosyn.com), Sigma Aldrich (www.sigmaaldrich.com), and Eurofins (www.eurofinsgenomics.com); Double-stranded probes (Yin-Yang probes) can be purchased from Integrated DNA Technologies (www.idtdna.com); and Catcher-Thrower assays can be purchased from Seegene (www.seegene.com). - M-TEC PROBE OLIGONUCLEOTIDES
[00276] This document provides methods and compositions that extend the multiplex analysis capabilities of nucleic acid targets. These methods and compositions employ multi-component temperature-controlled probes, referred to herein as M-Tec probes. Petition 870250103739, dated 12 / 11 / 2025, pp. 487 / 635 104 / 184 example title, M-Tec Probes are multi-component complexes comprising at least two oligonucleotide components, wherein a first oligonucleotide component (OC1) is connected to a first detection fraction and is capable of being modified by enzymatic activity in the presence of a target, and a second oligonucleotide component (OC2) is labeled with a second detection fraction. The first oligonucleotide component comprises a first capture region capable of hybridization with the second oligonucleotide component by complementary base pairing to form a double-stranded portion. The first and second oligonucleotide components are capable of hybridization at temperatures below the melting temperature (Tm) of the double-stranded portion (Tm OC1 / OC2).The first oligonucleotide component is connected to a detection fraction by direct labeling or through a complementarity region with a third oligonucleotide component (OC3) that is directly labeled with the detection fraction. If present, a third oligonucleotide component is capable of hybridization with the first oligonucleotide component at temperatures below the Tm of the complementary regions (Tm OC1 / OC3). If this temperature is higher than Tm OC1 / OC2, then at temperatures below Tm OC1 / OC2 all oligonucleotide components in a complex will be hybridized. The first and second detection fractions can be, for example, a fluorophore and a suppressor or vice versa. The region or position that is subject to enzymatic modification is located between the first capture region and the first detection fraction.In some embodiments, an M-Tec probe comprises only a first and a second detection fraction and no additional detection fraction. In some embodiments, the first and second detection fractions are located on different oligonucleotides, i.e., the first and second oligonucleotide components, neither of which is doubly labeled.
[00277] When all oligonucleotide components are hybridized, and the first oligonucleotide component is not modified, the fluorophore and the Petition 870250103739, dated 12 / 11 / 2025, pp. 488 / 635 105 / 184 suppressor fragments are located close together, resulting in an intact M-Tec Probe complex that is suppressed. In the presence of a target, a sensor region of the first oligonucleotide component is modified, for example, by cleavage or hydrolysis by an enzyme. The enzymatic modification of the sensor region of the first oligonucleotide component generates a first fragment comprising the first capture region connected to the second detection fraction and a second fragment connected to the first detection fraction, thus allowing the first and second detection fractions to spatially separate and generate a first detectable signal. As an example, this modification occurs in a sensor region positioned between the two detection fractions so that it causes the separation of, for example, the fluorophore and the suppressor. The resulting increase in target-dependent fluorescence can be measured at temperatures below Tm OC1 / OC2.At temperatures above Tm OC1 / OC2, the first and second oligonucleotide components dissociate, and the detection fractions are separated, resulting in a constant contribution to the background fluorescence levels, regardless of the presence or absence of the target. At this temperature, the second oligonucleotide component will no longer hybridize with the unmodified first oligonucleotide component in reactions where no target is present, or with a hydrolyzed / cleaved fragment of the first oligonucleotide component that was modified in the presence of the target. Therefore, M-Tec probes will generate target-dependent increases in fluorescence at temperatures below Tm OC1 / OC2, but no change in fluorescence will be observed, regardless of the presence or absence of the target, at temperatures above Tm OC1 / OC2.
[00278] Several types of M-Tec probes are disclosed and exemplified (see, for example, Figures 1, 16 to 19). Although exemplified with a fluorophore / suppressor pair, the technical recipient will recognize that any other suitable detection fractions may be used for the same purpose. One type of M-Tec probe is suitable for modification / cleavage by a PlexZyme in Petition 870250103739, dated 12 / 11 / 2025, pp. 489 / 635 106 / 184 presence of target. These probes are referred to in this document as M-Tec-P probes, exemplary components and complexes are illustrated in Figure 1(i) and Figures 2, 3 and 17. An M-Tec-P may have two oligonucleotide components, namely, a first oligonucleotide component (OC1) directly labeled with a detection fraction, for example, a suppressor, and comprising a sensor region that serves as a substrate for a PlexZyme, and a second oligonucleotide component (OC2) directly labeled with a second detection fraction, for example, a fluorophore (Figures 1 (i) and 2 (i)). Alternatively, M-Tec-P complexes can be labeled with a fluorophore at or near a terminal and comprise a sensor region that serves as a substrate for a PlexZyme and an OC2 labeled with a suppressor (Figure 1(ii)). The OC1 comprises a first capture region capable of hybridization with OC2 at “low” temperatures below the melting temperature of its complementary regions ( <Tm OC1 / OC2) (Figuras 3(i) e ii). O sítio passível de modificação / clivagem pela PlexZyme pode estar localizado dentro da região sensora entre a região de captura e a primeira fração de detecção.
[00279] M-Tec-P probes can be designed to be cleaved by PlexZymes, which can be assembled from component partzymes, where the partzymes bind adjacently to complementary regions on the target to be detected (Figures 1-3). The M-Tec-P can then bind to the PlexZyme after hybridization of the OC1 with the substrate-binding arms of a PlexZyme. (Figure 1(i) and (iii) and Figure 2(iv)). In some embodiments, an OC2 hybridizes with a capture region of the OC1 that does not hybridize / bind to the substrate-binding arms of the partzymes, as illustrated in the Figure (Figure 1(i) and (iii) and Figure 2(iv)). Cleavage of the OC1 sensor region of M-Tec-P generates two OC1 fragments, one of which is connected to the suppressor and the other contains the capture region complementary to OC2 (Figure 3(i) and (iii)).At “low” temperatures below Tm OC1 / OC2, an increase in fluorescence is indicative of the presence of the target that facilitated the assembly of PlexZyme (Figure 3(i) and Figure 4 top center panel). Petition 870250103739, dated 12 / 11 / 2025, pp. 490 / 635 107 / 184 In the absence of a target, the M-Tec probes are not cleaved, and the fluorophore and suppressor are not separated, and there is no increase in fluorescence above the background during the reaction at this temperature (Figure 3(ii) and Figure 4 top center panel). At “high” temperatures above Tm OC1 / OC2, no change in fluorescence is observed regardless of the presence or absence of the target (Figure 3(iii) and (iv) and Figure 4 bottom center panel). The background or baseline fluorescence resulting from the dissociation of OC1 and OC2 is constant and is not affected by the presence or absence of the target.
[00280] In some embodiments, the M-Tec-P probe may be universal. A universal M-Tec-P structure may contain a universal first oligonucleotide component comprising a universal first capture region and a universal sensing region that includes a universal catalytic nucleic acid substrate that can be cleaved by any PlexZyme with complementary substrate-binding arms, regardless of the PlexZyme target-sensing arm sequences. A single universal M-Tec-P probe may be used as a surrogate marker for any target capable of facilitating cleavage by a specific M-Tec-P probe. A series of universal M-Tec-P probes may be incorporated into any multiplex assay designed to analyze any set of targets.Furthermore, the first universal oligonucleotide component can be connected to a first detection fraction that can be a suppressor fraction capable of quenching a range of different fluorophores. In such cases, the first universal capture region of the first oligonucleotide component may be capable of hybridization with any one of a series of second oligonucleotide components, each of which has the same sequence but is tagged with a different fluorophore that can be suppressed by the suppressor connected to the first universal oligonucleotide component. Some M-Tec-P probes comprise nucleic acid enzyme substrates within the loop regions that may be universal and capable of catalytic cleavage by nucleic acid enzymes, such as... Petition 870250103739, dated 12 / 11 / 2025, pp. 491 / 635 108 / 184 PlexZymes, DNAzymes, aptazymes, and ribozymes. As an example, the same universal MTec-Probe can be used in conjunction with many specific PlexZymes to detect a range of nucleic acid targets and can additionally be used in conjunction with many specific aptazymes to detect a range of non-nucleic acid targets.
[00281] Another type of M-Tec probe is suitable for hydrolysis by exonuclease activity, for example, by Taq polymerase in the presence of the target. These probes are referred to herein as M-Tec-H probes, and exemplary components and complexes are illustrated in Figure 1(ii) and (iv) and Figure 7. An M-TecH may have two oligonucleotide components, OC1 and OC2. OC1 may be labeled with a suppressor at or near a terminus and have a sensing region, of which at least a portion is complementary to the target to be detected; while OC2 may be labeled with a fluorophore (Figures 1 (ii) and 7). Alternatively, M-Tec-H complexes may comprise an OC1 labeled with a fluorophore at or near a terminus, and an OC2 labeled with a suppressor (Figure 1 (iv)). OC1 and OC2 have complementary regions and are capable of hybridization or association at "low" temperatures below the melting temperature of their complementary regions ( <Tm OC1 / OC2) (Figuras 7(i) e ii).In some modes, OC2 hybridizes with a capture region of OC1 that does not hybridize / bind to the target.
[00282] M-Tec-H probes are designed to be hydrolyzed by exonuclease activity in the presence of the target. During PCR, at least a portion of the OC1 sensor region of M-Tec-H can bind to the target amplicon and at least a portion of the sensor region can be hydrolyzed by the exonuclease activity of the polymerase. Hydrolysis of the OC1 of the M-Tec-H probe results in the generation of two OC1 fragments, one of which is connected to the first detection fraction, for example, a suppressor, and the other contains the complementarity capture region with OC2 (Figure 7(i) and (iii)). At “low” temperatures below the Tm OC1 / OC2, an increase in fluorescence is indicative of the presence of the target. Petition 870250103739, dated 12 / 11 / 2025, pp. 492 / 635 109 / 184 (Figure 7(i)). In the absence of a target, the M-Tec-H probes are not hydrolyzed and there is no increase in fluorescence above the background during the reaction (Figure 7(ii)) at this temperature. At “high” temperatures above Tm OC1 / OC2, no change in fluorescence is observed regardless of the presence or absence of the target (Figures 7(iii) and (iv)). The background fluorescence contributed by the dissociation of OC1 and OC2 is constant and is not affected by the presence or absence of the target.
[00283] In some embodiments, M-Tec probes are used in combination with universal hairpin PlexZyme probes (Figure 6 and Figure 8), also known as LOCS (Loops Connected to Stems) probes (Figure 9 and Figure 10). In other embodiments, M-Tec probes can be combined with other types of probes and substrates known in the art, including, but not limited to, linear PlexZyme substrates, standard double-labeled TaqMan probes or Hydrolysis probes, Molecular Beacons, Sloppy Beacons, Eclipse probes, Scorpion UniProbes or Bi-Probes, Catcher-Thrower oligonucleotides, double-stranded probes (Yin-Yang probes), and double hybridization probes.
[00284] Combining M-Tec probes with other types of probes or substrates allows for greater multiplexing capability, where multiple targets can be detected, identified, and / or qualified at a single wavelength. For example, an M-Tec probe, along with one or more LOCS probes, both incorporating the same detection fraction (e.g., the same fluorophore), can be used to individually differentiate several targets within a single reaction. Alternatively, multiple targets can be differentiated within a single reaction using an M-Tec probe and a LOCS probe, which incorporate different detection fractions that emit a signal at a similar wavelength and can be monitored in the same fluorescence channel in a detection instrument. The approach involves measuring the signal generated by the probes at discrete temperatures.In some modalities, a first target is measured at a first temperature by monitoring changes in fluorescence associated with the modification of an M-Tec probe, and a second target is... Petition 870250103739, dated 12 / 11 / 2025, pp. 493 / 635 110 / 184 measured at a second temperature monitoring changes in fluorescence associated with modification of a LOCS probe (Figures 6 and 8).
[00285] The properties of the M-Tec probe components and other probe types with which they can be combined to increase multiplexing capability are part of the multiplexed assay design. In particular, the Tm of the complementarity regions between probe components (intermolecular bonds), or within probes (intramolecular bonds), and between components or probes and targets (intermolecular bonds) influences the ability to combine various probe types. Exploiting these properties of the probes and / or their components allows manipulation of the association or dissociation of probe regions and complex probe components at defined temperatures. In turn, these properties influence whether various probe types generate target-specific fluorescence at specific acquisition temperatures or whether only background fluorescence is observed in the presence or absence of the target.This can be better understood by considering the scenarios for different probe types tabulated in Tables 1, 2, and 3 below. The scenarios are merely examples, and a person skilled in the art will realize that there are many other scenarios that can be envisioned for combining probes to allow the analysis of multiple targets at a single wavelength when the principles of target- and background-dependent fluorescence manipulation described above and below are applied.
[00286] Table 1: Relationship of Tm of the components at Acquisition Temperature 1 (Temp 1) and Acquisition Temperature 2 (Temp 2) in the presence of the target (+T) or in the absence of the target (-T). Scenarios that result in an increase in the detectable signal, measured as Fluorescence above the background (F) or that contribute only to the background signal (B) at Temp 1 and 2, are tabulated.____________________________ Probe Type Interrelation between probe and component Tms and Temp 1 and 2 Temp 1 Temp 2 Petition 870250103739, dated 12 / 11 / 2025, pp. 494 / 635 111 / 184 Probe Type Interrelation between probe and component Tms and Temp 1 and 2 Temp 1 Temp 2 M-Tec Probe Tm OC1 / OC2 > Temp 1 Tm OC1 / OC2 < Temp 2 + T = F - T = B + / - T = B LOCS Probe Stem Tm Intact > Temp 2 Stem Tm Split > Temp 1 Stem Tm Split < Temp 2 + / - T = B + T = F - T = B Molecular Beacon Stem Tm < Loop / Target Tm Stem Tm and Loop / Target Tm > Temp 1 Stem Tm and Loop / Target Tm < Temp 2 + T = F - T = B + / - T = B Linear PlexZyme Probe Not Applicable + T = F - T = B + T = F - T = B TOCE Probe Tm Catcher / Thrower > Temp 1. Catcher / Thrower < Temp 2 + T = F - T = B + / - T = B Catcher / Thrower > Temp 1 Catcher / Thrower > Temp 2 + T = F - T = B + T = F - T = B
[00287] Thus, the following resources can be used to manipulate target-dependent fluorescence generation at specific acquisition temperatures for various probe types. For example, when the components of M-Tec probes have a Tm OC1 / OC2 above the first acquisition temperature but below the second acquisition temperature, target-dependent fluorescence will be observed only at the first acquisition temperature. Background fluorescence will be observed only at the first temperature in the absence of the target, and the Petition 870250103739, dated 12 / 11 / 2025, pp. 495 / 635 112 / 184 background fluorescence will be observed only at the second temperature, regardless of the presence or absence of the target.
[00288] When the Tm of the stem of an intact / uncleaved LOCS probe is above the second acquisition temperature, and the Tm of the stem of a split and cleaved LOCS probe is above the first acquisition temperature but below the second acquisition temperature, target-dependent fluorescence will be observed only at the second acquisition temperature. Background fluorescence will be observed only at the second temperature in the absence of the target, and background fluorescence will be observed only at the first temperature, regardless of the presence or absence of the LOCS probe target.
[00289] When the Tm of the stem of a Molecular Beacon is lower than the Tm of the loop / target hybrid, and the Tm of both the stem and the loop / target hybrid are above the first acquisition temperature but below the second acquisition temperature, target-dependent fluorescence will be observed only at the first acquisition temperature. Background fluorescence will be observed only at the first temperature in the absence of the target, and background fluorescence will be observed only at the second temperature, regardless of the presence or absence of the molecular beacon target.
[00290] PlexZyme linear probes that have been cleaved in the presence of a target do not have the same ability to have their fluorescence controlled by temperature. Thus, when these probes are cleaved in the presence of the target, they fluoresce at both the first and second acquisition temperatures. These probes will produce a background signal at both temperatures only when no target is present.
[00291] Catcher-Thrower complexes have some capability to have target-dependent fluorescence controlled by temperature. In the presence of a target, the TOCE system produces target-specific double-stranded Catcher-Thrower complexes. These complexes can be designed to have any length and therefore have Tms at various temperatures, which are Petition 870250103739, dated 12 / 11 / 2025, pp. 496 / 635 113 / 184 defined at the designer's discretion. If the Tm of the Catcher-Thrower complex is above the first acquisition temperature but below the second acquisition temperature, target-dependent fluorescence will only be observed at the first acquisition temperature. Background fluorescence will only be observed at the first temperature in the absence of the target and at the second temperature regardless of the presence or absence of the target. If the Tm of the Catch / Thrower complex is above both the first and second acquisition temperatures, target-dependent fluorescence will be observed at both the first and second acquisition temperatures. Background fluorescence will only be observed at both the first and second temperatures in the absence of the target.
[00292] The ability to manipulate target-dependent fluorescence and background at various temperatures for specific probe types, as exemplified above, provides a broad general approach to designing systems to combine probe types that allow target detection only at specific temperatures. Additionally, it provides a wide range of options for detecting multiple targets at a single wavelength. This can be illustrated by non-exhaustive exemplary combinations tabulated in Table 2.
[00293] Table 2: Generation of a measurable detectable signal as Fluorescence (F) above the background, or signals that contribute only to the Background (B) when probe types are combined to detect Target 1 (T1) and Target 2 (T2) at a single wavelength under temperature relationships consistent with those defined in Table 1 and, where indicated, as further defined in Table 2. The presence and absence of the target are indicated as plus (+) or minus (-), respectively. Each pair of probe types in the table may be labeled with the same fluorophore and read at the same wavelength. Alternatively, each pair of probe types in the table may be labeled with different fluorophores, provided the fluorophores have similar wavelengths that can be read in the same fluorescence channel. The total background signal at a given temperature may be the sum of the background signal Petition 870250103739, dated 12 / 11 / 2025, pp. 497 / 635 114 / 184 contributed by a probe in the absence of the target, plus the background signal contributed by additional probes in the presence or absence of the target. Probes (Target detected) Temp 1 Temp 2 Analysis M-Tec Probe (T1) LOCS Probe (T2) + T1 = F - T1 = B + / - T2 = B + / - T1 = B - T2 = B + T2 = F T1 = F at Temp 1 T2 = F at Temp 2 M-Tec Probe (T1) PlexZyme Linear Probe (T2) + T1 = F + T2 = F - T1 / T2 = B + / - T1 = B + T2 = F - T2 = B T1 = F at Temp 1 minus F at Temp 2 T2 = F at Temp 2 M-Tec Probe (T1) TOCE Probe (T2) with Catcher / Thrower Tm > Temp 2 + T1 = F + T2 = F - T1 / T2 = B + / - T1 = B + T2 = F - T2 = B T1 = F at Temp 1 minus F at Temp 2 T2 = F at Temp 2 Molecular Beacon (T1) LOCS Probe (T2) + T1 = F - T1 = B + / - T2 = B + / - T1 = B - T2 = B + T2 = F T1 = F at Temp 1 T2 = F at Temp 2 M-Tec Probe 1 (T1) M-Tec 2 Probe (T2) where Probe 1 Tm OC1 / OC2 is < Probe 2 Tm OC1 / OC2 and Probe 2 Tm OC1 / OC2 < Temp 2 + T1 = F + T2 = F - T1 / T2 = B + / - T1 = B + T2 = F - T2 = B T1 = F at Temp 1 minus F at Temp 2 T2 = F at Temp 2
[00294] As exemplified in Table 2, there are numerous ways in which specific types of probes can be combined to analyze multiple targets in Petition 870250103739, dated 12 / 11 / 2025, pp. 498 / 635 115 / 184 a single wavelength. The relationships between the Tm of intramolecular bonds for each probe type and for intermolecular bonds between probe components and probes and targets, as exemplified in Table 1, support the ability to multiplex different probe types for this purpose when the signal is acquired at specific temperatures. For example, an M-Tec probe designed to detect Target 1 can be combined with a LOCS probe designed to detect Target 2. In this scenario, an increase in fluorescence above the background will be observed for Target 1 only at the first acquisition temperature, and an increase in fluorescence above the background will be observed for Target 2 only at the second acquisition temperature.On the other hand, the background signal will only be observed at the first acquisition temperature in the absence of Target 1, regardless of the presence or absence of Target 2, and the background signal will only be observed at the second acquisition temperature in the absence of Target 2, regardless of the presence or absence of Target 1. Thus, the presence of Target 1 and / or the determination of the number of copies can be determined by analyzing data acquired at temperature 1, and the presence of Target 2 and / or the determination of the number of copies can be determined by analyzing data acquired at temperature 2. In this scenario, the detectable signal generated in the presence of each specific target is measured discretely at a specific temperature, and therefore there is no need to subtract any detectable signal generated by the presence of other target(s) that may or may not be present in the reaction, since these will not be measurable at the same specific temperature.This provides a significant advantage over protocols that require algorithms to subtract the target-dependent signal related to a single target when multiple targets generate fluorescence at the same specific measurement temperature.
[00295] An M-Tec probe designed to detect Target 1 can be combined with a PlexZyme Linear probe designed to detect Target 2. In this scenario, an increase in fluorescence above the background will be observed in the presence of Target 1. Petition 870250103739, dated 12 / 11 / 2025, pp. 499 / 635 116 / 184 and Target 2, or both, at the first acquisition temperature, and an increase in fluorescence above the background will be observed only in the presence of Target 2, at the second acquisition temperature. A background signal will only be observed at the first acquisition temperature in the absence of Target 1 and Target 2. The background signal will only be observed at the second acquisition temperature in the absence of Target 2, regardless of the presence or absence of Target 1. Thus, the presence of Target 1 and / or the determination of the number of copies of Target 1 can be determined by analyzing data acquired at temperature 1 and temperature 2, where the contribution to the fluorescence generated by target 1 can be calculated by subtracting the fluorescence acquired at temperature 2 from the total fluorescence acquired at temperature 1. The presence of Target 2 and / or the determination of the number of copies of the target can be determined by analyzing data acquired only at temperature 2.
[00296] An M-Tec probe designed to detect Target 1 can be combined with a TOCE probe designed to detect Target 2 where the Tm of the Catcher / Thrower complex is above acquisition temperature 2. In this scenario, an increase in fluorescence above the background will be observed in the presence of Target 1 and Target 2, or both, at the first acquisition temperature, and an increase in fluorescence above the background will be observed only in the presence of Target 2, at the second acquisition temperature. A background signal will only be observed at the first acquisition temperature in the absence of Target 1 and Target 2. The background signal will only be observed at the second acquisition temperature in the absence of Target 2, regardless of the presence or absence of Target 1.Thus, the presence of Target 1 and / or the determination of the number of copies of the target can be determined by analyzing data acquired at temperature 1 and temperature 2, where the contribution to the fluorescence of target 1 can be calculated by subtracting the fluorescence acquired at temperature 2 from the total fluorescence acquired at temperature 1. The presence of Target 2 and / or the determination of the number of copies of the target can be determined by analyzing data acquired only. Petition 870250103739, dated 12 / 11 / 2025, pages 500 / 635 117 / 184 at temperature 2.
[00297] A molecular beacon designed to detect Target 1 can be combined with a LOCS probe designed to detect Target 2. In this scenario, an increase in fluorescence above the background will be observed for Target 1 only at the first acquisition temperature, and an increase in fluorescence above the background will be observed for Target 2 only at the second acquisition temperature. Conversely, the background signal will only be observed at the first acquisition temperature in the absence of Target 1, regardless of the presence or absence of Target 2. Target 2, and the background signal will only be observed at the second acquisition temperature in the absence of Target 2, regardless of the presence or absence of Target 1. Thus, the presence of Target 1 and / or the determination of the number of copies of the target can be determined by analyzing data acquired at temperature 1, and the presence of Target 2 and / or the determination of the number of copies of the target can be determined by analyzing data acquired at temperature 2.
[00298] A person skilled in the art will realize that there are many other scenarios that can be considered for combining probes in order to allow the analysis of multiple targets at a single wavelength when the target- and background-dependent fluorescence manipulation principles described above are applied.
[00299] Table 2 provides several options for combinations of various probe types that incorporate the principle described in Table 1. It is possible to combine them further using different combinations of different probes labeled with the same fluorophores to be read in separate channels. This can be further understood by the non-exhaustive scenarios tabulated in Table 3.
[00300] Table 3: Exemplary reaction formats in which various probe types, labeled with various fluorophores, e.g., F1, F2, or F3, are combined to develop highly multiplexed reactions, in which one or more Targets, e.g., T1, T2, T3, T4, T5, are measured by a single Fluorophore with fluorescence acquisition at various temperatures, e.g., Temp 1 and Temp 2. When the Petition 870250103739, dated 12 / 11 / 2025, pages 501 / 635 118 / 184 The relationship of the Tm of the components to each other and the acquisition temperature are defined in Tables 1 and 2. The detectable signal, measurable as Fluorescence (F) above the background, or signals that contribute only to the Background (B), can be measured as tabulated below. The total background signal at a given temperature can be the sum of the background contributed by a probe in the absence of the target, plus the background contributed by additional probes in the presence or absence of the target. Fluorophore Probes (Target detected) Temp 1 Temp 2 F1 M-Tec Probe (T1) LOCS Probe (T2) + T1 = F - T1 = B + / - T2 = B + / - T1 = B - T2 = B + T2 = F F2 Molecular Beacon (T3) LOCS Probe (T4) + T3 = F - T3 = B + / - T4 = B + / - T3 = B - T4 = B + T4 = F F3 Linear PlexZyme Probe (T5) + T5 = F - T5 = B + T5 = F - T5 = B
[00301] The scenarios described in Table 3 provide an exemplary strategy that would allow the detection, specific identification, and / or quantification of five targets present in a single reaction when fluorescence is acquired at two temperatures at three different wavelengths, specific to three fluorophores. At a first wavelength, specific to a first fluorophore, a first target can be monitored at a first acquisition temperature using an M-Tec probe specific to Target 1, and a second target can be monitored at a second acquisition temperature using a LOCS probe specific to Target 2. At a second wavelength, specific to a second fluorophore, a third target could be monitored at a first acquisition temperature using a Molecular Beacon specific to Target 3, and a fourth target could be monitored at a second acquisition temperature using a LOCS probe specific to Target 4. At a third... Petition 870250103739, dated 12 / 11 / 2025, pp. 502 / 635 119 / 184 wavelength, specific to a third fluorophore, a fifth target can be monitored at the first and / or second acquisition temperature using a Target 5-specific PlexZyme Linear Probe.
[00302] In all exemplary strategies described in Tables 1, 2 and 3, and in the discussion related to them, the M-tec Probe included in the mixture can be an M-Tec-P Probe or an M-Tec-H Probe or an M-Tec E Probe, since all types exhibit similar properties with respect to their components and ability to generate target-dependent fluorescence at a first acquisition temperature and only background at a second acquisition temperature, provided that Tm OC1 / OC2 is below the second acquisition temperature.
[00303] A strategy for combining an M-Tec-P probe with a LOCS probe to analyze two targets at a single wavelength can be further understood by the illustration in Figure 6. Figure 6 schematically illustrates an approach for multiplex analysis of two targets using the combination of an M-Tec-P probe (A) and a LOCS probe (B), both labeled with the same fluorophore (F) and suppressor (Q). The reaction mixtures contain an intact M-Tec-P probe (Ai) composed of first and second oligonucleotide components and an intact LOCS probe (Bi). In the presence of Target 1 (T1), PlexZyme 1 (P1) assembles and cleaves the sensor region on the intact M-Tec-P probe to generate a cleaved M-Tec-P probe (Ac). In the presence of Target 2 (T2), PlexZyme 2 (P2) assembles and cleaves the intact LOCS probe to generate a split (Bc) and cleaved LOCS probe.Figure 6 Panel (i) illustrates structures that can form at acquisition temperature 1, which is below the Tm OC1 / OC2 of intact and cleaved M-Tec-P probes, and below the Tm of the stem of split and intact LOCS probe species. Figure 6 Panel (ii) illustrates structures that can form at acquisition temperature 2, which is above the Tm OC1 / OC2 of intact and cleaved M-Tec-P probes, and above the Tm of the stem of the split LOCS probe, but below the Tm of the stem of the intact LOCS probe. At temperature 1, the fluorescence above the... Petition 870250103739, dated 12 / 11 / 2025, pp. 503 / 635 At temperature 120 / 184, background fluorescence would be generated in the presence of Target 1, but not in the absence of Target 1. At this temperature, the intact LOCS probe can be cleaved, but no background fluorescence would be generated from the resulting split LOCS probe, as the stem would remain hybridized and the fluorophore would remain suppressed. Therefore, an increase in detectable signal measured as background fluorescence at temperature 1 would indicate the presence of Target 1, and the background fluorescence would be the same regardless of the presence or absence of Target 2. At temperature 2, the first and second oligonucleotide components of the cleaved and intact M-Tec-P probe complexes would dissociate and contribute steadily to background fluorescence. At this temperature, the stem of the split LOCS probe, but not the intact LOCS probe, would dissociate, resulting in an increase in background fluorescence.Therefore, a detectable signal measured as an increase in fluorescence above the background at temperature 2 would indicate the presence of Target 2, and the background fluorescence would be the same regardless of the presence or absence of Target 1.
[00304] A strategy for combining an M-Tec-H probe with a LOCS probe to analyze two targets at a single wavelength can be further understood by the illustration in Figure 8. Figure 8 schematically illustrates an approach for multiplex analysis of two targets using the combination of an M-Tec-H probe (A), comprising a first and a second oligonucleotide component, and a LOCS probe (B), both labeled with the same fluorophore (F) and suppressor (Q). The reaction mixtures contain an intact M-Tec-H probe (Ai) and an intact LOCS probe (Bi). In the presence of Target 1 (T1), the 5'-3' exonuclease polymerase activity hydrolyzes the sensor region in the intact M-Tec-H probe to generate a modified M-Tec-H probe (Ab). In the presence of Target 2 (T2), a PlexZyme (P) assembles and cleaves the intact LOCS probe to generate a split (Bc) and cleaved LOCS probe.Panel (i) illustrates structures that can be formed at acquisition temperature 1, which is below the Tm OC1 / OC2 of intact and cleaved M-Tec-H complexes, and below the Tm of the stem. Petition 870250103739, dated 12 / 11 / 2025, pp. 504 / 635 121 / 184 Split and Intact LOCS Species. Panel (ii) illustrates structures that can be formed at acquisition temperature 2, which is above the Tm OC1 / OC2 of the intact and cleaved M-Tec-H complexes, and above the Tm of the Split LOCS stem, but below the Tm of the Intact LOCS stem. At temperature 1, above-background fluorescence would be generated in the presence of Target 1, but not in the absence of Target 1. At this temperature, the intact LOCS could be cleaved, but no above-background fluorescence would be generated from the resulting Split LOCS probes, as the stem would remain hybridized and the fluorophore would remain suppressed. Therefore, an increase in above-background fluorescence at temperature 1 would indicate the presence of Target 1, and background fluorescence would be the same regardless of the presence or absence of Target 2.At temperature 2, the first and second oligonucleotide components of the intact and cleaved M-Tec-H complexes would dissociate and contribute steadily to background fluorescence. At this temperature, the stem of the split LOCS, but not the intact LOCS probe, would dissociate, resulting in an increase in fluorescence above the background. Therefore, an increase in fluorescence above the background at temperature 2 would indicate the presence of Target 2, and the background fluorescence would be the same regardless of the presence or absence of Target 1.
[00305] Skilled individuals will recognize that M-Tec probes can detect the target directly or can detect target amplicons after target amplification using methods well known in the art. Additionally, skilled individuals will recognize that M-Tec probes can detect amplicons in real time or at the end of the reaction. By way of example, a melting curve analysis could be used at the end of an amplification reaction containing M-Tec probes to determine the presence or absence of the specific target and / or its amplicon. Intact M-Tec probes remain suppressed at low temperature but produce fluorescence when oligonucleotide components dissociate, for example, OC1 / OC2. At the melting temperature, where 50% of the M-Tec probes are dissociated, an observable peak would appear in the first derivative of the melting curve. Petition 870250103739, dated 12 / 11 / 2025, pages 505 / 635 122 / 184 Cleaved M-Tec probes can produce fluorescence below and above this melting temperature and therefore would not have an observable peak at this temperature in the first derivative of the melting curve. Therefore, the presence of the melting peak at Tm OC1 / OC2 would indicate the absence of the target, and the absence of the melting peak would indicate the presence of the target.
[00306] An M-Tec probe can be used in combination with one or more probes for single-channel multiplexing, which can be analyzed with melting curve analysis. Multiple M-Tec probes with different Tm OC1 / OC2 would produce differentiable melting peaks at each Tm OC1 / OC2 in the absence of each target in the first derivative of the melting curve, which would not be observable in the presence of each target (see, for example, Figure 20). Alternatively, an M-Tec probe can be used with other probes that produce signals in a temperature-dependent manner, as these probes produce melting peaks in the first derivative of the melting curve, which may appear only in the presence or absence of the target. For example, a LOCS probe may produce a peak at a specific low temperature in the presence of the specific target and at a specific higher temperature in the absence of the target.The analysis of peaks produced by intact or cleaved LOCs can be performed simultaneously with the analysis of peaks produced by M-Tec probes. Skilled individuals will recognize that any possible combination of probe types can be used when more than two probes are used for analysis by fluorescence channel or wavelength, if each probe used in the reaction produces peaks that are distinguishable in the melting curve analysis. - OLIGONUCLEOTIDES LOCs
[00307] The exemplary LOCS oligonucleotides for use in the present invention are illustrated in Figure 9. The exemplary intact LOCS oligonucleotide shown (Figure 9A, LHS) has a Loop region, a Stem region, and a fluorophore (F) / suppressor (Q) dye pair. Although exemplified with a fluorophore / suppressor pair, the technical recipient will recognize that any other detection fractions Petition 870250103739, dated 12 / 11 / 2025, pp. 506 / 635 123 / 184 appropriate can be used for the same purpose. The Loop region contains a substrate region that is susceptible to cleavage or enzymatic degradation in the presence of target or target amplicons. Cleavage or degradation of the Loop within an Intact LOCS generates the Split LOCS duplex (Figure 9B, RHS).
[00308] In some embodiments, the melting temperature (“Tm”) of the intact LOCS oligonucleotide is higher than the Tm of the split LOCS structure.
[00309] Because intramolecular bonds are stronger than intermolecular bonds, the stem regions of intact LOCS structures generally melt at a higher temperature than the stem regions of split, cleaved, or degraded LOCS oligonucleotide structures. For example, the stem of an intact LOCS A will melt at Tm A, which is higher than Tm B, which is the temperature at which the stem of a split LOCS melts (Figure 9B). The presence of fluorescence at a temperature that allows the melting of split LOCS but not intact LOCS is indicative of the presence of target or target amplicons. In the exemplary LOCS depicted in Figure 10, the sequence of the loop region of an oligonucleotide LOCS may be, for example, a substrate for a PlexZyme or other catalytic nucleic acid(s).
[00310] An exemplary LOCS suitable for use in the invention may contain a Loop region comprising a substrate for a catalytic nucleic acid, as illustrated in Figure 10. In these embodiments, the LOCS oligonucleotides may comprise universal substrates that can be used to detect any target. The LOCS oligonucleotide contains a stem region, a dye / fluorophore suppressor pair (alternative detection fractions, as described herein, may be employed), and an intervening Loop region comprising a universal substrate for a catalytic nucleic acid, such as a PlexZyme. The PlexZyme may detect a target directly or may be used to detect amplicons generated during target amplification. The PlexZyme is formed when the target sensor arms of the partzymes hybridize with a target, or with target amplicons, by complementary base pairing to form the Petition 870250103739, dated 12 / 11 / 2025, pp. 507 / 635 124 / 184 active catalytic core of PlexZyme. The Loop region of the LOCS oligonucleotide hybridizes with the substrate-binding arms of PlexZyme by complementary base pairing, and the substrate within the Loop is cleaved by PlexZyme. This generates a Split LOCS structure that has a stem with a TmB lower than the TmA of the Intact LOCS. The measurement of a fluorescence signal at temperatures above TmB but below TmA is indicative of the presence of the target in the reaction. Skilled individuals will recognize that targets can be detected in real time or at the end of the reaction.
[00311] Other mechanisms for degrading the loop region of intact LOCS probes are known in the art. Alternative designs for LOCS probes have loop regions that can bind directly to the target. These types of LOCS probes can be degraded by the exonuclease activity of a polymerase or by a restriction endonuclease. It is understood that the term “LOCS probe,” as used herein, encompasses all known LOCS probes, including those disclosed in PCT patent publications numbers WO 2020 / 031156 A1 and WO2020206509A1 (the content of each of these documents is incorporated herein by reference in its entirety). - ADDITIONAL EXEMPLARY MODALITIES
[00312] In certain embodiments, reporter oligonucleotides, including M-Tec probes of the present invention, can be used to detect a target directly without being coupled to a target amplification protocol. In other exemplary embodiments, reporter probes or substrates can be used to detect target amplicons generated by target amplification technologies, including, but not limited to, PCR, RT-PCR, SDA, NEAR, HDA, RPA, LAMP, RCA, TMA, 3SR, LCR, RAM, or NASBA. Cleavage or degradation of an M-Tec probe can occur in real time during target amplification or can be performed post-amplification, at the reaction endpoint. OC1 can be modified by target-dependent cleavage or degradation mediated by the enzymatic activity of an acid. Petition 870250103739, dated 12 / 11 / 2025, pp. 508 / 635 125 / 184 catalytic nucleic acid, including, but not limited to, a PlexZyme, an aptazyme, an apta-MNAzyme, a DNAzyme, a ribozyme, or by the enzymatic activity of a protein enzyme, including an exonuclease or an endonuclease. By way of non-limiting example, exonuclease activity may be an inherent catalytic activity of, for example, a polymerase. By way of non-limiting example, endonuclease activity may be an inherent catalytic activity of, for example, a restriction enzyme including a cleavage endonuclease, a riboendonuclease, or a duplex-specific nuclease (DSN).
[00313] The reactions of the present invention can detect multiple targets simultaneously using a single M-Tec-P probe or probes in combination with other types of reporter probes. As would be evident to those skilled in the art, standard reporter probes can be combined with additional M-Tec-P probes, for example, wherein each M-Tec-P probe can comprise a different universal substrate within its OC1.
[00314] The reaction mixture may additionally comprise additional reporter probes or substrates combined with M-Tec probes labeled with different fluorophore and suppressor pairs. As a non-limiting example, a Reporter 1 oligonucleotide and an M-Tec 2 probe may be labeled with fluorophore A, and a Reporter 3 oligonucleotide and an Intacta M-Tec 4 probe may be labeled with fluorophore B. The target-dependent fluorescence-associated Fluorophore A may be detected at multiple temperatures in Fluorescence Channel A, and the target-dependent fluorescence-associated Fluorophore B may be detected at multiple temperatures in Fluorescence Channel B in an instrument.The reaction mixture may further comprise at least one pair of reporter probes comprising a reporter probe or substrate and an M-Tec probe labeled with different fluorophores that emit fluorescence at a similar wavelength that can be monitored in a single fluorescence channel on an instrument.
[00315] In a further exemplary embodiment, an M-Tec Probe and a Petition 870250103739, dated 12 / 11 / 2025, pp. 509 / 635 126 / 184 oligonucleotide LOCs can be combined, where both contain the same fluorophore / dye suppressor pair and the substrate regions are specific to a DNA enzyme or ribozyme, for example, a DNA enzyme or ribozyme that can only be catalytically active in the presence of a specific metal ion. It is known in the art that specific DNA enzymes and ribozymes require a metal cation cofactor to enable catalytic activity. For example, some DNA enzymes and ribozymes can only be catalytically active in the presence of, for example, lead or mercury. Such metals may be present, for example, in an environmental sample. A reaction may include an M-Tec-P probe suitable for cleavage by a DNA enzyme that is, for example, mercury-dependent, where the presence of mercury in a sample may result in substrate cleavage at OC1 and the generation of a fluorescence signal.The same reaction may also include a LOCS reporter containing a loop comprising a substrate for a DNA enzyme, which is, for example, lead-dependent, where the presence of lead in a sample may result in the cleavage of the LOCS and the generation of a fluorescence signal at a temperature higher than the Tm of the split LOCS. An increase in fluorescence at a first temperature, which is below the Tm OC1 / OC2 and below the Tm of the split LOCS, would indicate the presence of mercury. An increase in fluorescence at a second temperature, which is above the Tm OC1 / OC2 and the Tm of the split LOCS, but below the Tm of the intact LOCS, would indicate the presence of lead. A person skilled in the art would readily recognize that multiple cleavable probes in the presence of specific metal cofactors could be combined in a single reaction and detected in real time or at the end of the reaction.
[00316] Non-limiting examples of target nucleic acids (i.e., polynucleotides) that can be detected using M-Tec probes in combination with other well-known probe types may include DNA, methylated DNA, alkylated DNA, complementary DNA (cDNA), RNA, methylated RNA, microRNA, siRNA, shRNA, mRNA, tRNA, snoRNA, stRNA, smRNA, pre- and pri-microRNA, and other RNAs. Petition 870250103739, dated 12 / 11 / 2025, pp. 510 / 635 127 / 184 non-coding, ribosomal RNA, derivatives thereof, amplicons thereof or any combination thereof (including mixed polymers of deoxyribonucleotides and ribonucleotides).
[00317] M-Tec-P probes can also be used to detect proteins or other molecules that can be recognized by aptamers incorporated into aptazymes or apta-MMAzymes. The catalytic activity of aptazymes or aptaMMAzymes can be inhibited in the absence of target molecules capable of binding to the aptamer domain of these nucleic acid enzymes. The binding of a molecule, for example, a protein, to the aptamer domain can activate the catalytic potential of an aptazyme or apta-MMAzyme, which can facilitate the cleavage of a first oligonucleotide component of an M-Tec-P probe. - GENERATION OF DETECTABLE SIGNALS
[00318] The methods and compositions of the present invention utilize detection fractions to provide detectable signals. The nature of the detectable signal that the fractions are capable of producing will depend on the type of detection fraction and / or the conformation of the oligonucleotide to which it is associated.
[00319] Any suitable detection fraction may be used, provided it is capable of providing a detectable signal by modifying an oligonucleotide to which it is associated. Non-limiting examples of suitable detection fractions include fluorophores for fluorescence signal generation, nanoparticles for colorimetric or SPR signal generation, reactive fractions (e.g., alkaline phosphatase or peroxidase enzymes) for chemiluminescent signal generation, electroactive species for electrochemical signal generation, and any combination thereof. By way of non-limiting example, suitable electroactive species include Methylene Blue, Toluene Blue, Oracet Blue, ferrocene, Hoechst 33258, [Ru(phen)3]2+ or Daunomycin, and the most common electrode materials include gold, glassy carbon, pencil graphite, or ionic carbon liquid.Methods for detecting and measuring fluorescence, chemiluminescent, colorimetric, and surface plasmon resonance (SPR) signals. Petition 870250103739, dated 12 / 11 / 2025, pp. 511 / 635 128 / 184 and electrochemicals are well known to technicians in the field.
[00320] As a non-limiting example, the oligonucleotides of the present invention, including M-Tec probes, may have one or more fluorophores attached. The detectable signal inherently generated by the fluorophore may be suppressed due to the proximity of one or more suppressor molecules. Fluorophores and suppressors are referred to in this document as detection fractions, but it should be understood that it is the fluorophore that emits a fluorescence signal when spatially separated from the suppressor. For example, and without limitation, the fluorophore(s) may be attached to a single strand of a double-stranded stem portion (e.g., at the 5' or 3' end) of a Molecular Beacon or a LOCS, and the suppressor(s) may be attached to an opposite strand of the double-stranded stem portion (e.g., at the 5' or 3' end).Alternatively, the suppressor(s) may be attached to another entity (e.g., a surface or another oligonucleotide) to which the oligonucleotide is bound, so that the detectable signal inherently generated by the fluorophore can be suppressed. In the presence of a target, the oligonucleotide may undergo a modification that distances the fluorophore(s) from the suppressor molecule(s), thus generating a detectable signal.
[00321] In addition, or alternatively, oligonucleotides (including OC1 or OC2) can be attached to gold nanoparticles (GNPs) for colorimetric detection. When GNPs are aggregated very close to each other, they exhibit a purple color (i.e., absorbance at a longer wavelength) and when GNPs are separated, they exhibit a red color (i.e., absorbance at a shorter wavelength), wherein a measurable color change from purple to red (e.g., M-Tec, LOCS, linear PlexZyme substrates, Catcher-Pitcher probes, TaqMan probes, and restriction enzyme probes) or, alternatively, from red to purple (e.g., dual hybridization probes) is indicative of the presence of a specific target in a sample.
[00322] Additionally, or alternatively, oligonucleotides (including OC1 Petition 870250103739, dated 12 / 11 / 2025, pp. 512 / 635 129 / 184 or OC2) and / or oligonucleotide components can be attached to a GNP and / or a gold surface for SPR detection of a target in a sample. When GNPs approach or, alternatively, move away from a gold surface, they can generate a measurable change in the SPR signal, where a decrease in the SPR signal using some approaches (e.g., MTec probes, LOCS, linear PlexZyme substrates, TaqMan probes, and restriction enzyme probes) may be indicative of the presence of a specific target in a sample, or, alternatively, where an increase in the SPR signal using other approaches (e.g., Catcher-Pusher probes and dual hybridization probes) may be indicative of the presence of a specific target in a sample.
[00323] Additionally, or alternatively, the oligonucleotide reporter and probes (including OC1 or OC2) and / or oligonucleotide components can be attached to electroactive species and / or to an electrode surface for electrochemical detection. When oligonucleotides bound to electroactive species approach or move away from an electrode surface, they can generate a measurable change in the oxidation or reduction current. In some embodiments (e.g., M-Tec probes, LOCS, linear PlexZyme substrates, TaqMan probes, and restriction enzyme probes), the measurable signal resulting from an electroactive species moving away from the electrode surface is indicative of the presence of a specific target in a sample.Alternatively, in other embodiments (e.g., Catcher-Thrower probes and dual hybridization probes), the resulting measurable signal from an electroactive species moving in close proximity to the electrode surface is indicative of the presence of a specific target in a sample.
[00324] Changes in color, SPR signals, or electrochemical signals, in the presence or absence of targets, can be manipulated by temperature in a manner similar to that described above for fluorescence detection.
[00325] In some embodiments, the compositions and methods of the present invention use M-Tec oligonucleotide components linked to a fraction of Petition 870250103739, dated 12 / 11 / 2025, pp. 513 / 635 130 / 184 specific detection in combination with another oligonucleotide probe that is linked to the same detection fraction, or a similar detection fraction that generates a detectable signal capable of being detected simultaneously with the signal generated by the M-Tec probe detection fraction (e.g., using a single detector type, such as a fluorescence channel, or a specific colorimetric, surface plasmon resonance (SPR), chemiluminescent, or electrochemical detection mode). - FLUORESCENCE SIGNAL ANALYSIS
[00326] Without limitation and by way of example only, the detection fractions used in accordance with the present invention include fluorescence signals generated by such detection fractions after modification, cleavage or digestion of oligonucleotide probes to which they are attached, coupled or otherwise associated, including dissociation or association of oligonucleotide components, or fragments of oligonucleotide components, of M-Tec complexes, which may be analyzed in any manner suitable for detecting, differentiating and / or quantifying target molecules in accordance with the methods of the present invention.
[00327] By way of non-limiting example, fluorescence signal measurements at a single temperature, or at multiple temperatures, may be obtained at various time points within a reaction suitable for detecting oligonucleotide modifications of the M-Tec probe. By way of non-limiting examples, these time points may comprise (i) a time point at or near the beginning of a reaction, and / or (ii) a single time point, or multiple time points, during the course of the reaction; and / or (iii) a time point at the conclusion or endpoint of the reaction.
[00328] In some embodiments, the fluorescence signal measurement can be obtained at two or more temperatures in each cycle during an amplification reaction, such as during PCR amplification. The analysis can be performed by comparing the fluorescence levels obtained at a first and / or second temperature and / or at an additional temperature. For example, a first target Petition 870250103739, dated 12 / 11 / 2025, pp. 514 / 635 131 / 184 can be detected using an M-Tec probe, where fluorescence signals can be measured at various time points or across multiple cycles, for example, at each cycle during PCR. In the same reaction, a second target can be detected using a LOCS probe, where fluorescence signals can be measured at various time points or across multiple cycles, for example, at each cycle during PCR. In such modalities, quantitative data can be determined for both the first and second targets. By way of non-limiting example, the first M-Tec probe can be cleaved by a first PlexZyme in the presence of a first target and monitored in real time, while a LOCS probe can be cleaved by a second PlexZyme in the presence of a second target and monitored in real time.
[00329] In several embodiments, the fluorescence signal measurement can be obtained at two temperatures in reactions that are adapted to measure two targets at the same wavelength.
[00330] In some embodiments, a first target can be detected using an M-Tec probe, where fluorescence signals can be measured at multiple time points or across multiple cycles, for example, at each cycle during PCR. In the same reaction, a second target can be detected using a LOCS by comparing pre-PCR and post-PCR fluorescence levels. In such embodiments, quantitative data can be determined for the first target, while qualitative data can be generated for the second target. By way of non-limiting example, the first M-Tec probe might comprise a PlexZyme substrate cleaved by a first PlexZyme in the presence of a first target and monitored in real time at a single first temperature, while a LOCS probe might be cleaved by a second PlexZyme in the presence of a second target and monitored using endpoint detection analysis at a second temperature.
[00331] In some embodiments, an increase in fluorescence at the first temperature is indicative of the presence of the first or second target, and an increase in fluorescence at the second temperature is indicative of the presence of the second target. In other embodiments, an increase in fluorescence at the first temperature is Petition 870250103739, dated 12 / 11 / 2025, pages 515 / 635 132 / 184 indicates the presence of the first target, and an increase in fluorescence at the second temperature indicates the presence of the second target. In other embodiments, the fluorescence signal measurement can be obtained at two or more temperatures in each cycle during PCR, and amplification curves can be plotted for each series of measurements obtained at each temperature. Threshold fluorescence values can be assigned to each amplification graph for each specific temperature, and Ct or Cq values can be measured as the number of cycles in which the amplification graphs cross the threshold values.
[00332] In embodiments where a first probe is an M-Tec probe for target 1 detection and a second probe is a PlexZyme Linear probe for target 2 detection; and where the fluorescence signal measurement is obtained at two temperatures at the same wavelength in each cycle during PCR, the total fluorescence signal of the M-Tec probe and the PlexZyme Linear substrate is measured at the lower temperature, which is below Tm OC1 / OC2, and the detectable signal measured at a higher temperature, which is above Tm OC1 / OC2, is only from the PlexZyme Linear substrate, the M-Tec probe signal can be calculated using the differential between the signal measured at the two temperatures, and the Cq value for target 1 can be determined subsequently; and the Cq value for target 2 can be determined from the signal measured at the higher temperature.
[00333] In other embodiments, fluorescence signal measurement can be obtained at two or more temperatures in each cycle during PCR, and amplification curves can be plotted for each series of measurements obtained at each temperature. Threshold fluorescence values can be assigned to each amplification graph for each specific temperature, and Cq values can be measured as the number of cycles in which the amplification graphs cross the threshold values. In embodiments where a first probe for detection of a first target is an M-Tec probe, combined with a second probe for detection of a second target, which may be a LOCS reporter; and where fluorescence signal measurement is obtained at two temperatures in each cycle Petition 870250103739, dated 12 / 11 / 2025, pp. 516 / 635 133 / 184 during PCR, the Cq measured using the fluorescence signal from the first probe at the lowest temperature, which is below the Tm OC1 / OC2 and below the Tm of a Split LOCS, can allow direct quantification of the initial concentration of a first target; and the Cq measured using the fluorescence signal from the reporter LOCS at the highest temperature, which is above the Tm OC1 / OC2 and above the Tm of the Split LOCS, but below the Tm of the Intact LOCS, can allow direct quantification of the initial concentration of a second target.
[00334] By way of a non-limiting example, the baseline fluorescence signal can be obtained by measuring fluorescence at selected temperatures, for example, a first and a second temperature, at a time that is at or near the beginning of a reaction, for example, pre-PCR. Before PCR and at a first temperature, a reporter probe, for example, an M-Tec Probe, a linear PlexZyme substrate or a TaqMan probe or a Molecular Beacon, and the Intact LOCS would be suppressed and would not produce a significant fluorescence signal, provided that this temperature was below the Tm OC1 / OC2 and the Tm of the Intact LOCS stem (and the Molecular Beacon, if present).The analysis can be performed by comparing the fluorescence levels obtained at the first and second temperatures at a time point at the beginning of a reaction (e.g., pre-PCR) and the fluorescence levels obtained at the first and second temperatures at a time point, or times, during and / or after the reaction (e.g., during PCR or post-PCR). Exemplary applications of M-TEC probes when combined with other reporters / probes. - TARGET DETECTION DURING OR AFTER TARGET AMPLIFICATION
[00335] The M-Tec probes of the present invention can be used to determine the presence of amplified target nucleic acid sequences. There are no specific limitations regarding the amplification techniques to which the M-Tec probes can be applied. The amplicons generated by various Petition 870250103739, dated 12 / 11 / 2025, pp. 517 / 635 134 / 184 reactions can be detected by M-Tec probes, provided that the presence of target amplicons can promote the cleavage or degradation of an intact M-Tec probe to produce modified M-Tec probes. Non-limiting examples of useful methods for cleaving or degrading the sensor region of the first oligonucleotide components of M-Tec probes include cleavage by PlexZymes, DNAzymes, aptazimes, Apta-MNAzymes, ribozymes, restriction enzymes, endonucleases, or degradation by exonucleases, including but not limited to the exonuclease activity of a polymerase.
[00336] In general, nucleic acid amplification techniques utilize enzymes (e.g., polymerases) to generate copies of a target nucleic acid that is specifically ligated by one or more oligonucleotide primers. Non-limiting examples of amplification techniques in which M-Tec probes can be used include one or more of the following: polymerase chain reaction (PCR), reverse transcription polymerase chain reaction (RTPCR), strand displacement amplification (SDA), helicase-dependent amplification (HDA), recombinant polymerase amplification (RPA), loop-mediated isothermal amplification (LAMP), rolling circle amplification (RCA), transcription-mediated amplification (TMA), self-sustaining sequence replication (3SR), nucleic acid sequence-based amplification (NASBA), ligase chain reaction (LCR), or branching amplification method (RAM).
[00337] The technical recipient in the subject matter will readily understand that the applications of the M-Tec probes described above are provided for non-limiting illustrative purposes only. The disclosed M-Tec probes can be used in any primer-based nucleic acid amplification technique and the invention is not limited to the embodiments specifically described. - DETECTION OF AMPLICONS GENERATED USING M-TEC PROBES
[00338] As discussed above, the M-Tec probes of the present invention can be used in any polynucleotide amplification technique, whose Petition 870250103739, dated 12 / 11 / 2025, pp. 518 / 635 135 / 184 non-limiting examples include PCR, RT-PCR, SDA, HDA, RPA, LAMP, RCA, TMA, RAM, LCR, 3SR or NASBA.
[00339] Amplicons generated by these techniques can be detected using M-Tec probes, which can be cleaved or degraded using any suitable method known in the art. Non-limiting examples include the use of catalytic nucleic acids, exonucleases, endonucleases, and the like.
[00340] A PlexZyme can be used to generate cleaved or modified M-Tec probes detecting amplicons generated by methods such as PCR, RT-PCR, SDA, HDA, RPA, TMA, LAMP, RCA, LCR, RAM, 3SR, and NASBA. A PlexZyme may comprise one or more partzyme(s). PlexZymes are multicomponent nucleic acid enzymes that are assembled and catalytically active only in the presence of an assembly facilitator, which may be, for example, a target to be detected, such as an amplicon generated from a polynucleotide sequence using primers. PlexZymes are composed of multiple partial enzymes, or partzymes, that self-assemble in the presence of one or more assembly facilitators and form active PlexZymes that catalytically modify substrates. The substrate and assembly facilitators (target) are separate nucleic acid molecules.Partzymes have multiple domains, including (i) sensor arms that bind to the assembly facilitator (such as a target nucleic acid); (ii) substrate arms that bind to the substrate; and (iii) partial catalytic core sequences that, after assembly, combine to provide a complete catalytic core. PlexZymes can be designed to recognize a wide range of assembly facilitators, including, for example, different target nucleic acid sequences. In response to the presence of the assembly facilitator, PlexZymes modify their substrates. This substrate modification can be linked to signal generation, and therefore PlexZymes can generate an enzymatically amplified output signal. The assembly facilitator can be a target nucleic acid present in a biological or environmental sample (e.g., an amplicon generated from a polynucleotide target using primers). In these cases, detection of... Petition 870250103739, dated 12 / 11 / 2025, pp. 519 / 635 136 / 184 Substrate modification by PlexZyme activity is indicative of the presence of the target. Several PlexZymes capable of cleaving nucleic acid substrates are known in the art. PlexZymes and modified forms thereof are known in the art and disclosed in PCT patent publications numbers WO / 2007 / 041774, WO / 2008 / 040095, WO2008 / 122084 and in related U.S. patent publications numbers 2007-0231810, 2010-0136536, and 20110143338 (the contents of each of these documents are incorporated herein by reference in their entirety). - USE OF M-TEC PROBES AS AN INTERNAL CALIBRATOR FOR MACHINE-TO-MACHINE OR WELL-TO-WELL VARIATION
[00341] An M-Tec probe can be used as an internal calibrator, since the fluorescence signal can be generated by heating the reaction above the probe's Tm OC1 / OC2, and the signal can be suppressed by lowering the reaction temperature below Tm OC1 / OC2, regardless of the presence of the target in the reaction. Therefore, if measurements were taken before target amplification, while the M-Tec probe remained intact, the difference between the measured values could function as a passive reference signal, which could be used for signal normalization to account for well-to-well variations.
[00342] A calibration method using an M-Tec probe would have several advantages over other approaches, including not requiring the use of additional reagents to be added to the reaction, nor the use of data obtained from other wells. This method would work to calibrate and correct well-to-well variations that may be present. Furthermore, the calibration would be processed using data acquired in the same channel and therefore would not be affected by any channel-to-channel variations that may be present in the instrument. When multiple channels are used for a multiplex reaction, each channel can be calibrated independently with respect to the M-Tec probe signal in each channel. This would be favorable in a scenario where signals are calibrated relative to signals in a different channel, such as a passive reference dye. Petition 870250103739, dated 12 / 11 / 2025, pp. 520 / 635 137 / 184 conventional or internal or endogenous control signals, as calibration is negatively affected if the expected signal strength ratio between channels differs significantly between instruments, causing channel-to-channel variations. - DIAGNOSTIC AND RELATED APPLICATIONS
[00343] Methods using M-Tec probes optionally in combination with LOCS oligonucleotides and / or other well-known reporter probes can be used for diagnostic and / or prognostic purposes according to the methods described herein. The diagnostic and / or prognostic methods can be performed ex vivo or in vitro. However, the methods of the present invention do not necessarily need to be used for diagnostic and / or prognostic purposes, and therefore, applications that are not diagnostic or prognostic are also contemplated. The methods and probes described herein can be used in the design and application of logic gates, biosensors and / or nanosensors (see, for example, Yin et al., (2020) VIEW 2(2); Xi et al., (2022) RSC Adv. 12, 27421-27430).
[00344] In some embodiments, the methods described in this document can be used to diagnose infection in an individual. For example, the methods can be used to diagnose infection by bacteria, viruses, fungi / yeasts, protists, and / or nematodes in the individual. In one embodiment, the virus may be an enterovirus. The individual may be a bovine, equine, ovine, primate, avian, or rodent species. For example, the individual may be a mammal, such as a human, a dog, a cat, a horse, a sheep, a goat, or a cow. The individual may be affected by a disease resulting from the infection. For example, the individual may have meningitis resulting from an enterovirus infection. Consequently, the methods of the present invention can, in certain embodiments, be used to diagnose meningitis.
[00345] In some examples, the present disclosure provides the use of a temperature-controlled multicomponent probe, as described herein, in the preparation of a composition or kit for use in a method of Petition 870250103739, dated 12 / 11 / 2025, pp. 521 / 635 138 / 184 detection of a target, such as a nucleic acid target. In some examples, this disclosure provides the use of a temperature-controlled multicomponent probe, as described herein, in the preparation of a composition or kit for use in a method of diagnosing an infection. In some examples, this disclosure provides the use of a temperature-controlled multicomponent probe to detect a nucleic acid target in the preparation of a composition or kit for diagnosing a disease.
[00346] The methods of the present invention can be performed on a sample. The sample can be derived from any source. For example, the sample can be obtained from an environmental source, an industrial source, or by chemical synthesis.
[00347] It will be understood that a “sample,” as contemplated herein, includes a sample that is modified from its original state, for example, by purification, dilution, or the addition of any other component or components.
[00348] The methods of the present invention, including but not limited to diagnostic and / or prognostic methods, can be performed on a biological sample. The biological sample can be taken from an individual. Stored biological samples can also be used. Non-limiting examples of suitable biological samples include whole blood or a component thereof (e.g., blood cells, plasma, serum), urine, cervicovaginal mucus, feces, saliva, lymph, bile fluid, sputum, tears, cerebrospinal fluid, bronchoalveolar lavage fluid, synovial fluid, semen, ascitic tumor fluid, breast milk, and pus. - KITS
[00349] The present invention provides kits comprising one or more agents for carrying out methods of the present invention. Typically, the kits for carrying out the methods of the present invention contain all the reagents necessary to carry out the method.
[00350] In some forms, the kits may include components of Petition 870250103739, dated 12 / 11 / 2025, pp. 522 / 635 139 / 184 oligonucleotides capable of forming one or more PlexZymes in the presence of appropriate assembly facilitator(s) (e.g., an amplicon as described herein) and / or one or more M-Tec probes. For example, the kit may comprise a first container comprising at least one first and one second oligonucleotide component of an M-Tec probe and a second container comprising one third and one fourth oligonucleotide component comprising partzymes, wherein the self-assembly of the third and one fourth partzymes into a PlexZyme requires the association of a first assembly facilitator (e.g., an amplicon) present in a test sample.Optionally, for example, the kit may comprise at least a fifth and sixth oligonucleotide components comprising a third and fourth partzyme, and a second container comprising a LOCS substrate, wherein the self-assembly of the third and fourth partzymes, and the LOCS substrate, into a LOCS PlexZyme complex requires the association of a second assembly facilitator (e.g., an amplicon) present in a test sample. Thus, in such an embodiment, the first and second partzymes and an oligonucleotide component for a substrate within the Loop region may be applied to the test sample to determine the presence of one or more target amplicons. In general, the kits comprise at least a first and a second oligonucleotide component for an M-Tec probe, provided in this document. In some examples, the kit comprises a first oligonucleotide component and a second oligonucleotide component of an M-Tec probe.The kit may comprise a first oligonucleotide component, a second oligonucleotide component, and a third oligonucleotide component of an M-Tec probe. In some examples, the kit comprises a first container comprising a first oligonucleotide component, a second oligonucleotide component, and optionally a third oligonucleotide of an M-Tec probe (e.g., an M-Tec-P probe), and a second container comprising oligonucleotides. Petition 870250103739, dated 12 / 11 / 2025, pp. 523 / 635 140 / 184 partzymes capable of self-assembly into a PlexZyme in the presence of a first assembly facilitator (e.g., an amplicon). In some examples, the kit comprises a first container comprising a first oligonucleotide component, a second oligonucleotide component, and optionally a third oligonucleotide component of an M-Tec probe (e.g., an M-Tec-H probe), and a second container comprising an exonuclease or a polymerase with exonuclease activity. In some examples, the kit comprises a first container comprising a first oligonucleotide component, a second oligonucleotide component, and optionally a third oligonucleotide component of an M-Tec probe (e.g., an M-Tec-E probe), and a second container comprising an endonuclease, such as a restriction enzyme or a cleavage endonuclease.
[00351] Typically, the kits of the present invention will also comprise other reagents, washing reagents, enzymes and / or other reagents, as needed in carrying out the methods of the invention, such as PCR or other nucleic acid amplification techniques.
[00352] Kits may be fragmented kits or combined kits, as defined in this document.
[00353] Fragmented kits comprise reagents that are stored in separate containers and may include small glass containers, plastic containers, or strips of plastic or paper. These containers can allow for the efficient transfer of reagents from one compartment to another, preventing cross-contamination of samples and reagents, and the quantitative addition of agents or solutions from one container to another.
[00354] These kits may also include a container that will accept the test sample, a container that holds the reagents used in the assay, containers that hold washing reagents, and containers that hold a detection reagent.
[00355] Combined kits encompass all the components of a reaction assay in a single container (e.g., in a single box that houses each Petition 870250103739, dated 12 / 11 / 2025, pp. 524 / 635 141 / 184 (one of the desired components).
[00356] A kit of the present invention may also include instructions for using the kit components to conduct the appropriate methods. The kits and methods of the invention may be used in conjunction with automated analytical equipment and systems, for example, including, but not limited to, real-time PCR machines.
[00357] For application in the amplification, detection, identification or quantification of different targets, a single kit of the invention may be applicable or, alternatively, different kits, for example, containing specific reagents for each target, may be required. The methods and kits of the present invention find application in any circumstance where it is desirable to detect, identify or quantify any entity.
[00358] Those skilled in the art will understand that numerous variations and / or modifications can be made to the present invention, as disclosed in the specific embodiments, without departing from the spirit or scope of the present invention, as fully described. The present embodiments should therefore be considered in all respects as illustrative and not restrictive. - EXAMPLES
[00359] The present invention will now be further described by reference to the following specific examples, which should not be interpreted as limiting the scope of the invention. - EXAMPLE 1: TARGET DETECTION USING AN MTEC-P PROBE THAT GENERATES A SIGNAL AT ONLY ONE TEMPERATURE.
[00360] The following example demonstrates how an M-Tec-P probe can be used to detect the presence of a target (Chlamydia trachomatis; CT) by monitoring increases in the fluorescence signal at a first temperature (52 °C). Fluorescence is generated in the presence, but not in the absence, of the target at the first temperature, while showing no change in signal at a second, higher temperature (76 °C), regardless of the presence or absence of the target. Petition 870250103739, dated 12 / 11 / 2025, pp. 525 / 635 142 / 184 - OLIGONUCLEOTIDES
[00361] The oligonucleotides for amplification and detection of Target 1 (CT) specific to this experiment include: Direct Primer 1 (SEQ ID: 1) Reverse Primer 1 (SEQ ID: 2), Partzyme A1 (SEQ ID: 3), Partzyme B1 (SEQ ID: 4), OC1 / 1Q1 (SEQ ID: 5), OC2 / 1-SUN (SEQ ID: 6). - REACTION CONDITIONS
[00362] Real-time qPCR detection of the target sequence was performed in a total reaction volume of 20 pl using a Bio-Rad® CFX96 thermocycler. Cycle parameters were 95 °C for 30 seconds, 50 cycles of 95 °C for 5 seconds, 52 °C for 40 seconds, 61 °C for 10 seconds, and 76 °C for 3 seconds. Fluorescence data were acquired in the HEX Channel at 52 °C and 76 °C in each PCR cycle. All reactions were performed in duplicate and contained 40 nM of Forward Primer 1, 200 nM of each Reverse Primer 1, Partzyme A1, Partzyme B1, OC1 / 1-Q1 and OC2 / 1-SUN, 1x NH4 buffer (Meridian Bioscience), 8 mM MgCl2 (Sigma-Aldrich), 800 pM dNTP mixture (Meridian Bioscience) and 2 U of AptaTaq exo DNA polymerase (Roche CustomBiotech).
[00363] The reactions contained either no target (NF H2O), or 10000, 400, or 10 copies of synthetic double-stranded DNA fragments (IDTs) that are homologous to the target gene (CT). All reactions, except the no-target control (NF H2O), contained a background of 35 ng of human genomic DNA (Promega). - RESULTS
[00364] During PCR amplification, fluorescence was measured at two temperatures in real time. The presence of the CT target was detected and monitored by the increase in fluorescence acquired at 52 °C. No change in the fluorescence signal was observed at 76 °C, regardless of the presence or absence of the target. The signal observed at 52 °C was generated by cleavage of the substrate sequence within OC1 by PlexZymes assembled in the presence of the CT target template. Cleavage resulted in the separation of the fluorophore and suppressor fractions in the presence, but not in the absence, of the target, as schematically illustrated in Figure 3 (i) Petition 870250103739, dated 12 / 11 / 2025, pp. 526 / 635 143 / 184 and (ii), respectively. The first temperature of 52 °C is below Tm OC1 / OC2 and therefore OC2 remains hybridized with the capture region of a first fragment of OC1 when the target is present (Figure 3 (i)), or an intact, uncleaved OC1 in the absence of a target (Figure 3 (ii)). No change in signal was observed at 76 °C because all reactions exhibit the same constant baseline fluorescence regardless of whether the target is present or absent, as schematically illustrated in Figure 3 (iii) and (iv), respectively. The background fluorescence at high temperature is contributed by the separation of OC1 and OC2 because 76 °C is above Tm OC1 / OC2.
[00365] Experimental results in Figure 11 show amplification curves in which fluorescence was acquired at 52 °C (LHS) and 76 °C (RHS) for reactions containing a CT-specific M-Tec-P probe and various copy numbers of the CT target or no target. At 52 °C there was an increase in fluorescence in the presence of CT (A, B, C; black solid line), while there was no increase in fluorescence in reactions that did not contain a target (D; gray solid line). The cycle limit (Ct) value has a linear relationship with the logarithm of the target copy number, as the average Ct value for 10000 (A), 400 (B) or 10 (C) copies were 22.51, 27.13 and 32.37, respectively. Data acquired at 76 °C showed no increase in fluorescence signal over 50 PCR cycles in the same reactions, regardless of the presence or absence of the target.
[00366] This example demonstrates that M-Tec-P probes allow the target-specific fluorescence signal to be detected at a designated temperature in real time. Additionally, it showed that the M-Tec-P probe can be completely “switched off” at higher temperatures, demonstrating the ability of this type of probe to control signal generation at various temperatures. The M-Tec probe demonstrated high sensitivity, detecting only 10 copies and maintaining a robust signal throughout the entire linear dynamic range. Petition 870250103739, dated 12 / 11 / 2025, pp. 527 / 635 144 / 184 EXAMPLE 2: COMPARATIVE PERFORMANCE OF AN M-TEC PROBE AND A MOLECULAR BEACON USING TAQ POLYMERASE WITH AND WITHOUT EXONUCLEASE ACTIVITY.
[00367] The following example compares the performance of an M-Tec-P probe and a Molecular Beacon, both designed to detect a target (Trichomonas vaginalis; TV) by monitoring fluorescence at a first temperature (52 °C) without showing an increase in signal at a second, higher temperature (76 °C), regardless of the presence or absence of the target. The probe performance is compared in reactions where different polymerases mediate the PCR. The two polymerases used in this example were AptaTaq DNA polymerase, which has 5'-3' exonuclease activity, and AptaTaq exo DNA polymerase, which does not have 5'-3' exonuclease activity. OLIGONUCLEOTIDES
[00368] The oligonucleotides in this experiment that are specific for amplification and detection of Trichomonas vaginalis (TV) include: Direct Primer 2 (SEQ ID: 7), Reverse Primer 2 (SEQ ID: 8), Partzyme A2 (SEQ ID: 9), Partzyme B2 (SEQ ID: 10), OC1 / 2-Q1 (SEQ ID: 11), OC2 / 2-FAM (SEQ ID: 12), Molecular Beacon 1 (SEQ ID: 13). REACTION CONDITIONS
[00369] Real-time amplification and detection were performed on a total reaction volume of 20 µl using a Bio-Rad® CFX96 thermocycler. The cycling parameters and fluorescent data acquisition (DA) points were: 1 cycle at 95 °C for 30 seconds, 50 cycles at 95 °C for 5 seconds, 52 °C for 40 seconds, 61 °C for 10 seconds, and 76 °C for 3 seconds. Fluorescence data were acquired in the FAM Channel at 52 °C and 76 °C in each PCR cycle. All reactions were performed in duplicate and contained 40 nM of Forward Primer 2, 200 nM of Reverse Primer 2, 1x NH4 buffer (Meridian Bioscience), 8 mM MgCl2 (SigmaAldrich), 800 pM dNTP mixture (Meridian Bioscience), and 2 units of AptaTaq DNA polymerase (Roche CustomBiotech) or 2 units of AptaTaq exo polymerase. Petition 870250103739, dated 12 / 11 / 2025, pages 528 / 635 145 / 184 DNA (Roche Custom Biotech). The Beacon Molecular reactions contained 200 nM of Beacon Molecular 1, while the M-Tec-P reactions contained 200 nM of Partzyme A2, Partzyme B2, OC1 / 2-Q1, and OC2 / 2-FAM.
[00370] The reactions contained no target (NF H2O) or 10000 or 100 copies of synthetic double-stranded DNA fragments (IDTs), which are homologous to the target gene (TV). All reactions, except the targetless control (NF H2O), contained a background of 35 ng of human genomic DNA (Promega). Ct values were determined using the single limit method with the limits for the amplification curves set at 75 RFU for 52 °C and 30 RFU for 76 °C in Bio-Rad® CFX Manager 3.1 software. RESULTS
[00371] During PCR amplification, fluorescence was acquired during each cycle in real time at two temperatures, 52 °C and 76 °C. Amplification plots for data acquired at 52 °C from reactions containing the exo AptaTaq DNA polymerase (Figure 12A) showed an increase in fluorescence above the background in the presence of the TV target ((i) 10000 and (ii) 100 copies), but not in the absence of the target (iii), using the M-Tec-P Probe (Figure 12A MT-52) and the Molecular Beacon (Figure 12A MB-52). Data acquired at 76 °C showed no increase in the fluorescence signal above the background for either probe, regardless of the presence or absence of the target (Figure 12A; MT-76 and MB-76) after baseline background fluorescence stabilization in the first cycles.
[00372] When amplification was facilitated by AptaTaq exo DNA polymerase, the M-Tec-P probe reactions showed faster Ct values than the Molecular Beacon in the presence of the target, as shown in Table 4 and Figure 12A MT / MB-52. The ΔCt between the M-Tec-P probe and the Molecular Beacon were 2.90 and 2.59 for 10,000 and 100 copies, respectively. The amplification curves of the M-Tec-P probe were associated with a faster increase in fluorescence than the Molecular Beacon, had a larger dynamic range, and stabilized completely. Petition 870250103739, dated 12 / 11 / 2025, pp. 529 / 635 146 / 184
[00373] Table 4: Ct values generated during PCR when the target was detected using an M-Tec-P probe and a Molecular Beacon using two polymerases. N / A equals No, Not Applicable (no Ct observed)._______________ Enzyme Probe Type TV Copies per Reaction Average Ct at 52 °C Average Ct at 76 °C AptaTaq exo DNA polymerase M-Tec-P probe 10000 24.14 N / A 100 29.20 N / A No target N / AN / A Molecular Beacon 10000 27.04 N / A 100 31.79 N / A No target N / AN / A AptaTaq DNA polymerase M-Tec-P probe 10000 24.27 N / A 100 28.94 N / A No target N / AN / A Molecular Beacon 10000 25.69 24.71 100 30.40 29.71 No target 45.22 45.71
[00374] Amplification plots for data acquired at 52 °C from reactions containing the AptaTaq DNA polymerase (Figure 12B) showed an increase in fluorescence above the background in the presence of the TV target (10000 (i) and 100 (ii) copies) using the M-Tec-P probe (Figure 12B MT-52) and the Molecular Beacon (Figure 12B MB-52). Additionally, as seen with the other polymerase, the M-Tec-P probe reactions produced faster Ct values than the Molecular Beacon in the presence of the target, as shown in Table 4 and Figure 12B (MT / MB-52). The ΔCt between the M-Tec-P probe and the Molecular Beacon were 1.42 and 1.46 for 10000 and 100 copies, respectively. The amplification curves of the M-Tec-P probe were steeper than those of the Molecular Beacon and stabilized completely. Petition 870250103739, dated 12 / 11 / 2025, pages 530 / 635 147 / 184 At 52 °C, in the absence of a target, no amplification was observed with the MTec-P probe; however, low-level fluorescence, generating a late Ct value, was observed in reactions containing the Molecular Beacon, indicating some non-specific signal. Data acquired at 76 °C showed no increase in the fluorescence signal above the background for the M-Tec-P probe, regardless of the presence or absence of the target (Figure 12B; MT-76) after baseline background fluorescence stabilization in the first cycles. In contrast, data acquired at 76 °C showed an increase in the fluorescence signal above the background for the Molecular Beacon in both the presence and absence of the target (Figure 12B; MT-76), indicating some non-specific signal. The Ct values for the target-specific signal were similar for the data acquired at 52 °C and 76 °C.This is undesirable and indicates that fluorescence is occurring, which can be attributed to the hydrolysis of Molecular Beacons by the 5'-3' exonuclease activity of the polymerase when the Molecular Beacon is bound to the target. Therefore, the conditions under which it is possible to completely turn off Molecular Beacons at elevated temperatures are restricted and will likely depend on several factors, including the properties of the selected polymerase and the melting temperatures of the Molecular Beacon Loop / target hybrids. While useful under specific conditions, Molecular Beacons have considerably more limitations than M-Tec-P probes for use in these protocols and are therefore inferior for this purpose. Additionally, the data from this experiment indicated that the M-Tec-P probe may be more efficient in detection, as evidenced by faster Ct values and steeper amplification curves.Finally, the data from this experiment also indicated that the M-Tec-P probe may be more specific than molecular beacons. EXAMPLE 3: REAL-TIME DETECTION AND QUANTIFICATION OF TWO TARGETS AT A SINGLE WAVELENGTH USING A COMBINATION OF AN M-TEC PROBE AND A LOCS PROBE.
[00375] The following example demonstrates how the combination of an M-Tec Probe Petition 870250103739, dated 12 / 11 / 2025, pp. 531 / 635 The 148 / 184 probe and a LOCS reporter can enable the simultaneous detection and quantification of two targets in a single fluorescence channel, acquiring fluorescence at two temperatures in real time during PCR. Both the M-Tec probe and the LOCS probe are labeled with the same fluorophore and suppressor fractions for simultaneous detection in the same fluorescence channel. Each probe is designed to produce a detectable signal at only one temperature, without any interference from the other temperature.
[00376] In this example, the same pair of probes, an M-Tec-P probe and a LOCS probe, were combined and used in two separate reactions, each to simultaneously detect two targets at two temperatures on the same wavelength during PCR.
[00377] The first reaction (Mixture 1) included (i) an M-Tec-P probe that was designed to be cleaved by a first PlexZyme in the presence of a first target Trichomonas vaginalis (TV) and to generate fluorescence above baseline only at a first temperature (52 °C), and (ii) a LOCS reporter that was designed to be cleaved by a second PlexZyme in the presence of a second target, the human TFRC gene in human genomic DNA (gDNA) and to generate fluorescence above baseline only at a second temperature (76 °C).
[00378] The second reaction (Mixture 2) included (i) an M-Tec-P probe that was designed to be cleaved by a first PlexZyme in the presence of a first target Neisseria gonorrhoeae (NG) and to generate above-baseline fluorescence at a first temperature (52 °C) only, and (ii) a LOCS reporter that was designed to be cleaved by a second PlexZyme in the presence of a second target Chlamydia trachomatis (CT) and to generate above-baseline fluorescence at a second temperature (76 °C) only. OLIGONUCLEOTIDES
[00379] The specific oligonucleotides for this experiment include: Direct Primer 1 (SEQ ID: 1), Reverse Primer 1 (SEQ ID: 2), Direct Primer 2 (SEQ ID: 7), Reverse Primer 2 (SEQ ID: 8), Partzyme A2 (SEQ ID: 9), Partzyme B2 (SEQ ID: 10), Petition 870250103739, dated 12 / 11 / 2025, pp. 532 / 635 149 / 184 OC1 / 2-Q1 (SEQ ID: 11), OC2 / 2-FAM (SEQ ID: 12), Direct Primer 3 (SEQ ID: 14), Reverse Primer 3 (SEQ ID: 15), Partzyme A3 (SEQ ID: 16), Partzyme B3 (SEQ ID: 17), Direct Primer 4 (SEQ ID: 18), Reverse Primer ID: 18 (SEQ ID: 19), Partzyme A4 (SEQ ID: 20), Partzyme B4 (SEQ ID: 21), Partzyme A5 (SEQ ID: 22), Partzyme B5 (SEQ ID: 23) and LOCS-1-FAM / Q1 (SEQ ID: 24). REACTION CONDITIONS
[00380] Real-time detection of the target sequence was performed in a total reaction volume of 20 pl using a Bio-Rad® CFX96 thermocycler. The cycle parameters were 95 °C for 30 seconds, 50 cycles of 95 °C for 5 seconds, 52 °C for 40 seconds, 61 °C for 10 seconds, and 76 °C for 3 seconds (data collected at the 52 °C and 76 °C steps). All reactions were performed in triplicate and contained 200 nM of OC1 / 2-Q1, OC2 / 2-FAM, and LOCS-1-FAM / Q1, 1x NH4 buffer (Meridian Bioscience), 8 mM MgCl2 (Sigma-Aldrich), 800 pM dNTP mixture (Meridian Bioscience), and 2 U of AptaTaq DNA polymerase (Roche CustomBiotech). Reactions in Mixture 1 contained 40 nM of Direct Primers 2 and 3, and 200 nM of each of Reverse Primers 2 and 3, Partzymes A2, B2, A3, and B3. Reactions in Mixture 2 contained 40 nM of Direct Primers 1 and 4, and 200 nM of each of Reverse Primers 1 and 4, Partzymes A4, B4, A5, and B5.
[00381] The reactions in Mixture 1 contained 10,000, 800, or 40 copies of synthetic double-stranded DNA (IDT) fragments homologous to the target gene for TV only; or 10,000, 800, or 40 copies of the TFRC gene present only in human genomic DNA (gDNA; Promega); or 10,000, 800, or 40 copies of the TV and TFRC gene in gDNA; or no target (NF H2O only). The reactions in Mixture 2 contained 10,000, 800, or 40 copies of synthetic double-stranded DNA (IDT) fragments homologous to the target gene for NG only, or CT only, or NG and CT; or no target (NF H2O only). RESULTS
[00382] During PCR, fluorescence was measured at two temperatures in real time (Figure 13; Table 5). In the Mixture 1 reaction, the presence of a first Petition 870250103739, dated 12 / 11 / 2025, pp. 533 / 635 The 150 / 184 target TV was detected at 52 °C only (Figure 13A), and the presence of a second target, the TFRC gene, was detected only at 76 °C (Figure 13B). In the Mixture 2 reaction, the presence of a first target NG was detected only at 52 °C (Figure 13C), and the presence of a second target CT was detected only at 76 °C (Figure 13D).
[00383] Table 5: Limit cycle values (Ct values) for reactions containing one or two targets with acquisition at 52 °C and 76 °C.__________________________________ 52 °C 76 °C Target 1 = T1 Target 2 = T2 Copy Number T1 T1 + T2 T2 T1 T1 + T2 T2 Mixture 1 T1 = TV T2 = TFRC 10000 22.23 22.38 0 0 23.82 23.68 800 26.75 26.54 0 0 27.31 27.75 40 30.57 30.93 0 0 31.65 31.52 0 0 0 0 0 0 0 Mixture 2 T1 = NG T2 = CT 10000 23.15 23.04 0 0 24.01 24.21 800 26.83 26.83 0 0 28.21 28.32 40 31.31 30.95 0 0 32.25 32.03 0 0 0 0 0 0 0
[00384] Figure 13A shows real-time amplification curves acquired at 52 °C in the FAM channel of the Bio-Rad® CFX96 Thermocycler with Mixture 1. There was an increase in fluorescence in reactions containing only TV (solid black line) and in those containing TV and TFRC / gDNA (dashed gray line), but not in reactions without any target (solid gray line) or that contained only gDNA (dashed black line). Figure 13B shows the amplification curves acquired at 76 °C in the same channel. At this temperature, there was an increase in fluorescence in reactions containing only TFRC / gDNA (dashed black line) and in those containing TV and TFRC / gDNA (dashed gray line), but not in reactions without any target (solid gray line) or that contained only TV (solid black line). The Ct values have a linear relationship with the logarithmic number of copies of Petition 870250103739, dated 12 / 11 / 2025, pp. 534 / 635 151 / 184 target at both temperatures.
[00385] The amplification plots show similar Ct values at 52 °C for TV only and for TV and TFRC / gDNA combined; and at 76 °C for TFRC / gDNA only and for TV and TFRC / gDNA combined (Figure 13A and B; Table 5). This confirms that the fluorescence observed at 52 °C is generated by the M-Tec-P probe only in the presence of TV and that the fluorescence observed at 76 °C is generated by the LOCS probe only in the presence of the TFRC gene present in the gDNA.
[00386] Similarly, Figures 13C show real-time amplification curves acquired at 52 °C in the FAM channel obtained using Mixture 2. There was an increase in fluorescence in reactions containing only NG (solid black line) and in those containing NG and CT (dashed gray line), but not in reactions without a target (solid gray line) or containing only CT (dashed black line). Figures 13D show the amplification curves acquired at 76 °C in the same channel. At this temperature, there was an increase in fluorescence in reactions containing only CT (dashed black line) and in those containing NG and CT (dashed gray line), but not in reactions without targets (solid gray line) or containing only NG (solid black line). Similar to the results of the first mixture, the Ct values have a linear relationship with the logarithmic number of copies of the target at both temperatures.
[00387] The amplification graphs show similar Ct values at 52 °C for NG only and for NG and CT combined; and at 76 °C for CT only and for CT and NG combined (Figure 13C and D; Table 5). This confirms that the fluorescence observed at 52 °C is generated by the M-Tec-P probe only in the presence of NG and that the fluorescence observed at 76 °C is generated by the LOCS probe only in the presence of CT.
[00388] This example demonstrates that combining the M-Tec-P Probe reporter and the LOCS reporter in a single reaction allows the target-specific fluorescence signal to be detected simultaneously at each designated temperature in real time. This example shows that co-amplification of another target being Petition 870250103739, dated 12 / 11 / 2025, pp. 535 / 635 The detection of 152 / 184 at the same wavelength did not affect the specific signal at either temperature. This indicates that t...
Claims
1. Method for determining the presence or absence of a target in a sample, the method characterized by comprising: (a) preparing a mixture for a reaction by contacting the sample or a derivative thereof purportedly comprising the target with: - a temperature-controlled multicomponent probe comprising a first oligonucleotide component and a second oligonucleotide component, wherein the first oligonucleotide component comprises a first capture region capable of hybridization with the second oligonucleotide component by complementary base pairing to form a first double-stranded portion, wherein the first oligonucleotide component further comprises a sensor region capable of serving as a substrate for an enzyme, wherein the first oligonucleotide component is connected to a first detection fraction and the second oligonucleotide component is connected to a second detection fraction;- an enzyme capable of modifying the sensing region of the first oligonucleotide component only when the target is present in the sample; (b) treating the mixture under suitable conditions so that the enzyme modifies the sensing region of the first oligonucleotide component to generate a first fragment comprising the first capture region and a second fragment connected to the first detection fraction, thus allowing the first and second detection fractions to spatially separate and generate a first detectable signal; (c) measuring a background signal level or detectable signal generated at a defined temperature at or below which the first capture region is hybridized with the second oligonucleotide component;and Petition 870250103739, dated 12 / 11 / 2025, page 569 / 635 2 / 40 (d) determine the presence or absence of the target based on the level of detectable signal measured at the defined temperature, where a detectable signal at the defined temperature is indicative of the presence of the target in the sample.; 2. Method according to claim 1, characterized in that the enzyme is able to digest the sensor region of the first oligonucleotide component only when the target is present in the sample, and wherein step (b) comprises treating the mixture under suitable conditions for the enzyme to digest the sensor region of the first oligonucleotide component in order to generate a first fragment comprising the first capture region and a second fragment connected to the first detection fraction.
3. Method according to claim 1 or 2, characterized in that the method comprises: (i) measuring a background signal level or detectable signal generated by the first and second detection fractions in the mixture at the defined temperature - at a time before or during said mixture treatment, and - at one or more subsequent time(s) during or after said mixture treatment; and (ii) determining the presence of or a change in the detectable signal level that differs from the background signal and is indicative of the presence of the target in the sample.
4. Method, according to claim 3, characterized in that step (c) comprises measuring the detectable signal and / or any said background signal: - at one or more time points prior to said treatment; - at one or more time points during said treatment; - at one or more time points after said treatment; - at one or more time points during said treatment and at one or more time points after said treatment; - at one or more time points before said treatment and at one or more time points after said treatment; or - at one or more time points before and during said treatment and at one or more time points after said treatment.
5. Method according to claim 3 or 4, characterized in that step (d) comprises using a predetermined threshold value to determine whether the detectable signal differs from any said background signal at the defined temperature.
6. Method according to claim 1 or 2, characterized by further comprising measuring a background control signal level generated at the defined temperature in a control mixture, and wherein step (c) comprises measuring a background or detectable signal level in the mixture in contact with the sample or derived therefrom, and wherein step (d) comprises determining whether a detectable signal that differs from the background control signal is generated and indicative of the presence of the target in the sample.
7. Method according to claim 1 or 2, characterized by further comprising: measuring a background control signal level generated at the defined temperature in a control mixture, and determining whether the background control signal level measured in the control mixture differs from the background signal level or detectable signal measured in the mixture in step (c), wherein a difference in the background signal level or detectable signal measured in the mixture in step (c) compared with the background control signal level measured in the control mixture is indicative of the presence of the target in the sample.
8. A method according to claim 6 or 7, characterized in that the control mixture does not comprise the target, but is otherwise equivalent to the mixture.
9. A method according to claim 6 or 7, characterized in that the control mixture does not comprise the enzyme, but is otherwise equivalent to the mixture.
10. Method according to claim 1 or 2, characterized by Petition 870250103739, dated 11 / 12 / 2025, page 571 / 635 4 / 40 further comprising: measuring a detectable control signal level generated at the defined temperature in a control mixture, wherein the control mixture comprises a predetermined quantity of the target, but is otherwise equivalent to the mixture; and determining whether the level of the detectable control signal measured in the control mixture differs from the level of the background signal or detectable signal measured in the mixture in step (c), wherein a difference in the level of the background signal or detectable signal measured in the mixture in step (c) compared with the level of the detectable control signal measured in the control mixture is indicative of the presence and / or quantity of the target in the sample.
11. A method, according to any one of claims 1 to 10, characterized in that the target is a nucleic acid and at least a portion of the sensor region hybridizes with a complementary sequence in the target to form, thereby, a duplex between the sensor region and the target.
12. Method according to claim 11, characterized in that the enzyme is an endonuclease that recognizes a sequence in the duplex.
13. Method according to claim 12, characterized in that the endonuclease digests at least one strand of the duplex to thereby form the first and second fragments.
14. Method according to claim 12, characterized in that the endonuclease is a cutting endonuclease that digests the sensor region of the first oligonucleotide component after duplex formation to thereby form the first and second fragments.
15. Method according to claim 11, characterized in that the enzyme is an exonuclease that hydrolyzes the sensor region of the first oligonucleotide component after duplex formation to thereby form the first and second fragments.
16. Method according to claim 15, characterized by the exonuclease being a polymerase with exonuclease activity.
17. A method according to claim 16, characterized in that: - the target being a nucleic acid; - at least a portion of the sensor region hybridizing with a complementary sequence on the target to thereby form a duplex between the sensor region and the target; - said mixture further comprising a target primer capable of binding to the target in a region upstream of said complementary sequence; - said treatment of the mixture comprising: hybridization of the target primer with the target by complementary base pairing; extending the primer using the polymerase with exonuclease activity; and using the nucleic acid target as a template, wherein the polymerase comprising exonuclease activity digests the sensor region of the first oligonucleotide component after duplex formation to thereby form the first and second fragments.
18. Method, according to any one of claims 1 to 10, characterized in that the enzyme is a DNA enzyme.
19. A method according to any one of claims 1 to 10, characterized in that the target is a nucleic acid and the sensing region of the first oligonucleotide component is not complementary to the target.
20. A method according to any one of claims 1 to 10 or 19, characterized in that the target is a nucleic acid and the enzyme is a multicomponent nucleic acid enzyme (MNAzyme) comprising two partzyme oligonucleotides capable of self-assembling to form the MNAzyme only in the presence of the target.
21. Method, according to claim 20, characterized in that said treatment comprises: hybridizing the sensor arms of the MNAzyme to the target by complementary base pairing, and hybridizing substrate arms of the MNAzyme with at least a portion of the sensor region of the first oligonucleotide component by complementary base pairing to facilitate the cleavage of the first oligonucleotide component and the generation of the first and second fragments.
22. A method according to any one of claims 1 to 21, characterized in that the target is a nucleic acid.
23. Method according to claim 22, characterized in that the target is an amplicon of a nucleic acid.
24. Method according to claim 23, characterized in that the amplicon is produced by an amplification reaction selected from the group consisting of polymerase chain reaction (PCR), strand displacement amplification (SDA), cleavage enzyme amplification reaction (NEAR), helicase-dependent amplification (HDA), recombinant polymerase amplification (RPA), loop-mediated isothermal amplification (LAMP), rolling circle amplification (RCA), transcription-mediated amplification (TMA), self-sustaining sequence replication (3SR), nucleic acid sequence-based amplification (NASBA), ligase chain reaction (LCR) or branching amplification method (RAM) and reverse transcription polymerase chain reaction (RT-PCR).
25. Method according to claim 24, characterized in that said detection: - occurs before said amplification or within 1, 2, 3, 4 or 5 cycles from the start of said amplification; and / or - occurs after the completion of said amplification.
26. Method, according to any one of claims 23 to 25, characterized in that the determination of the presence or absence of the target comprises an analysis of the melting curve.
27. Method, according to any one of claims 1 to 10, Petition 870250103739, dated 11 / 12 / 2025, page 574 / 635 7 / 40 characterized by: - the enzyme being a DNA enzyme or a ribozyme that requires a cofactor for catalytic activity, - said treatment of the mixture comprising the use of suitable conditions to: bind the cofactor to the DNA enzyme or ribozyme to make it catalytically active, hybridize the DNA enzyme or ribozyme to the first oligonucleotide component by complementary base pairing, catalytic activity of the DNA enzyme or ribozyme to digest the first oligonucleotide component and generate the first fragment and the second fragment, and - the target being the cofactor.
28. Method according to claim 27, characterized in that the cofactor is a metal ion, such as a metal ion selected from: Mg2+, Mn2+, Ca2+ and Pb2+.
29. A method according to any one of claims 1 to 10, characterized in that the enzyme is an aptazyme wherein: - the sensor region comprises a substrate for an aptazyme; - the target is an analyte, protein, peptide, compound or nucleic acid; - the mixture comprises an aptazyme comprising an aptamer capable of binding to the target; and - said treatment of the mixture further comprises binding the aptazyme to the target and the sensor region to facilitate the cleavage of the first oligonucleotide component to thereby generate the first fragment and the second fragment.
30. Method for determining the presence or absence of a target in a sample, the method characterized by comprising: (a) preparing a mixture for a reaction by contacting the sample or a derivative thereof purportedly comprising the target with: - a temperature-controlled multicomponent probe, which Petition 870250103739, dated 12 / 11 / 2025, p. 575 / 635 8 / 40 comprises a first oligonucleotide component and a second oligonucleotide component, wherein the first oligonucleotide component comprises a first capture region capable of hybridization with the second oligonucleotide component by complementary base pairing to form a first double-stranded portion, wherein the first oligonucleotide component further comprises a sensor region capable of serving as a substrate for an enzyme,wherein the first oligonucleotide component is connected to a first detection fraction and the second oligonucleotide component is connected to a second detection fraction; - an enzyme capable of modifying the sensing region of the first oligonucleotide component only when the target is present in the sample; (b) treating the mixture under suitable conditions so that the enzyme modifies the sensing region of the first oligonucleotide component to generate a first fragment comprising the first capture region and a second fragment connected to the first detection fraction, thus allowing the first and second detection fractions to spatially separate and generate a first detectable signal; (c) measuring a level of detectable signal generated at a plurality of temperatures.including temperatures below and above a temperature at which the first capture region hybridizes with the second oligonucleotide component; and (d) determine the presence or absence of the target based on the presence or absence of a detectable signal change generating a melting curve peak, where the absence of a melting curve peak is indicative of the presence of the target in the sample and the presence of a melting curve peak is indicative of the absence of the target in the sample. Petition 870250103739, dated 12 / 11 / 2025, pp. 576 / 635 9 / 40, 31. A method according to any one of claims 1 to 30, characterized in that the second oligonucleotide component is directly labeled with the second detection fraction.
32. Method, according to any one of claims 1 to 31, characterized in that the first fragment is not directly labeled with a detection fraction.
33. A method, according to any one of claims 1 to 32, characterized in that the second fragment is not directly labeled with the first detection fraction.
34. Method, according to any one of claims 1 to 33, characterized in that the first oligonucleotide component is not directly labeled with the first detection fraction.
35. A method according to any one of claims 1 to 34, characterized in that the first oligonucleotide component is connected to the first detection fraction by means of a third oligonucleotide component, wherein the first oligonucleotide component further comprises a second capture region capable of hybridization with the third oligonucleotide component by complementary base pairing to form a second double-stranded portion, and the third oligonucleotide component is directly labeled with the first detection fraction.
36. Method according to claim 35, characterized in that the first double-tape portion and the second double-tape portion of the temperature-controlled multicomponent probe have a melting temperature (Tm) that is above the defined temperature.
37. Method according to claim 35 or 36, characterized in that the Tm of the first double-strand portion is less than the Tm of the second double-strand portion. Petition 870250103739, dated 12 / 11 / 2025, p. 577 / 635 10 / 40 38. Method, according to claim 35 or 36, characterized in that the Tm of the second double-strand portion is less than the Tm of the first double-strand portion.
39. Method, according to any one of claims 1 to 31, characterized in that the first oligonucleotide component is directly labeled with the first detection fraction.
40. A method according to any one of claims 1 to 39, characterized in that the temperature-controlled multicomponent probe comprises no more than two detection fractions.
41. A method, according to any one of claims 1 to 40, characterized in that the first oligonucleotide component is not directly labeled with more than one detection fraction.
42. A method according to any one of claims 1 to 41, characterized in that the first oligonucleotide component is not connected to more than one detection fraction.
43. A method according to any one of claims 1 to 42, characterized in that the second oligonucleotide component is not directly labeled with more than one detection fraction.
44. A method according to any one of claims 1 to 43, characterized in that the second oligonucleotide component is not connected to more than one detection fraction.
45. A method according to any one of claims 1 to 44, characterized in that: the first detection fraction is a fluorophore and the second detection fraction is a suppressor; or the first detection fraction is a suppressor and the second detection fraction is a fluorophore.
46. Method, according to any one of claims 1 to 45, characterized by: Petition 870250103739, 12 / 11 / 2025, p. 578 / 635 11 / 40 the first detection fraction being a fluorophore and the second detection fraction being a suppressor; or the first detection fraction being a suppressor, and the second detection fraction being a fluorophore; and where the temperature-controlled multicomponent probe comprises no more than one suppressor.
47. A method according to any one of claims 1 to 46, characterized in that: the first detection fraction is a fluorophore and the second detection fraction is a suppressor; or the first detection fraction is a suppressor and the second detection fraction is a fluorophore; and wherein the detectable signal is the fluorescence emitted in the presence of the target.
48. A method according to any one of claims 1 to 47, characterized in that neither the first oligonucleotide component, nor the second oligonucleotide component, nor the third oligonucleotide component serves as a primer for a DNA polymerase in an extension reaction.
49. A method according to any one of claims 1 to 48, characterized in that neither the first oligonucleotide component, nor the second oligonucleotide component, nor the third oligonucleotide component serves as a template for a DNA polymerase in an extension reaction.
50. A method according to any one of claims 1 to 49, characterized in that neither the second oligonucleotide component nor the third oligonucleotide component is enzymatically cleaved or degraded.
51. A method, according to any one of claims 1 to 50, characterized in that the sensing region is located between the first capture region and the first detection fraction.
52. Method, according to any one of claims 1 to 51, characterized in that after said treatment of the mixture, the first fragment is capable of hybridizing with the second oligonucleotide component through the first capture region.
53. A method, according to any one of claims 1 to 52, characterized in that the biological sample is obtained from an individual.
54. A method, according to any one of claims 1 to 53, characterized in that the generation of the detectable signal at the defined temperature is not reversible.
55. Method, according to any one of claims 1 to 54, characterized in that the method is carried out in vitro.
56. Method, according to any one of claims 1 to 54, characterized in that the method is performed ex vivo.
57. Method for determining the presence or absence of a first target and a second target in a sample, the method characterized by comprising: (a) preparing a mixture for a reaction by contacting the sample or a derivative thereof purportedly comprising the first and / or second target with: - a temperature-controlled multicomponent probe for detection of the first target, the temperature-controlled multicomponent probe comprising a first oligonucleotide component and a second oligonucleotide component, wherein the first oligonucleotide component comprises a first capture region capable of hybridization with the second oligonucleotide component by complementary base pairing to form a first double-stranded portion, wherein the first oligonucleotide component further comprises a sensor region capable of serving as a substrate for an enzyme,wherein the first oligonucleotide component is connected to a first detection fraction and the second oligonucleotide component is connected to a second detection fraction, - a second nucleic acid probe for detection of the second target, the second nucleic acid probe comprising third and fourth detection fractions, wherein the first and second detection fractions are capable of generating a first detectable signal, and the third and fourth detection fractions are capable of generating a second detectable signal, and - a first enzyme capable of modifying the sensor region of the first oligonucleotide component only when the first target is present in the sample; (b) treat the mixture under suitable conditions to: - modify the sensor region of the first oligonucleotide component to, thus,(a) generate a first fragment comprising the first capture region and a second fragment connected to the first detection fraction, thus allowing the first and second detection fractions to spatially separate and generate a first detectable signal; - the second target to induce a modification of the second nucleic acid probe, thus allowing the third and fourth detection fractions to spatially separate and generate a second detectable signal; (c) measure a background or detectable signal level: - at a first temperature at or below which the first capture region is hybridized with the second oligonucleotide component, - at a second temperature equal to or greater than which the first capture region is not hybridized with the second oligonucleotide component,(d) determine whether at one or more time points during or after said treatment: - a first detectable signal is generated at or below the first capture region hybridized with the second oligonucleotide component, Petition 870250103739, 12 / 11 / 2025, p. 581 / 635 14 / 40 - a second detectable signal resulting from said modification of the second nucleic acid probe is generated at the second temperature, wherein the second detectable signal is indicative of the presence of the second target in the sample.
58. Method according to claim 57, characterized in that the first enzyme is able to digest the sensor region of the first oligonucleotide component only when the first target is present in the sample, and wherein step (b) comprises treating the mixture under suitable conditions for the first enzyme to digest the sensor region of the first oligonucleotide component in order to generate a first fragment comprising the first capture region and a second fragment connected to the first detection fraction.
59. Method, according to claim 57 or 58, characterized in that a first detectable signal at the first temperature is indicative of the presence of the first target in the sample.
60. Method, according to claim 59, characterized in that the presence of the first target is determined at the first temperature based on the first detectable signal generated at the first temperature.
61. A method, according to any one of claims 57 to 60, characterized in that the presence of the second target is determined at the second temperature based on the second detectable signal generated at the second temperature.
62. Method according to claim 57 or 58, characterized by: (i) at the first temperature - a first detectable signal being generated in the presence of the first target, - a second detectable signal being generated in the presence of the second target, or - a first detectable signal and a second detectable signal being generated in the presence of both the first and second targets; and (ii) a second detectable signal being generated at the second temperature only in the presence of the second target.
63. Method, according to claim 62, characterized in that the presence of the first target is determined by subtracting any second detectable signal detected at the second temperature from any first and / or second detectable signal detected at the first temperature.
64. Method, according to any one of claims 57 to 63, characterized in that the method comprises: - measuring a background signal level or detectable signal at the first and second temperatures generated by the first and second detection fractions and by the third and fourth detection fractions in the mixture, - determining the presence of, or a change in the level of, the first detectable signal that differs from the background signal and is indicative of the presence of the first target in the sample, and - determining the presence of, or a change in the level of, the second detectable signal resulting from said change generated at the second temperature that differs from the background signal and is indicative of the presence of the second target in the sample.
65. A method according to any one of claims 57 to 64, characterized in that, at the second temperature, the dissociation of the second oligonucleotide component from the capture region of the first oligonucleotide component present in the absence of the first target, or from the first fragment generated by modification of the first oligonucleotide component in the presence of the first target, generates an equal, similar or equivalent background signal.
66. Method, according to any one of claims 57 to 65, characterized in that said determination comprises the detection of the first detectable signal and / or any said background signal: - at one or more time points before said treatment; - at one or more time points during said treatment; - at one or more time points after said treatment; - at one or more time points during said treatment and at one or more time points after said treatment; - at one or more time points before said treatment and at one or more time points after said treatment; or Petition 870250103739, dated 12 / 11 / 2025, p. 583 / 635 16 / 40 - at one or more time points before and during said treatment and at one or more time points after said treatment.
67. Method according to any one of claims 57 to 66, characterized in that said determination in part (d) comprises: - using a predetermined limit value to determine whether the first detectable signal differs from any said background signal at the first temperature; and / or - using a predetermined limit value to determine whether the second detectable signal differs from any said background signal at the second temperature.
68. Method, according to any one of claims 57 to 63, characterized by comprising: measuring a level of the first background control signal at the first temperature provided by the first and second detection fractions and by the third and fourth detection fractions in a control mixture; measuring a level of the second background control signal at the second temperature provided by the first and second detection fractions and by the third and fourth detection fractions in the control mixture; determining whether a level of the first detectable signal generated at the first temperature in step (c) in the mixture in contact with or derived from the sample differs from the level of the first background control signal measured in the control mixture, wherein a difference in the level of the detectable signal measured in the mixture at the first temperature in step (c) compared with the first background control signal measured in the control mixture is indicative of the first target in the sample;and determine whether a level of the second detectable signal generated at the second temperature in step (c) in the mixture in contact with or derived from the sample differs from the level of the second background control signal measured in the control mixture, wherein a difference in the level of the detectable signal measured in the mixture at the second temperature in step (c) compared with the second background control signal measured in the control mixture is indicative of the second target in the sample.
69. Method according to claim 68, characterized in that the control mixture does not comprise: - the first target; - the second target; or - the first and second targets, but is otherwise equivalent to the mixture.
70. Method according to claim 68, characterized in that the control mixture does not comprise the first enzyme, but is otherwise equivalent to the mixture.
71. Method, according to any one of claims 57 to 63, characterized by further comprising: measuring a level of the first detectable control signal generated at the first temperature in a control mixture, wherein the control mixture comprises a predetermined quantity of the first target, the second target, or the first and second targets, but is otherwise equivalent to the mixture; measuring a level of the second detectable control signal generated at the second temperature in the control mixture; determining whether a level of the first detectable signal generated at the first temperature in step (c) in the mixture in contact with or derived from the sample differs from the level of the first detectable control signal measured in the control mixture, wherein a difference in the level of the detectable signal measured in the mixture at the first temperature in step (c) compared with the first detectable control signal measured in the control mixture is indicative of the first target in the sample;and determine whether a level of the second detectable signal generated at the second temperature in step (c) in the mixture in contact with or derived from the sample differs from the level of the second detectable control signal measured in the control mixture, wherein a difference in the level of the detectable signal measured in the mixture at the second temperature in step (c) compared with the second detectable control signal measured in the control mixture is indicative of the second target in the sample.
72. Method according to any one of claims 57 to 67, characterized in that part (c) comprises measuring a first background signal at or within 1 °C, 2 °C, 3 °C, 4 °C or 5 °C of the first temperature, and a second background signal at or within 1 °C, 2 °C, 3 °C, 4 °C or 5 °C of the second temperature.
73. Method according to claim 72, characterized in that part (d) comprises determining whether at one or more times during or after said treatment: a first detectable signal is generated at the first temperature which differs from the first background signal and is indicative of the presence of the first target in the sample; and a second detectable signal is generated at the second temperature which differs from the second background signal and is indicative of the presence of the second target in the sample.
74. Method, according to any one of claims 57 to 73, characterized in that at the first temperature the third and fourth detection fractions do not generate a signal that differs from the background signal.
75. Method, according to any one of claims 57 to 74, characterized in that at the second temperature the first and second detection fractions do not generate a signal that differs from the background signal.
76. A method according to any one of claims 57 to 75, characterized in that the first and second detectable signals are detectable by a single detector.
77. Method, according to any one of claims 57 to 76, characterized in that the first and second detectable signals are detectable in the same fluorescence channel.
78. Method, according to any one of claims 57 to 77, characterized in that the first and second detectable signals are detectable as fluorescent emission at a single wavelength.
79. Method, according to any one of claims 57 to 78, Petition 870250103739, dated 11 / 12 / 2025, p. 586 / 635 19 / 40 characterized in that the first and second detection fractions, and the third and fourth detection fractions emit a detectable signal at the same wavelength or at a similar wavelength, which can be detected in the same fluorescence channel.
80. Method, according to any one of claims 57 to 79, characterized in that the second oligonucleotide component is directly labeled with the second detection fraction.
81. Method, according to any one of claims 57 to 80, characterized in that the first fragment is not directly labeled with a detection fraction.
82. Method, according to any one of claims 57 to 81, characterized in that the second fragment is not directly marked with the first detection fraction.
83. Method, according to any one of claims 57 to 82, characterized in that the first oligonucleotide component is not directly labeled with the first detection fraction.
84. A method according to any one of claims 57 to 83, characterized in that the first oligonucleotide component is connected to the first detection fraction by means of a third oligonucleotide component, wherein the first oligonucleotide component further comprises a second capture region capable of hybridization with the third oligonucleotide component by complementary base pairing to form a second double-stranded portion, and the third oligonucleotide component is directly labeled with the first detection fraction.
85. Method according to claim 84, characterized in that the first double-tape portion and the second double-tape portion of the temperature-controlled multicomponent probe have a Tm that is above the first temperature.
86. Method according to claim 84 or 85, characterized in that the first double-tape portion and / or the second double-tape portion of the temperature-controlled multicomponent probe have a Tm that is below the second temperature.
87. Method, according to any one of claims 84 to 86, characterized in that the Tm of the first double-strand portion is less than the Tm of the second double-strand portion.
88. Method, according to any one of claims 84 to 86, characterized in that the Tm of the second double-strand portion is less than the Tm of the first double-strand portion.
89. Method, according to any one of claims 57 to 80, characterized in that the first oligonucleotide component is directly labeled with the first detection fraction.
90. Method, according to any one of claims 57 to 89, characterized in that the temperature-controlled multicomponent probe comprises no more than two detection fractions.
91. A method, according to any one of claims 57 to 90, characterized in that the first oligonucleotide component is not directly labeled with more than one detection fraction.
92. Method, according to any one of claims 57 to 91, characterized in that the first oligonucleotide component is not connected to more than one detection fraction.
93. Method, according to any one of claims 57 to 92, characterized in that the second oligonucleotide component is not directly labeled with more than one detection fraction.
94. Method, according to any one of claims 57 to 93, characterized in that the second oligonucleotide component is not connected to more than one detection fraction. Petition 870250103739, dated 12 / 11 / 2025, p. 588 / 635 21 / 40 95. Method according to any one of claims 57 to 94, characterized in that the second nucleic acid probe is directly labeled with the third and fourth detection fractions.
96. Method according to any one of claims 57 to 94, characterized in that the second nucleic acid probe is not directly labeled with the third and fourth detection fractions.
97. A method according to any one of claims 57 to 96, characterized in that: the first detection fraction is a fluorophore and the second detection fraction is a suppressor; or the first detection fraction is a suppressor and the second detection fraction is a fluorophore.
98. A method according to any one of claims 57 to 97, characterized in that: the first detection fraction is a fluorophore and the second detection fraction is a suppressor; or the first detection fraction is a suppressor and the second detection fraction is a fluorophore; and wherein the temperature-controlled multicomponent probe comprises no more than one suppressor.
99. A method according to any one of claims 57 to 98, characterized in that: the first detection fraction is a fluorophore and the second detection fraction is a suppressor; or the first detection fraction is a suppressor and the second detection fraction is a fluorophore; and wherein the first detectable signal is fluorescence emitted in the presence of the first target.
100. Method according to any one of claims 57 to 99, Petition 870250103739, dated 11 / 12 / 2025, p. 589 / 635 22 / 40 characterized in that neither the first oligonucleotide component, nor the second oligonucleotide component, nor the third oligonucleotide component serve as a primer for a DNA polymerase in an extension reaction.
101. A method according to any one of claims 57 to 100, characterized in that neither the first oligonucleotide component, nor the second oligonucleotide component, nor the third oligonucleotide component serves as a template for a DNA polymerase in an extension reaction.
102. A method according to any one of claims 57 to 101, characterized in that neither the second oligonucleotide component nor the third oligonucleotide component is enzymatically cleaved or degraded.
103. A method, according to any one of claims 57 to 102, characterized in that the sensing region is located between the first capture region and the first detection fraction.
104. Method, according to any one of claims 57 to 103, characterized in that after said treatment, the first fragment is able to hybridize with the second oligonucleotide component through the first capture region.
105. Method according to any one of claims 57 to 104, characterized in that: the third detection fraction is a fluorophore and the fourth detection fraction is a suppressor; or the third detection fraction is a suppressor, and the fourth detection fraction is a fluorophore.
106. A method according to any one of claims 57 to 105, characterized in that the first target is a nucleic acid and at least a portion of the sensor region hybridizes with a complementary sequence in the first target to form, thereby, a duplex between the sensor region and the first target.
107. Method according to claim 106, characterized in that the first enzyme is an endonuclease that recognizes a sequence in the duplex. Petition 870250103739, dated 12 / 11 / 2025, pp. 590 / 635 23 / 40 108. Method according to claim 107, characterized in that the endonuclease digests the duplex to form the first and second fragments.
109. Method according to claim 107, characterized in that the endonuclease is a cutting endonuclease that digests the sensor region of the first oligonucleotide component after duplex formation to thereby form the first and second fragments.
110. Method according to claim 106, characterized in that the first enzyme is an exonuclease that hydrolyzes the sensor region of the first oligonucleotide component after duplex formation to thereby form the first and second fragments.
111. Method according to claim 110, characterized in that the exonuclease is a polymerase with exonuclease activity.
112. Method according to claim 111, characterized in that: - the first target being a nucleic acid, - at least a portion of the sensor region hybridizing with a complementary sequence in the first target to thereby form a duplex between the sensor region and the first target, - said mixture further comprising a first target primer capable of binding to the first target in a region upstream of said complementary sequence, - said treatment of the mixture comprising: hybridizing the first target primer with the first target by complementary base pairing, extending the primer using the polymerase with exonuclease activity and using the first target as a template, wherein the polymerase comprising exonuclease activity digests the sensor region of the first oligonucleotide component after duplex formation.
113. Method, according to any one of claims 57 to 105, Petition 870250103739, dated 12 / 11 / 2025, p. 591 / 635 24 / 40, characterized in that the first enzyme is a DNA enzyme.
114. A method according to any one of claims 57 to 105, characterized in that the first target is a nucleic acid and the sensing region of the first oligonucleotide component is not complementary to the first target.
115. A method according to any one of claims 57 to 105 or 114, characterized in that the first target is a nucleic acid and the first enzyme is a first multicomponent nucleic acid target enzyme (MNAzyme) comprising two partzyme oligonucleotides capable of self-assembling to form the first MNAzyme target only in the presence of the first target.
116. Method according to claim 115, characterized in that said treatment comprises: hybridizing the sensor arms of the first target MNAzyme with the first target by complementary base pairing, and hybridizing the substrate arms of the first target MNAzyme with at least a portion of the sensor region of the first oligonucleotide component by complementary base pairing to facilitate the cleavage of the first oligonucleotide component and the generation of the first and second fragments.
117. Method, according to any one of claims 57 to 116, characterized by: - the second nucleic acid probe being a substrate for a second target multicomponent nucleic acid enzyme (MNAzyme), the second target MNAzyme comprising two partzyme oligonucleotides capable of self-assembling to form the second target MNAzyme only in the presence of the second target; - the mixture further comprising: the second target MNAzyme being capable of cleaving the second nucleic acid probe only when the second target is present in the sample; - said treatment further comprising: hybridizing the sensor arms of the second target MNAzyme with the second target by complementary base pairing, and Petition 870250103739, dated 12 / 11 / 2025, p.592 / 635 25 / 40 hybridize the substrate arms of the second target MNAzyme with the second nucleic acid probe by complementary base pairing to facilitate the cleavage of the second nucleic acid probe, thus providing said modification to the second nucleic acid probe and allowing the third and fourth detection fractions to spatially separate and generate the second detectable signal.
118. Method according to claim 117, characterized in that the second nucleic acid probe is a stem-loop oligonucleotide comprising a double-stranded stem portion of hybridized nucleotides, opposite strands of which are linked by an unbroken single-stranded loop portion of non-hybridized nucleotides, all or a portion of which is complementary to the substrate arms of the second target MNAzyme.
119. Method according to claim 118, characterized in that the stem-loop oligonucleotide is an intact stem-loop oligonucleotide and said modification comprises cleaving the loop portion and forming a split stem-loop oligonucleotide.
120. Method, according to any one of claims 57 to 116, characterized by: - the second target being a nucleic acid, - the second nucleic acid probe being a stem-loop oligonucleotide comprising a double-stranded stem portion of hybridized nucleotides, the opposite strands of which are linked by an uninterrupted single-stranded loop portion of unhybridized nucleotides, all or part of which is complementary to the second target, - the mixture further comprising a polymerase with exonuclease activity, - said treatment of the mixture comprising the use of suitable conditions for: hybridizing the second target with the single-stranded loop portion of the stem-loop oligonucleotide by complementary base pairing to form Petition 870250103739, dated 12 / 11 / 2025, p.593 / 635 26 / 40 a first double-stranded sequence comprising a portion of the second target, hybridize a primer with the second target to form a second double-stranded sequence located upstream relative to the first double-stranded sequence comprising the portion of the second target, extend the primer using the polymerase with exonuclease activity and using the second target as a template, wherein the polymerase comprising exonuclease activity digests the single-stranded loop portion of the first double-stranded sequence and thus forms a split-loop oligonucleotide.
121. A method according to any one of claims 57 to 116, characterized in that: - the second target is a nucleic acid, - the second nucleic acid probe is a stem-loop oligonucleotide comprising a double-stranded stem portion of hybridized nucleotides, the opposite strands of which are linked by an unbroken single-stranded loop portion of unhybridized nucleotides, all or a portion of which is complementary to the second target, - the mixture further comprises an endonuclease, and - said treatment of the mixture comprises the use of suitable conditions for: hybridization of the second target with the single-stranded loop portion of the stem-loop oligonucleotide by complementary base pairing to form a double-stranded sequence comprising a portion of the second target, association of the endonuclease with the double-stranded sequence comprising a portion of the second target,and the catalytic activity of the endonuclease allowing it to digest the single-stranded loop portion of the double-stranded sequence and thus form a split-stem loop oligonucleotide.
122. Method according to any one of claims 118 to 121, Petition 870250103739, 12 / 11 / 2025, p. 594 / 635 27 / 40 characterized by: - the stem portion of the intact stem-loop oligonucleotide having a melting temperature (Tm) that is above the Tm of the stem portion of the split stem-loop oligonucleotide; - the first temperature being below the Tm of both the stem portion of the intact stem-loop oligonucleotide and the stem portion of the split stem-loop oligonucleotide; - the second temperature being below the Tm of the intact stem portion of the stem-loop oligonucleotide and above the Tm of the stem portion of the split stem-loop oligonucleotide; and - the first temperature being below the second temperature.
123. Method, according to any one of claims 118 to 122, characterized in that the Tm of the stem portion of the split stem-loop oligonucleotide is above the first temperature.
124. Method, according to any one of claims 118 to 123, characterized in that the Tm of the stem portion of the intact and split stem-loop oligonucleotide(s) is greater than the Tm of the first double-stranded portion of the temperature-controlled multicomponent probe.
125. Method according to any one of claims 57 to 116, characterized in that: the second nucleic acid probe being a stem-loop oligonucleotide comprising a double-stranded stem portion of hybridized nucleotides, the opposite strands of which are linked by an uninterrupted single-stranded loop portion of non-hybridized nucleotides, all or a portion of which is complementary to the second target, and wherein the modification of the second nucleic acid probe is a conformational change resulting from the hybridization of the second target with the single-stranded loop portion by complementary base pairing that causes spatial separation of the third and fourth detection fractions. Petition 870250103739, dated 12 / 11 / 2025, p. 595 / 635 28 / 40 126. Method according to claim 125, characterized in that the conformational change is the dissociation of the opposing strands in the double-stranded stem portion of the second nucleic acid probe.
127. Method according to any one of claims 118 to 126, characterized in that the third and fourth detection fractions are connected to opposite strands of the double-stranded rod portion of the second nucleic acid probe.
128. A method according to any one of claims 57 to 116, characterized in that: - the second target being a nucleic acid, - the mixture further comprising: a primer complementary to a first sequence in the second target, a pitcher oligonucleotide comprising a region complementary to a second sequence in the second target that differs from the first sequence, and a tag portion that is not complementary to the second target, a first polymerase comprising exonuclease activity, and optionally, a second polymerase, and - said treatment of the mixture comprising: suitable conditions for hybridizing the primer and the pitcher oligonucleotide with the second target, extending the primer using the first or second polymerase and the second target as a template to thereby cleave the tag portion, hybridizing the cleaved tag portion with the second nucleic acid probe by complementary base pairing,and extend the tag portion using the polymerase and the second nucleic acid probe as a template to generate a double-stranded collector sequence comprising the second nucleic acid probe, thus providing said modification to the second nucleic acid probe and enabling the third and fourth detection fractions to provide the second detectable signal.
129. Method according to claim 128, characterized by: Petition 870250103739, dated 11 / 12 / 2025, p. 596 / 635 29 / 40 - the double-tape collector sequence having a Tm that is above the first temperature; and - the second temperature being below the Tm of the double-tape collector sequence.
130. Method, according to claim 128 or 129, characterized in that said extension of the tag portion spatially separates the third and fourth detection fractions in order to generate the second detectable signal.
131. A method according to any one of claims 57 to 116, characterized in that the second target is a nucleic acid and the second nucleic acid probe is a two-part probe comprising a first oligonucleotide part and a second oligonucleotide part, wherein: - the first oligonucleotide part is complementary to a first portion of the second target, - the second oligonucleotide part is complementary to a second portion of the second target, - the first and second portions of the second nucleic acid target flank each other but do not overlap, - said treatment of the mixture comprises: forming a duplex structure comprising: a first double-stranded portion by hybridizing the first oligonucleotide part with the second target by complementary base pairing, and a second double-stranded portion by hybridizing the second oligonucleotide part with the second target by complementary base pairing,By bringing the first and second oligonucleotide fractions closer together and providing the aforementioned modification to the second nucleic acid probe, the third and fourth detection fractions are then brought closer together and generate the second detectable signal.
132. Method according to claim 131, characterized in that the second detectable signal is a decrease in fluorescence. Petition 870250103739, dated 12 / 11 / 2025, pp. 597 / 635 30 / 40 133. Method according to claim 131, characterized in that the second detectable signal is an increase in fluorescence.
134. A method according to any one of claims 57 to 116, characterized in that: - the second target being a nucleic acid, - the second nucleic acid probe comprising a sequence complementary to the second target, - the mixture further comprising: a primer complementary to a portion of the second target, and a polymerase with exonuclease activity; - said treatment of the mixture comprising: hybridizing the primer with the second target by complementary base pairing, hybridizing the second nucleic acid probe with the second target by complementary base pairing, extending the primer using the polymerase and the second target as a template to thereby digest the second nucleic acid probe and provide said modification to the second nucleic acid probe, enabling the third and fourth detection fractions to spatially separate and generate the second detectable signal.
135. Method, according to any one of claims 57 to 116, characterized by: - the second target being a nucleic acid, - the mixture further comprising a restriction endonuclease capable of digesting a double-stranded duplex comprising the second target; and - said treatment of the mixture comprising: hybridizing the second nucleic acid probe with the second target by complementary base pairing to thereby form the double-stranded duplex, digesting the duplex using the restriction endonuclease to thereby provide said modification to the second nucleic acid probe and enabling the third and fourth detection fractions to spatially separate and manage the second detectable signal.
136. Method according to any one of claims 57 to 116, characterized by: - the second nucleic acid probe being a second temperature-controlled multicomponent probe comprising a first oligonucleotide component and a second oligonucleotide component, wherein the first oligonucleotide component of the second temperature-controlled multicomponent probe comprises a capture region capable of hybridizing with the second oligonucleotide component of the second temperature-controlled multicomponent probe by complementary base pairing to form a double-stranded portion, wherein the first oligonucleotide component of the second temperature-controlled multicomponent probe further comprises a sensor region capable of serving as a substrate for a second enzyme only when the second target is present in the sample,wherein the first oligonucleotide component of the second temperature-controlled multicomponent probe is connected to the third detection fraction and the second oligonucleotide component of the second temperature-controlled multicomponent probe is connected to the fourth detection fraction; the mixture further comprises the second enzyme; said treatment of the mixture comprises: suitable conditions for the second enzyme to digest the sensor region of the second temperature-controlled multicomponent probe to thereby generate a first fragment comprising the capture region and a second fragment connected to the third detection fraction, thereby allowing the third and fourth detection fractions to spatially separate and generate a second detectable signal.
137. Method according to claim 136, characterized by the first enzyme being the same as the second enzyme.
138. Method according to claim 136 or 137, characterized in that the double-tape portion or portions of the second temperature-controlled multicomponent probe have a Tm higher than the Tm of the first double-tape portion and / or the second double-tape portion of the first temperature-controlled multicomponent probe.
139. A method according to any one of claims 57 to 138, characterized in that: - the first target is a nucleic acid; - the second target is a nucleic acid; or - the first target is a nucleic acid and the second target is a nucleic acid.
140. Method according to claim 139, characterized in that the first target and / or the second target is an amplicon of a nucleic acid.
141. Method according to claim 140, characterized in that the amplicon is produced by an amplification reaction selected from the group consisting of polymerase chain reaction (PCR), strand displacement amplification (SDA), cleavage enzyme amplification reaction (NEAR), helicase-dependent amplification (HDA), recombinant polymerase amplification (RPA), loop-mediated isothermal amplification (LAMP), rolling circle amplification (RCA), transcription-mediated amplification (TMA), self-sustaining sequence replication (3SR), nucleic acid sequence-based amplification (NASBA), ligase chain reaction (LCR) or branching amplification method (RAM) and reverse transcription polymerase chain reaction (RT-PCR).
142. Method according to claim 141, characterized in that said determination: - occurs before said amplification or within 1, 2, 3, 4 or 5 cycles from the start of said amplification; and / or Petition 870250103739, dated 12 / 11 / 2025, p. 600 / 635 33 / 40 - occurs after the completion of said amplification.
143. Method, according to any one of claims 140 to 142, characterized in that the determination of the presence or absence of the first and second targets comprises an analysis of the melting curve.
144. A method according to any one of claims 57 to 116 or 136 to 143, characterized in that: - the mixture further comprises a DNA enzyme or a ribozyme that requires a cofactor for catalytic activity; - said treatment of the mixture comprises the use of suitable conditions for: binding the cofactor to the DNA enzyme or ribozyme to make it catalytically active, hybridization of the DNA enzyme or ribozyme with the second nucleic acid probe by complementary base pairing, and catalytic activity of the DNA enzyme or ribozyme to digest the second nucleic acid probe and thus provide said modification to the second nucleic acid probe, allowing the third and fourth detection fractions to spatially separate and generate the second detectable signal; and - the second target being the cofactor.
145. Method, according to any one of claims 57 to 106 or 117 to 144, characterized by: - the first enzyme being a DNA enzyme or a ribozyme that requires a cofactor for catalytic activity, - said treatment of the mixture comprising the use of suitable conditions for: binding the cofactor to the DNA enzyme or ribozyme to make it catalytically active, hybridization of the DNA enzyme or ribozyme to the first oligonucleotide component by complementary base pairing, Petition 870250103739, 12 / 11 / 2025, p. 601 / 635 34 / 40 catalytic activity of the DNA enzyme or ribozyme to digest the first oligonucleotide component and generate the first fragment and the second fragment, and - the first target being the cofactor.
146. Method according to claim 144 or 145, characterized in that the cofactor is a metal ion, such as a metal ion selected from: Mg2+, Mn2+, Ca2+ and Pb2+.
147. A method according to any one of claims 57 to 106 or 117 to 144, characterized in that the first enzyme is an aptazyme, wherein: - the sensor region comprises a substrate for an aptazyme; - the first target is an analyte, protein, peptide, compound or nucleic acid; - the mixture comprises an aptazyme comprising an aptamer capable of binding to the first target; and - said treatment of the mixture further comprises binding the aptazyme to the first target and to the sensor region to facilitate the cleavage of the first oligonucleotide component to thereby generate the first fragment and the second fragment.
148. Method, according to any one of claims 57 to 147, characterized in that the generation of the first detectable signal is not reversible at the first temperature.
149. Method for determining the presence or absence of a first target and a second target in a sample, the method characterized by comprising: (a) preparing a mixture for a reaction by contacting the sample or a derivative thereof purportedly comprising the first and / or second target with: - a temperature-controlled multicomponent probe for detection of the first target, the temperature-controlled multicomponent probe comprising a first oligonucleotide component and a second oligonucleotide component, wherein the first oligonucleotide component comprises a first capture region capable of hybridization with the second oligonucleotide component by complementary base pairing to form a first double-stranded portion, wherein the first oligonucleotide component further comprises a sensor region capable of serving as a substrate for an enzyme,(a) wherein the first oligonucleotide component is connected to a first detection fraction and the second oligonucleotide component is connected to a second detection fraction, - a second nucleic acid probe for detection of the second target, the second nucleic acid probe comprising third and fourth detection fractions, wherein the first and second detection fractions are capable of generating a first detectable signal, and the third and fourth detection fractions are capable of generating a second detectable signal, and - a first enzyme capable of modifying the sensor region of the first oligonucleotide component only when the first target is present in the sample; (b) treat the mixture under suitable conditions to: - the first enzyme to modify the sensor region of the first oligonucleotide component to thereby generate a first fragment comprising the first capture region and a second fragment connected to the first detection fraction,thus allowing the first and second detection fractions to spatially separate and generate a first detectable signal, - the second target to induce a modification of the second nucleic acid probe, thus allowing the third and fourth detection fractions to spatially separate and generate a second detectable signal; Petition 870250103739, 12 / 11 / 2025, p. 603 / 635 36 / 40 (c) measure a background or detectable signal level: - at a first temperature at or below which the first capture region is hybridized with the second oligonucleotide component, - at a second temperature at or below which the first capture region is hybridized with the second oligonucleotide component, (d) determine whether at one or more time points during or after said treatment: - a first detectable signal is generated at the second temperature at or below which the first capture region is hybridized with the second oligonucleotide component,- A second detectable signal resulting from the aforementioned modification of the second nucleic acid probe is generated at the first temperature, where the second detectable signal is indicative of the presence of the second target in the sample.
150. Method, according to any one of claims 57 to 149, characterized in that the first temperature is lower than the second temperature.
151. Method, according to any one of claims 57 to 150, characterized in that the first enzyme does not digest the first target and / or the second target.
152. A method according to any one of claims 57 to 151, characterized in that the first temperature differs from the second temperature by more than: 1 °C, 2 °C, 3 °C, 4 °C, 5 °C, 6 °C, 7 °C, 8 °C, 9 °C, 10 °C, 11 °C, 12 °C, 13 °C, 14 °C, 15 °C, 16 °C, 17 °C, 18 °C, 19 °C, 20 °C, 25 °C, 30 °C, 35 °C, 40 °C, 45 °C, 50 °C, 55 °C or 60 °C.
153. Method, according to any one of claims 57 to 152, characterized in that the biological sample is obtained from an individual.
154. Method, according to any one of claims 57 to 153, characterized in that the method is carried out in vitro.
155. Method, according to any one of claims 57 to 153, characterized in that the method is performed ex vivo.
156. Composition, characterized by comprising: Petition 870250103739, dated 12 / 11 / 2025, pp. 604 / 635 37 / 40 a temperature-controlled multicomponent probe comprising a first oligonucleotide component and a second oligonucleotide component, wherein the first oligonucleotide component comprises a first capture region capable of hybridization with the second oligonucleotide component by complementary base pairing to form a first double-stranded portion, wherein the first oligonucleotide component is connected to a first detection fraction and the second oligonucleotide component is connected to a second detection fraction, wherein: the first oligonucleotide component further comprises a sensor region capable of serving as a substrate for an enzyme, wherein digestion of the sensor region by the enzyme generates a first fragment and a second fragment,and wherein the first fragment comprises the first capture region, and the second fragment is connected to the first detection fraction; and wherein: the temperature-controlled multicomponent probe does not comprise more than two detection fractions; the first oligonucleotide component is not connected to more than one detection fraction; or the first fragment is not directly labeled with a detection fraction.
157. Composition according to claim 156, characterized in that the first oligonucleotide component is hybridized with the second oligonucleotide component by complementary base pairing in the first capture region.
158. Composition, according to claim 156 or 157, Petition 870250103739, dated 12 / 11 / 2025, pp. 605 / 635 38 / 40, characterized in that the second oligonucleotide component is not directly labeled with more than one detection fraction.
159. Composition, according to any one of claims 156 to 158, characterized in that the second oligonucleotide component is not connected to more than one detection fraction.
160. Composition, according to any one of claims 156 to 159, characterized in that the second oligonucleotide component is directly labeled with the second detection fraction.
161. Composition, according to any one of claims 156 to 160, characterized in that the second fragment is not directly labeled with the first detection fraction.
162. Composition, according to any one of claims 156 to 161, characterized in that the first oligonucleotide component is not directly labeled with the first detection fraction.
163. Composition according to claim 162, characterized in that the first oligonucleotide component is connected to the first detection fraction by means of a third oligonucleotide component, wherein the first oligonucleotide component further comprises a second capture region capable of hybridization with the third oligonucleotide component by complementary base pairing to form a second double-stranded portion, and the third oligonucleotide component is directly labeled with the first detection fraction.
164. Composition according to claim 163, characterized in that the first capture region differs in length or sequence from the second capture region.
165. Composition, according to any one of claims 156 to 160, characterized in that the first oligonucleotide component is directly labeled with the first detection fraction. Petition 870250103739, dated 12 / 11 / 2025, pp. 606 / 635 39 / 40 166. Composition according to any one of claims 156 to 165, characterized in that: the first detection fraction is a fluorophore and the second detection fraction is a suppressor; or the first detection fraction is a suppressor and the second detection fraction is a fluorophore.
167. Composition, according to any one of claims 156 to 166, characterized in that: the first detection fraction is a fluorophore and the second detection fraction is a suppressor; or the first detection fraction is a suppressor, and the second detection fraction is a fluorophore; and wherein the temperature-controlled multicomponent probe comprises no more than one suppressor.
168. Composition, according to any one of claims 156 to 167, characterized in that the sensing region is located between the first capture region and the first detection fraction.
169. Composition, according to any one of claims 156 to 168, characterized in that after digestion of the sensor region, the first fragment is able to hybridize with the second oligonucleotide component through the first capture region.
170. Composition, according to any one of claims 156 to 169, characterized by further comprising a multicomponent nucleic acid enzyme (MNAzyme) comprising two partzyme oligonucleotides, each partzyme oligonucleotide having a substrate arm capable of hybridizing with at least one portion of the sensor region of the first oligonucleotide component.
171. Composition according to claim 170, characterized in that the substrate arms of the two partzyme oligonucleotides are hybridized with the sensor region of the first oligonucleotide component. Petition 870250103739, dated 12 / 11 / 2025, pp. 607 / 635 40 / 40 172. Composition, according to any one of claims 156 to 171, characterized by further comprising a DNA enzyme capable of cleaving the sensor region of the first oligonucleotide component only in the presence of a target.
173. Composition, according to any one of claims 156 to 172, characterized by further comprising an aptazyme capable of cleaving the sensor region of the first oligonucleotide component only in the presence of a target.
174. Composition, according to any one of claims 156 to 173, characterized by further comprising a restriction endonuclease capable of cleaving the sensor region of the first oligonucleotide component only in the presence of a nucleic acid target.
175. Composition, according to any one of claims 156 to 174, characterized by further comprising an exonuclease capable of digesting the sensor region of the first oligonucleotide component only in the presence of a nucleic acid target.
176. Composition according to claim 175, characterized in that the exonuclease is a polymerase with exonuclease activity.
